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ABSTRACT 
 
Tuberculosis (TB) is the deadliest disease caused by a single organism, killing 1.7 million 
people in 2016. TB is especially deadly in immuno-compromised populations, including HIV-
positive patients and children. In 2014, HIV-associated TB was responsible for roughly one-third 
of all deaths associated with HIV/AIDS, and TB was one of the top ten causes of death in 
children. Additionally, drug resistant strains of the causative agent, Mycobacterium tuberculosis 
(Mtb), have emerged, and those infected with these strains have an elevated mortality rate. There 
is a need for a rapid testing of new treatment regimens in pre-clinical studies, and a need for a 
sensitive, rapid diagnostic tool for childhood TB. 
In vivo optical detection of Mtb has previously been used to study disease pathogenesis in 
small animal models. However, whole-animal imaging suffers from a high detection threshold 
and high-intensity tissue autofluorescence (TAF) background signal. Intravital illumination of 
the lung has significantly reduced this detection threshold and is a potential tool for longitudinal 
studies of therapeutic efficacy. However, the system is not robust enough to provide reproducible 
results at low bacterial doses, and its current detection threshold is 1-2 orders of magnitude 
higher than the infectious dose of Mtb. We have developed an optical model of the mouse torso 
and Mtb infection to understand the physiological limitations imposed on the optical system and 
the sensitivity of the system to experimental variability. The optical model is validated with 
multiple iterations of phantoms to assess the capability of the model to simulate radiative 
transport in three-dimensional complex structures, porous and multi-layered materials, and 
fluorescent materials. We explore the efficacy of different illumination methods and show the 
system sensitivity to manipulations of the intravital source. The optical model also shows that the 
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tissue-limited detection threshold of the system is between 10 and 100 colony forming units, and 
that TAF will further increase this detection threshold if the TAF cannot be spectrally separated 
from bacteria fluorescence. The fluorescence model is extrapolated to a human child, showing 
the potential to detect a manifestation of childhood TB known as miliary TB. Finally, we 
simulate and test an external mirror device to enhance luminescence collection in a mouse model 
of infection. The validated fluorescence model of infection is shown to accurately replicate 
previous pre-clinical experiments and accurately predicts the signal enhancements provided by 
external mirror devices. The extrapolation of the model to the torso of a human child is expected 
to be a valid preliminary estimate of the performance of the optical system as a clinical 
diagnostic of TB in children.  
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MC Monte Carlo 
MCML multi-layer Monte Carlo 
MDR-TB multi-drug resistant tuberculosis 
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VC vital capacity 
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WHO World Health Organization 
XDR-TB extremely drug resistant tuberculosis 
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1. INTRODUCTION AND MOTIVATION 
 
1.1 Tuberculosis: Disease burden and pathogenesis 
Tuberculosis (TB) is a deadly disease resulting from infection with the pathogen 
Mycobacterium tuberculosis (Mtb). TB recently surpassed HIV as the deadliest disease caused 
by a single infectious agent, killing more than 1.8 million people in 20161. TB is also one of the 
leading killers of HIV-positive individuals, and is responsible for roughly one third of deaths 
associated with HIV/AIDS2. Additionally, TB is one of the top ten causes of death in children 
worldwide. Disease rates are highest in low-resource areas and developing countries, with 94% 
of cases and 98% of deaths coming from these areas1. The TB epidemic is a multi-faceted world 
health problem, and addressing it effectively requires an in-depth understanding of the disease 
pathogenesis and shortcomings of the current diagnostic and treatment methods.  
Mtb is a slow-growing pulmonary pathogen with a complex, multi-stage pathogenesis that is 
still not fully agreed upon by experts in the field3. Although TB is primarily a result of a 
pulmonary infection with Mtb, extrapulmonary infections are not uncommon4, 5. It is estimated 
that up to one third of the world population is infected with Mtb; however, only 10-15% of those 
infected ever develop symptoms of the disease TB6. During this asymptomatic infection, known 
as latent TB infection (LTBI), it is assumed that Mtb remains viable, but dormant within the host 
until the immune system becomes compromised7. Once the latent infection progresses to the 
active disease, the bacteria becomes transmittable. The most identifiable symptom of TB is a 
harsh cough, which is also the mode of transmission. A sick individual will cough and expel 
droplet nuclei, which are small, aerosolized particles containing 1-10 bacilli8. These small 
particles remain aerosolized, and the bacteria inside remain viable for several hours. Therefore, 
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direct contact with a sick individual is not necessary for disease transmission, rather a prolonged 
shared airspace 9. After falling ill, it is estimated that a person will infect up to 20 others before 
successful diagnosis and treatment10. 
1.1.1 Geographical disease burden 
TB predominantly affects low-resource areas, with upwards of 95% of TB-related deaths 
coming from developing countries. While high-population countries like India and China have 
the largest number of cases (roughly 23% and 10% of total cases, respectively), sub-Saharan 
Africa has the highest disease burden, with nearly 300 incident cases per 100,000 individuals10. 
Access to healthcare is a limiting factor in many of these areas, and TB requires many visits to 
the doctor or clinic. A lack of advanced microscopy centers and labs means that a positive 
diagnosis requires a secondary appointment, and therefore a delay in treatment. While recent 
developments such as the Xpert MTB/RIF assay have alleviated some of these issues 11, 12, the 
strict antibiotic regimens are difficult for patients to adhere to, which contributes to the 
emergence of drug-resistant strains of Mtb.  
1.1.2 Drug resistance 
In addition to a complex disease progression and a low infectious dose, multiple drug-
resistant strains of Mtb have emerged. This is due in most part to a lapse in patient compliance 
with the strict antibiotic regimens that are necessary for treatment 13. Up to 20% of previously 
treated TB cases and 3.5% of new cases have been identified as resistant to Rifampin (RIF) and 
Isoniazid (INH), the two most common frontline antibiotics for TB. This form of drug resistance, 
known as multidrug-resistant TB (MDR-TB), accounts for 4.1% of new cases and 19% of 
previously treated cases of TB 1. Additionally, nearly 10% of these MDR-TB cases are also 
extensively drug-resistant TB (XDR-TB). In addition to RIF and INH resistance, the strains of 
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Mtb responsible for XDR-TB are also resistant to fluoroquinolones, and at least one other 
second-tier antibiotic TB treatment 14. Strains of totally drug resistant Mtb have even reportedly 
been found in India 15. As Mtb continues to evolve to resist current treatments, the demand for 
new, highly effective treatments and early and effective diagnostic methods also increases.  
1.1.3 Vaccine efficacy 
Vaccine efficacy is also a factor contributing to the spread of TB. The most widely used TB 
vaccine is the bovine strain of Mtb, bacille Calmette-Guérin (BCG), a strain with attenuated 
virulence in humans with sufficient antigen presentation to build an acquired immune response 
to Mtb antigens. In many populations, the BCG vaccine is up to 80% effective. However, in 
some populations, the vaccine shows little to no efficacy 16, 17. Unfortunately, the 
underperformance of the vaccine coincides with high burden areas, compounding the difficulties 
in addressing the epidemic 18. Without rapid development methods of new vaccines, preventative 
treatment for TB will remain ineffective.  
1.1.4 Bacterial pathogenesis 
As previously mentioned, the most common form of transmission of Mtb is through shared 
airspace 8. The infectious dose of bacteria is expected to be as low as 1-10 colony forming units 
(CFU) 19. Upon preliminary infection, a disease stage with flu-like symptoms, the host immune 
system recognizes the bacteria as a foreign body. Resident macrophages in the lung parenchyma 
(alveolar macrophages) then internalize the bacteria and attempt to lyse the cell 18. However, Mtb 
has evolved to be resistant to this phagocytic process, and multiplies within the phagosome. The 
infected macrophage will rupture, releasing the multiplied bacteria into the lung. Mtb will also 
survive within foamy macrophages without rupturing the cell 20, 21. This process also recruits 
more macrophages to the site of infection, and the host immune systems attempts to kill the 
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bacteria. Eventually, the immune system of a non-immunocompromised host will wall off the 
bacteria, infected macrophages, and dead immune cells into a calcified granuloma.  
This concludes the preliminary infection, and many people never experience a relapse. It is 
unknown whether the bacteria is actually eradicated in these people, or if they live healthily with 
a latent TB infection (LTBI) encased in these granulomas 6, 22-24. In this LTBI stage, the bacteria 
slip into a slow-metabolic state, and become very difficult to detect. Unfortunately, in 10-15% of 
LTBI cases, the host immune system becomes compromised and fewer lymphocytes are 
available to maintain a stable granuloma; granulomas become unstable and rupture, releasing 
live, active bacteria and necrotic tissue into the lung 20, 25. This stage of disease is the 
symptomatic active stage of TB, with ~70% of untreated cases leading to death 26. The immune 
system attempts to fight this secondary infection as it did in the preliminary infection, but is 
usually unable to kill or encase the bacteria 27-29. The patient will essentially drown from the 
build-up of liquid, necrotic tissue, and dead immune cells that slowly fill the lungs.  
1.2 Current diagnostic methods: strengths and weaknesses 
One of the factors contributing to the severity of the TB epidemic is the inefficiency of 
diagnosing the disease. The current gold standard for diagnosing active TB is sputum culture, but 
this is a multi-step process (Figure 1), with each step having its own limitations. In general, a 
patient will start with a consultation with a clinician. If the patient is suspected of having an 
infection, even if they show no signs of active disease, the next step is to test the acquired 
immune system for a response to Mtb antigens. This will be done with either the tuberculin skin 
test (TST) or the interferon-gamma release assay (IGRA) blood test 30. These methods both have 
poor sensitivity and specificity in certain populations, on top of general limitations in low 
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resource settings (Table 1). Given a positive response to this test, the patient will receive a chest 
x-ray to search for granulomas characteristic of TB within the lung 31, 32.  
 
 
Figure 1. Flowchart of the general diagnostic process used to gain a confident diagnosis of TB. 
Each step has its own time scale ranging from 1 day to 8 weeks. 
 
If a patient has severe symptoms of TB, they will often go to direct diagnostic methods, 
which require collection of the bacteria. Even if a confirmation of infection or previous exposure 
to Mtb was reached with the TST or IGRA, an active infection cannot be confirmed without 
further testing, usually acid-fast microscopy and a sputum culture. Mtb has a notoriously slow 
growth rate, and a positive sputum culture could take up to 10 weeks to confirm that the patient 
has TB33. Given the proper equipment, the bacteria can be stained with an acid-fast stain and 
imaged under white-light microscopy. Although this method is quick, it has a high detection 
threshold (~104 CFU), and it is not specific to Mtb, but a larger group of mycobacteria. For low 
resource settings where TB is most rampant, the long timeline for confirmation with sputum 
culture can be extended if sputum samples must be sent to an external lab for processing. Within 
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the past decade, successful diagnostic tests for identifying TB and MDR-TB, such as the Xpert 
Mtb/RIF assay, have been recently developed using antigen and biomarker recognition 
techniques34. While these methods are improving diagnostic yield and time, there are still some 
shortcomings, specifically the efficacy of the diagnostic in children. 
 
Table 1. A side-by-side comparison of the TST and IGRA diagnostics shows the strengths and 
weaknesses of each method. 
  Tuberculin Skin Test 
(TST) 
Interferon-γ Release 
Assay (IGRA) 
False positive for BCG vaccinated 
patients Yes No 
False negative for 
immunocompromised (HIV) Yes Yes 
Number of appointments required 
2; one for injection and 
another 48-72 hours 
later for analysis 
1; results available 
within 24-30 hours 
Differentiate between active and 
latent infection No No 
Method of detection Acquired inflammatory 
response in vivo 
Acquired inflammatory 
response ex vivo 
Preferred for testing infants/ 
pregnant mothers Yes/Yes No/Ask doctor 
Acceptable test for recent exposure 
to Mtb No No 
 
 
Diagnosing an active infection via sputum culture is also problematic for infection young 
children. Infants are susceptible to pulmonary infection with Mtb, but are not prime candidates 
for the diagnostic methods above due an under-developed immune system and an inability to 
expectorate35. In developed countries, gastric aspiration is available as an alternative to sputum 
culture in young children, but these methods are simply not available or even feasible in low 
resource areas. This expresses a need for a sensitive point-of-care method of diagnosis which 
does not require an immunogenic test or sputum culture to confirm an active infection.  
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1.3 Pre-clinical studies for therapy development 
The rise of drug resistance in strains of Mtb increases the need for new antibiotics and 
antibiotic regimens. Development of new treatments for MDR-TB and XDR-TB patients is 
hindered by the slow growth rate of Mtb and a minimal understanding of the mycobacterium’s 
complex, multi-stage pathogenesis 18, 22, 23. Animal studies on disease pathogenesis require a 
large number of animals because disease progression is tracked by sacrificing animals at discrete 
time points, then excising, homogenizing, and culturing the lungs to enumerate bacteria 36, 37. Not 
only does this method require a large sample size (multiple animals at each time point), but it 
discards vital information that could be gained from monitoring infection in a single organism 
over time. Pre-clinical studies on potential therapeutics also use this method of sacrificing at 
selected stages to quantify the reduction of CFU in the lung and consequently treatment efficacy 
37, 38. Utilizing a method which would allow longitudinal studies on treated animals could 
maximize information gained from pre-clinical experiments while simultaneously reducing costs 
and number of animals required to achieve significant results. 
1.4 Exploiting optics to address the TB epidemic 
Difficulties exist on all fronts when it comes to treating the TB epidemic; all but the newest 
diagnostics have low sensitivity and/or specificity, drug-resistant strains render even our most 
advances antibiotics ineffective, and vaccination is completely ineffective in some populations. 
To address these problems, we look more specifically at where current medical technologies can 
alleviate the disease burden. First, diagnosis of TB has a few clear problems: 1) diagnosis by 
sputum culture is too slow, 2) rapid diagnosis by smear microscopy is not sensitive enough, and 
not accessible in areas of high burden, and 3) infants children cannot produce sputum to get a 
proper diagnosis. All of these problems with diagnosis involve sputum. Even the Xpert 
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MTB/RIF diagnostic, which has shown great potential for improving rapid diagnosis of TB and 
MDR-TB, is ineffective in small children because it requires a sputum sample. Secondly, the 
development of new reactionary and preventative therapies is greatly hindered by the slow 
growth rate of Mtb. Pre-clinical studies on new treatments and vaccines require a high number of 
animals and/or a long post-sacrifice culture step.  
 Optical technologies show potential to address both of these problems. In addressing 
diagnosis, especially in small children, optical imaging or sensing of virulent bacteria would 
provide rapid feedback if the quantification of bacteria could be tied to an optical signal. 
However, an even more accessible goal is to design optical tools for pre-clinical analyses for 
development of TB therapies and vaccines. Optical imaging of animals during pre-clinical 
studies allows for longitudinal studies. If an optical signal can be confidently correlated to a 
bacterial load, a single animal can be imaged over the course of an infection, rather than multiple 
animals being sacrificed at discrete time points. Pre-clinical studies also allow for genetic 
modification of pathogens, rather than sensing wild-type bacteria with an exogenous chemical. 
With a method for linking bacterial load to an optical signal, detecting bacteria transforms from a 
biological/biochemical problem into and bio-optical engineering problem.   
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2. TECHNICAL BACKGROUND* 
 
2.1 Optical imaging and sensing of pathogenic bacteria 
 Addressing the TB epidemic requires a multi-pronged approach including development 
of new diagnostics and therapies, methods for minimizing transmission of Mtb, and research into 
the complex pathogenesis of the disease. Optical sensing and imaging has been used to observe 
disease pathogenesis in small animal models and even in preliminary studies for the development 
of antibiotic treatment regimens 39-43. Different methods exist for detection of viable bacteria. 
First, a bovine strain of the bacteria, bacille Calmette-Guérin (BCG) can be transfected as a 
fluorescent vector to make the bacteria produce the tdTomato fluorescent protein. Because the 
bacteria itself is fluoresces when transfected with this vector, there is no baseline fluorescence 
associated with an exogenous probe. However, the excitation and emission wavelengths of 
tdTomato lie in the range of visible wavelengths, and biological tissue has a high optical 
attenuation and high tissue autofluorescence (TAF) in this spectral range. This physiological 
phenomenon limits the signal to noise ratio (SNR) of in vivo detection optical systems. 
Another method for detecting viable bacteria is through using an exogenous fluorogenic 
probe. Xie et al have developed an NIR fluorescent probe that is sensitive to the class C beta-
lactamase enzyme, a surface enzyme expressed by a small group of mycobacteria, including 
Mtb44. This probe consists of a NIR fluorophore connected to a large organic quenching 
molecule by a lactam ring. When the molecule is intact, the fluorescence from the NIR dye is 
quenched through Forster resonance energy transfer (FRET). However, if the molecule is 
                                                 
* Portions reprinted with permission from “Optical model of the murine lung to optimize pulmonary 
illumination” by Durkee, Madeleine S., Nooshabadi, Fatemeh, Cirillo, Jeffrey D., Maitland, Kristen C., 
2018. Journal of Biomedical Optics, 23, 071208, Copyright 2018 by International Society for Optics and 
Photonics. 
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cleaved by a beta-lactamase enzyme on the surface of a bacterium, the large tail of the probe is 
no longer close enough to the fluorophore to quench fluorescence via FRET, and the remaining 
marker will fluoresce. This method has two main advantages 1) NIR light is much less attenuated 
by biological tissue and produces less TAF, so a higher SNR is theoretically possible, and 2) 
because this method can detect wild-type bacteria, there is potential for translation to a clinical 
diagnostic tool. However, this sensing method also has downsides. The probe enters the 
bloodstream of the animal, and is broken down by the body, so fluorescence can be generated 
even if there are no bacteria present. Also, an exogenous probe will be broken down and cleared 
by the body. The marker will therefore have a pharmacokinetic time scale of efficacy 39, 41, 
unlike imaging transfected bacteria, which have no time-dependence on signal intensity because 
the infection is not cleared by the body.  
Recently, the incorporation of an internal illumination source has improved the sensitivity 
of optical detection for both of the previously mentioned detection schemes to be within the 
range of physiologic doses of bacteria 41, 45. Previously, a high detection threshold of >105 colony 
forming units (CFU)40 prevented the use of these optical tools in pre-clinical trials because the 
reduction of CFU could not be monitored along the course of treatment. The use of a fiber 
microendoscope for intravital illumination has shown a reduction of that detection threshold to 
~103 CFU in the visible spectrum (tdTomato-transfected BCG)45 and ~102 CFU in the NIR 
(exogenous bacteria-sensing probe)41. These detection thresholds come from experiments with 
intravital illumination with external detection, and while this method works for experiments with 
small animal imaging, internal fluorescence collection with the microendoscope would help to 
translate this method to a clinical diagnostic tool. 
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2.2 Integrated imaging system for in vivo detection of pathogenic bacteria 
 In previous research, a multiscale imaging system was designed and tested to improve the 
detection of BCG and Mtb in vivo 41, 45, 46. This system includes a high-resolution 
microendoscope (HRME) and the IVIS Lumina small animal imaging system (Figure 2). The 
HRME consists of an LED or laser diode source depending on the operating wavelength, 
collimating optics if necessary, excitation and emission filters, a dichroic mirror, objective lens, 
and CCD camera. The excitation light is projected through the objective lens and coupled into a 
10,000-microfiber endoscope with an outer diameter of 0.66 mm. This endoscope is fed through 
a light-tight fiber port in the side of the IVIS, and used for intravital illumination of the animal. 
Fluorescence can be collected through the HRME or through the external IVIS camera.  
 
 
Figure 2. Integrated imaging system: Custom microendoscope (red box) coupled into the IVIS 
Lumina whole animal imaging system through a light-tight port in the side (red circle). Inset: 
Diagram of fluorescence microendoscope with filters (EX/EM), lenses (CL, OL), and dichroic 
mirror (DM). The CCD camera can be used for detection or guidance for source placement.  
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While this system has already shown improvement in the detection level of bacteria and 
potential for correlating fluorescence signal with bacterial load, the effects of both physiologic 
and instrument variables are unknown. Rather than optimizing this system through multiple 
iterations of animal experiments, we have developed a radiative transport model of the mouse 
torso to computationally assess the current status of the system and predict effective 
improvements to the instrumentation to overcome any currently limiting variables. Simulations 
also provide the opportunity to expand the size of the tissue representation from mouse lungs to 
larger mammalian lungs for a prediction as to how this technology would behave in larger 
animal models and if it would translate well into clinical studies. The mouse and other rodent 
lung models will aid longitudinal studies on therapeutic treatments for TB with the goal of 
determining the bacterial load within the animal, while the human model will simply aim to 
provide a yes/no diagnosis of bacterial infection. It is important to point out that the optimized 
imaging system is only intended to diagnose active TB infections and not LTBI. 
2.3 Radiative transport: A brief overview 
 Radiative transport generally refers to the interaction of electromagnetic (EM) radiation 
with matter. Radiative transport is fundamentally explained by Maxwell’s equations, which 
characterize the response of both the electric and magnetic field components of a wave incident 
on a material47. Maxwell’s equations can be used across all size scales, given enough 
computational power. The radiative transport equation (RTE) (Eq. 1) is derived from Maxwell’s 
equations, and describes the spatio-temporal radiance (L) in a material48.  
1
𝑣
𝜕𝐿(𝒓, ?̂?, 𝑡)
𝜕𝑡
+ ?̂? ∙ ∇𝐿(𝒓, ?̂?, 𝑡) 
= −𝜇𝑡𝐿(𝒓, ?̂?, 𝑡) + 𝜇𝑠 ∫ 𝐿(𝒓, 𝜴′̂, 𝑡)𝑝(𝒓, 𝜴′̂ → ?̂?)𝑑𝜴′̂4𝜋 + 𝑄(𝒓, ?̂?, 𝑡)  (1) 
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There is no analytic solution to the RTE, but analytic approximations exist with valid 
assumptions about the material in question 48, 49. For example, the diffusion approximation is 
used for larger scales, assuming the material scatters light at a higher rate than it absorbs it48. 
Fine details on the directional dependence of the radiance are lost, but those details are not often 
a concern when looking at the radiance on a larger scale. Stochastic solutions to the RTE, most 
commonly Monte Carlo simulations, use a high number of deterministic scattering and 
absorption events to approximate the tissue radiance. Monte Carlo modeling is discussed in more 
detail in section 2.4. Here, we discuss the different light-matter interactions which contribute to 
the overall radiance within a material. 
2.3.1 Light absorption 
 Light absorption occurs when a photon or wave is incident on a particle or molecule, and 
the energy of the photon is wholly transferred to that particle. As described by Beer’s Law in 
(Eq.2), 
𝐼 = 𝐼0𝑒
−𝜇𝑎𝑙 (2) 
if an absorbing medium is illuminated with a collimated beam, the intensity of transmitted light 
is related to the intensity of the initial beam through a decaying exponential function (Figure 3). 
The exponential term relates the path length (l) of the light through the medium and the 
absorption coefficient (µa), a medium-dependent and wavelength dependent term that describes 
the probability of a photon being absorbed. In a medium with multiple populations of absorbers, 
the total absorption coefficient is a weighted sum of the coefficients of each absorbing particle 
(Eq. 3)50. 
𝜇𝑎 =  ∑ 𝑐𝑖𝜇𝑎,𝑖
𝑛
𝑖=1  (3) 
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 The optical imaging window is ideal for biological and biomedical imaging due to the 
low absorption of water within this spectral region. The primary absorbers in biological tissue 
within this range are melanin and oxy- and deoxy-hemoglobin. The absorption of all of these 
decrease in the NIR compared to visible, making the NIR even more favorable for bio-optical 
imaging50, 51. 
 
Figure 3. Optical attenuation through an absorbing sample follows an exponential decay. 
 
2.3.1.1 Fluorescence 
 Fluorescence is a phenomenon stemming from an absorption event of a specific energy. 
If a photon incident on a molecule has the appropriate energy, the absorbing molecule can 
undergo an electronic transition upon absorbing the photon energy. As with most absorption 
events, the molecule will experience some non-radiative decay—motion, heat, vibrational 
relaxation— in transitioning back to its ground state. However, upon reaching the lowest 
vibrational state in its elevated electronic state, the molecule may undergo radiative decay. This 
releases a photon with energy equivalent to the remaining energy differential. The light emitted 
from a fluorescent molecule is incoherent, isotropic, and always a lower energy than the 
excitation energy (Figure 4)51.  
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Figure 4. Linear excitation and fluorescence. A photon with sufficient energy to increase a 
molecules energy state can be absorbed by that molecule, resulting in an electronic transition 
(green arrows). The molecule undergoes non-radiative vibrational relaxation (red arrow) to the 
lowest vibrational state within its elevated electronic state. The molecule can then emit a photon 
through radiative decay (orange arrows), returning to its ground electronic state.  
 
 Biological tissues have characteristic tissue autofluorescence (TAF), a fluorescence 
signal produced by molecules naturally occurring in the organism. TAF molecules in humans 
and animals include collagen, keratin, metabolic cofactors NADH and FAD, melanin, and 
others52. These molecules have stronger fluorescence at lower wavelengths, and can contribute 
significant background to in vivo imaging systems in which they are not target fluorophores. For 
example, optical sensing of biological phenomena can be accomplished through detecting the 
fluorescence of an exogenous fluorophore, and spectral overlap with resident TAF molecules 
will lower sensitivity to that molecular marker45.  
2.3.2 Optical scattering 
 Rather than transferring energy to a material or molecule it is incident upon, an EM wave 
can experience an elastic interaction with the media, resulting in a change of direction of the total 
energy of the wave. In a truly scattering medium, no energy is lost to the material, but redirected 
depending on the size and refractive index of the scattering particles in the medium (Figure 5). 
The likelihood of a photon hitting a scatterer over a unit distance is known as the scattering 
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coefficient (µs). Similarly, the mean free path (MFP) is the inverse of µs and represents the 
average distance a photon will travel between scattering events47, 50, 51, 53. As with absorption, an 
overall scattering coefficient can be calculated from multiple populations of scattering particles, 
each having its own concentration-dependent weight in the summation of scattering coefficients 
(Eq. 4). 
𝜇𝑠 = ∑ 𝑐𝑖𝜇𝑠,𝑖
𝑛
𝑖=0  (4) 
 
 
Figure 5. Optical attenuation through a scattering sample. Light incident on a particle is redirected 
rather than absorbed. 
 
Unlike absorption, scattering is not fully described by the density of scatterers within the 
media. A photon will continue moving after encountering a scatterer, and the directionality of 
that continued motion is defined by the phase function. The phase function varies for each 
particle, and describes the probability of a photon to continue travel at a different angle after a 
scattering event. Most particles yield a scattering distribution that is not isotropic. The degree of 
this anisotropy is described by the anisotropy factor (g)50. This factor is the average cosine of the 
scattering angle of a photon incident on a particle with values spanning -1 to 1. A particle which 
yields isotropic scattering will have a g = 0, while values of -1 and 1 correspond to complete 
backscattering and forward scattering, respectively. Most biological tissues have a g-value 
between 0.7-0.95, meaning that a given scattering event will likely be forward biased. 
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2.3.2.1 Henyey-Greenstein phase function 
 Tissue scattering is well-approximated by the Henyey-Greenstein phase function 
(Eq.5)51. 
𝑝(𝜃) =  
1−𝑔2
4𝜋[1+𝑔2−2𝑔(𝑐𝑜𝑠𝜃)]
3
2⁄
 (5) 
This function is the relation between g and the scattering distribution, and fully describes the 
probability of a photon being scattered at a given angle, θ. The phase function and g, just like µa 
and µs, are wavelength dependent, and can be calculated or estimated based on particle size, 
particle shape, medium refractive index, and particle refractive index. The scattering coefficient 
and anisotropy factor can be combined into the reduced scattering coefficient (µs’) to give a 
spatial average of scattered light (Eq. 6). 
𝜇𝑠
′ =  𝜇𝑠(1 − 𝑔)  (6) 
2.3.2.2 Rayleigh and Mie Scattering 
 Light scattering in biological tissue is best approximated using to populations of 
scattering particles, Rayleigh and Mie scatterers. Both theories model optical scatterers as 
spherical particles that redirect the energy of an incident photon or wave. Rayleigh scattering is 
an elastic scattering event that occurs when the scattering particle is much smaller than the 
wavelength of light. The intensity of scattered light in the Rayleigh model of scattering is related 
to the wavelength through a λ-4 (Eq. 7), meaning higher energy light is preferentially scattered47.  
𝐼 =  𝐼0
8𝜋4𝛼2(1+𝑐𝑜𝑠2𝜃)
𝜆4𝑅2
  (7) 
In this equation, α is the molecular polarizability, which is related to refractive index, and R is 
the distance from the scatterer. Rayleigh scattering is also characterized by a fairly isotropic 
distribution of scattering angles, with equal likelihood of forward and back scatter.  
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 Mie scattering is described by the Mie solution to Maxwell’s equations, an infinite 
converging series of Legendre polynomials. The Mie equations fully described the EM 
components of the incident, internal, and scattered waves, for spherical particles of any size. At 
small particle sizes, Mie theory converges to Rayleigh scattering53. However, as particle size 
approaches the wavelength of incident light, the Rayleigh scattering model begins to fall apart, 
and the full Mie model is necessary to accurately predict light scattering. Mie theory calculates 
the coefficients an and bn (Eq. 8-9) using the relative refractive index, m = npar/nmed, and 
spherical Bessel functions of the first (jn) and third (hn) kind to fully describe the amplitude of 
the scattered field47.  
𝑎𝑛 =
𝑚2𝑗𝑛(𝑚𝑥)[𝑥𝑗𝑛(𝑥)]
′−𝑗𝑛(𝑚𝑥)[𝑥𝑗𝑛(𝑚𝑥)]
′
𝑚2𝑗𝑛(𝑚𝑥)[𝑥ℎ𝑛
(1)
(𝑥)]
′
−ℎ𝑛
(1)
(𝑚𝑥)[𝑥𝑗𝑛(𝑚𝑥)]′
 (8) 
𝑏𝑛 =
𝑗𝑛(𝑚𝑥)[𝑥𝑗𝑛(𝑥)]
′−𝑗𝑛(𝑚𝑥)[𝑥𝑗𝑛(𝑚𝑥)]
′
𝑗𝑛(𝑚𝑥)[𝑥ℎ𝑛
(1)
(𝑥)]
′
−ℎ𝑛
(1)
(𝑚𝑥)[𝑥𝑗𝑛(𝑚𝑥)]′
 (9) 
These coefficients are also used to calculate the scattering efficiency of the particle (Eq. 
10), a value which conceptually relates the geometrical cross section of the particle to the 
scattering cross-section (Eq.11). The scattering cross-section is directly related to µs, through the 
particle density in the medium, ρs, (Eq. 12) therefore deriving material-level scattering properties 
based on the incidence of and EM wave on a single spherical particle47, 53.  
𝑄𝑠𝑐𝑎 =
2
𝑥2
∑ (2𝑛 + 1)(|𝑎𝑛|
2 + |𝑏𝑛|
2)∞𝑛=1   (10) 
𝜎𝑠 = 𝜋𝑟
2𝑄𝑠𝑐𝑎   (11) 
𝜇𝑠 = 𝜎𝑠𝜌𝑠   (12) 
 The overall scattering coefficient of biological tissue can be estimated by (Eq. 13): 
𝜇𝑠,𝑡𝑜𝑡𝑎𝑙 = 𝐴 [𝑓𝑅𝑎𝑦 (
𝜆
𝜆0
)
−4
+ (1 − 𝑓𝑅𝑎𝑦) (
𝜆
𝜆0
)
−𝑏𝑀𝑖𝑒
]  (13) 
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where λ0 is a reference wavelength, fRay is the fraction of scatterers in the Rayleigh regime, and 
A is the scattering coefficient at the reference wavelength, and bMie is the scattering power of the 
Mie particles present50.  
2.3.3 Measurement of optical properties 
 Absorption and scattering properties of biological tissues can be estimated through 
mathematical models if the components of the tissue are known. However, given the complexity 
and variability of biological tissues, directly probing the optical properties of the material may be 
more accurate. One of the most common ways to determine µa and µs’ of a material is through 
integrating sphere (IS) measurements and inverse adding-doubling (IAD) convergence 
algorithms51, 54. Because these measurements are indirect and IAD is a stochastic convergence 
algorithm, the acceptable error between the measured and expected optical properties is 
relatively high, sometimes up to 15%55. Despite this high error, this is still a widely accepted 
method for measurement of optical properties of turbid biological tissue.  
2.3.3.1 Integrating sphere measurements 
 Absorption and scattering coefficients of turbid media cannot be directly measured, so 
they must be inferred from other measurements. Using an integrating sphere, diffuse reflectance 
(R) and transmittance (T) of thin samples are directly measured. In the measurement setup 
(Figure 6), a collimated broadband light source is launched at the entry port of the integrating 
sphere. A detector is connected to another port on the integrating sphere, offset from the light 
path. For transmission measurements, the sample is placed at the entry port, and the exit port of 
the sphere is capped. For reflectance measurements, the sample is placed at the exit port of the 
sphere, so that any diffusely reflected light can be measured. Calibration measurements including 
dark spectra and reflectance from standard(s) and the sphere are also collected to calculate the R 
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and T values of the sample. Assuming a sample thin enough to minimize multiply scattered 
photons, a these R and T values and sample thickness can be used as inputs into IAD to estimate 
optical coefficients.   
 
 
Figure 6. System for measuring sample reflectance, transmittance, and unscattered transmittance. 
A) The integrating sphere system used for reflectance and transmittance measurements consists of 
a collimated light source launched into an integrating sphere. Scattered light is collected with a 
spectrometer connected to an offset port. Reflectance is measured with the sample at port 2 with 
port 1 open. Transmittance is measured with the sample at port 1 and port 2 closed. B) The 
unscattered transmittance pathway consists of the same collimated source incident on the sample, 
then a pinhole and the detector. This pathway allows for angular characterization of scattering. 
 
2.3.3.2 Inverse adding-doubling 
 IAD is the inverse process of adding-doubling, a forward modeling method which 
simplified the 6-dimensional RTE to a one-dimensional problem51. By taking a very thin sample 
and summing over all angles, the radiance at a single point is assumed to be a sum of two terms: 
the transmitted radiance from a neighboring thin slice, and the radiance reflected from a 
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neighboring point off the boundary. Each radiance term is calculated based off of the absorption 
and scattering coefficients of the material. “Doubling” takes the radiance from this thin slice and 
propagates it to an arbitrarily thick sample. “Adding” propagates the radiance through different 
thin slabs of varying optical properties. This forward adding-doubling method calculates the R 
and T values of a sample of a known thickness. Inverse adding-doubling simply does the reverse. 
The software iteratively estimates µa and µs’, calculates R and T based on the forward model, 
and re-estimates µa and µs’ based on the error between measured the measured R and T values 
and the R and T values calculated from the most recent iteration of the forward model.   
2.4 Monte Carlo Modeling 
Monte Carlo simulations of light transport have a well-defined general structure and flow 
(Figure 7). The propagation of each photon through the tissue is determined by a decision tree 
and a random number generator. A photon is launched into the tissue, and propagated at a step 
size calculated based on the material optical properties. If the photon hits a boundary over this 
transition, the photon is transmitted or reflected accordingly. If it does not hit a boundary, the 
photon deposits energy in the tissue at that point, and/or is re-directed (scattered) based on the 
optical properties of the material in that region. The photon undergoes a roulette step based on 
the random number generator, and if the photon survives, it is propagated in the same manner 
until the photon no longer survives. As the number of photons launched approaches infinity, the 
error between the actual and modeled radiance will converge to zero53, 56.  
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Figure 7. Flowchart of the decision process of Monte Carlo models of radiative transport. This 
decision process continues for the lifespan of a single photon. It is repeated for every photon 
launched in the model.  
  
Stochastic optical simulations such as Monte Carlo models can predict both the fluence 
of light within the tissue and the diffuse reflectance which travels back to an external detector, 
making them useful for both optically radiative therapeutic treatments and optical diagnostic 
methods. A variety of these stochastic models have been developed to describe the complex 
interaction of light and tissue. Time-resolved Monte Carlo simulations have helped to describe 
the fluorescence lifetime shift in the endogenous fluorophores present in fluorescence lifetime 
imaging. Multi-layer Monte Carlo (MCML) has frequently been used to analyze the diffuse 
reflectance of dysplastic, precancerous and cancerous epithelial tissues for optical diagnosis of 
cancer 56-59. Complex geometry MCML models have incorporated cylindrical structures 
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representative of capillaries to find the necessary dose to rupture blood vessel walls in the 
elimination of port wine stain birthmarks60, 61. 
2.5 Optical tissue phantoms 
 Tissue-simulating phantoms have historically played a large part in the development of 
new optical techniques for biological and medical imaging. As a model of the optical 
environment of a biological sample or subject, optical tissue phantoms are used for simulation 
validation, device development, calibration, and quality control. Commercial phantoms with 
highly controlled properties are available, but for many research labs developing novel system, it 
is necessary to have a custom standard or model to characterize and test the system during and 
post-development. Depending on the purpose, the phantom must have one or all of the following 
characteristics: 1) mimic a specific biology or physiology, 2) highly controlled properties 
including optical, mechanical, and geometric, 3) long-term stability, and 4) reproducibility62. 
As new optical imaging techniques emerge or are combined into multi-modality systems, 
new phantoms are developed for appropriate testing and calibration of these systems. Many 
optical imaging systems are gaining prevalence in both preclinical and clinical settings, and it is 
imperative to have tools to ensure the proper performance of these systems. Phantoms and 
standards often serve as inter-device calibration tools, ensuring optimal performance of the 
imaging system. These phantoms need to be long-lasting, consistent, and stable for continued, 
reliable use. Other phantoms are used for device characterization and optimization, and may not 
need long-term stability, but must be more structurally complex, or even modular to fully define 
the capabilities of a biological imaging system. While some phantoms have been developed to 
test multiple types of optical systems, it is more common for a phantom to be modality-specific, 
with many also being specific to the sample or physiological system to be imaged. Both the 
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modality and sample will inform the design of the optical phantom. A variety of techniques have 
emerged to create phantoms and standards for optical imaging.  
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3. OPTICAL PHANTOM DESIGN AND FABRICATION* 
 
3.1 Optical phantoms as simulation validation 
Tissue phantoms are used widely for system characterization and calibration of optical 
imaging and spectroscopy instruments, including multimodality systems incorporating 
ultrasound or nuclear modalities 63-66. Phantoms provide a controlled optical environment for 
system characterization and quality control of multiple biological imaging techniques. Tissue-
mimicking phantoms are useful tools in predicting system performance and optimizing system 
design for the physiological task at hand; for example, to predict the probing depth of 
spectroscopic probes for assessing tumor margins67. Optical properties and structural design of 
the phantoms can be tuned to mimic the specific physiological environment in which the 
instrument will be used, therefore allowing for both feasibility studies and verification of system 
performance 65, 68, 69. Verification of imaging system performance with realistic optical phantoms 
prior to entering pre-clinical or clinical trials reduces risk of malfunction or acquisition of 
unusable data during in vivo studies. The reproducibility and stability of optical phantoms make 
them customizable calibration standards for optical techniques to monitor intra- and inter-
instrument variability, particularly in multicenter clinical trials with different instruments, 
operators, and environmental conditions 70, 71. 
Tissue-mimicking phantoms also serve as tunable and reproducible physical models for 
validation of theoretical optical models. Simulations aid in the design and optimization of in vivo 
optical instruments, while reducing the need for animal experiments 72, 73. The development and 
                                                 
* Reprinted with permission from “Fabrication and Characterization of Optical Tissue Phantoms 
Containing Macrostructure” by Durkee, Madeleine S., Nash, Landon D., Nooshabadi, Fatemeh, Cirillo, 
Jeffrey D., Maitland, Duncan J., Maitland, Kristen C., 2018. Journal of Visualized Experiments, 132, 
e57031, Copyright 2018 by MyJoVE Corps. 
 
 
26 
 
 
validation of optical simulations to accurately represent the in vivo environment can be 
encumbered by the complexity of the tissue structure, the biochemical content, and the location 
of the target or tissue within the body. Variability between subjects makes validation of 
theoretical models challenging using animal or human measurements. Polymer optical tissue 
phantoms allow for validation of theoretical models by supplying a known and reproducible 
optical environment in which to study photon migration 62, 74-76.  
 
 
Figure 8. Flow diagram of fabrication of optical tissue phantom. (A) Determine optimal recipe for target 
optical properties of tissue of interest. (B) Verify recipe. (C) Design internal structure. (D) Print internal 
structure using dissolvable material. (E) Vapor polish printed part to smooth surface. (F) Mix polymer and 
optical particles, and pour into heat-resistant mold. (G) Degas and cure polydimethylsiloxane (PDMS). (H) 
Dissolve printed part to create internal void. (I) verify phantom geometry and optical properties. 
 
For the purpose of system calibration, solid optical phantoms may consist of a single 
homogeneous slab of cured polymer with the optical scattering, absorption, or fluorescence tuned 
for the wavelengths of interest. Layered polymer phantoms are frequently used to mimic the 
depth variance of the tissue optical properties in epithelial tissue models 77, 78. These phantom 
structures are sufficient for epithelial imaging and modeling, because the tissue structure is fairly 
homogeneous through each layer. However, larger scale and more complex structures affect 
radiative transport in other organs. Methods to create more complex phantoms have been 
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developed to simulate the optical environment of subcutaneous blood vessels79, 80 and even 
whole organs, such as the bladder81. Modeling light transport in the lungs provides a unique 
problem due to the branching structure of the air-tissue interface; a solid phantom would not 
likely replicate radiative transport in the organ accurately82. To describe a method for 
incorporating complex structure into an optical phantom, we describe a method to create an 
internal, reproducible fractal tree void that represents the three-dimensional (3D) macroscopic 
structure of the airway (Figure 8c). 
3.2 Material optical properties 
 The material matrix for the mouse lung tissue phantoms was designed to simulate 
measured optical properties of excised healthy and inflamed murine lung tissue at 535 nm and 
730 nm (Tables 2-3). These wavelengths of interest are the excitation wavelengths for tdTomato 
fluorescent protein used in recombinant reporter strains of mycobacteria and the NIR fluorescent 
bacteria-sensing probe used in the mouse model of infection 45, 83. Reflectance (R) and 
transmittance (T) values of ex vivo mouse lung tissue were obtained using an integrating sphere. 
Inverse adding-doubling (IAD) software was used to convert these R and T values into 
absorption and scattering coefficients. Use of animals was approved by the Institutional Animal 
Care and Use Committee (IACUC) at Texas A&M University. 
Table 2. Optical properties of healthy and inflamed mouse lung tissue compared to the 
corresponding phantom recipes for properties at 535 nm. 
535 nm 
Absorption 
Coefficient (cm-1) 
Reduced Scattering 
Coefficient (cm-1) 
Healthy mouse lung tissue 2.05 ± 0.58 52.69 ± 7.83 
Healthy phantom             
(2 mg TiO
2 
+ 3.5 µL India ink) 1.96 ± 0.699 49.66 ± 0.12 
Inflamed mouse lung tissue 5.49 ± 1.32 38.94 ± 9.68 
Inflamed phantom             
 (1 mg TiO
2
 + 10 µL India ink) 4.34 ± 0.873 39.56 ± 5.02 
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Table 3. Optical properties of healthy and inflamed mouse lung tissue compared to the 
corresponding phantom recipes for properties at 730 nm. 
730 nm 
Absorption Coefficient 
(cm
-1
) 
Reduced Scattering 
Coefficient (cm
-1
) 
Healthy mouse lung tissue 0.71 ± 0.16 58.44 ± 5.14 
Healthy phantom               
(2 mg TiO
2 
+ 1 µL India ink) 0.62 ± 0.48 51.18 ± 11.20 
Inflamed mouse lung tissue 1.01 ± 0.55 34.84 ± 8.19 
Inflamed phantom             
 (2 mg TiO
2
 + 2.5 µL India ink)  1.44 ± 0.26  34.18 ± 5.06 
 
 
Figure 9. Trends in absorption coefficient for India ink and TiO2 concentration. Absorption 
coefficients are shown for a range of India ink and titanium dioxide concentrations at 488 nm (A), 
535 nm (B), 630 nm (C), and 775 nm (D). Absorption is low for low concentrations for both 
particles, and generally increases with concentrations of each particles. A plateau is reached 
between 5-7.5 µL India ink per mL PDMS. The rate of increase depends on the concentration of 
the other particle and the wavelength. 
 
 Polydimethylsiloxane (PDMS, Sylgaard, Dow Corning) was used as the base material for 
these phantoms due to a similar refractive index to biological tissue50. Titanium dioxide (TiO2) 
and India ink were used as scattering and absorbing particles, respectively. To optimize the 
optical properties of material to model the four desired tissue states (healthy and inflamed tissue 
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at 535 nm and 730 nm), an array of phantoms were made with concentrations of TiO2 ranging 
from 1-8 mg/mL PDMS and concentrations of India ink ranging from 2.5-10 µL/mL PDMS.  
 
 
Figure 10. Trends in reduced scattering coefficient for India ink and TiO2 concentration. Reduced 
scattering coefficients are shown for a range of India ink and titanium dioxide concentrations at 
488 nm (A), 535 nm (B), 630 nm (C), and 775 nm (D). The reduced scattering coefficient is low 
for low concentrations for both particles, and generally increases with concentrations of each. Like 
absorption, the rate of increase depends on the concentration of the other particle and the 
wavelength. 
 
Figures 9-10 show the resulting absorption and reduced scattering coefficients for these 
recipes. The dependence of absorption and scattering on particle concentration are summarized 
in Figure 11. Trends in absorption coefficient and reduced scattering coefficient for phantoms 
with a constant concentration of TiO2 (scattering particle) (Figure 11a, b) and a constant 
concentration of India ink (absorbing particle) (Figure 11c, d) demonstrate the relation of optical 
properties to both particles. To ensure reproducibility of these optical properties, proper mixing 
technique must be used. Settling and ribboning of TiO2 particles will cause a shift in the 
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scattering coefficient of the cured phantom (Figure 12). India ink staining the mixing container 
will also reduce the absorption coefficient. Look-up tables for phantom recipes corresponding 
physiologically relevant values of absorption and scattering coefficients for 488 nm, 535 nm, 630 
nm, and 775nm light can be used to help achieve the desired optical properties at the spectral 
region of interest (Tables 4-7). 
 
Figure 11. Interdependency of optical properties on India ink and TiO2 concentration. Absorption 
coefficients and reduced scattering coefficients are shown for recipes with a constant TiO2 
concentration of 1 mg/mL PDMS (A, B) and constant India ink concentration of 5 µL/mL PDMS 
(C, D). Panel (B) shows that scattering coefficient will change with a constant TiO2 concentration 
when India ink concentration is varied, and panel (C) shows that absorption coefficient will 
change for a constant India ink concentration when TiO2 is varied. 
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Figure 12. Mixing effects on optical scattering. Improper mixing of the uncured polymer and 
optical particles can result in a shift in the optical properties. The poorly mixed phantom 
represented in this figure showed settling of TiO2 particles prior to curing. 
 
Table 4. Look-up table for phantom recipes at 488 nm base on experimental measurements. 
Greyed out recipes do not follow the expected trend.  
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Table 5. Look-up table for phantom recipes at 535 nm base on experimental measurements. 
 
Table 6. Look-up table for phantom recipes at 630 nm base on experimental measurements. 
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Table 7. Look-up table for phantom recipes at 775 nm base on experimental measurements. 
 
 
3.3 Advanced methods for complex, multi-layer structure 
 The first generation of complex phantoms was a rectangular phantom with a mock 
airway, fractal tree void (Figure 8c).  This void was obtained by 3D printing a fractal tree in a 
base-soluble material and securing it to the base of the polymer mold (Figure 8f). The 3D printed 
structure was vapor polished to create a smooth internal surface inside the phantom (Figure 8e). 
After pouring the PDMS mixture into this mold, the uncured phantom was degassed to remove 
unwanted air bubbles, then cured at 80 °C for 2 hours. Figure 13 shows a comparison of light 
scattering from a PDMS phantom (with no TiO2 or India ink) that was not degassed or vapor 
polished (Figure 13a, c), and a phantom that had a vapor polished internal part and was degassed 
(Figure 13b, c). The phantoms were imaged using illumination from an external white light 
source (Figure 13a, b) and with an internal microendoscope source at 535 nm (Figure 13c, d). 
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Vapor polishing and degassing minimize the presence of irreproducible scatterers, including 
surface roughness (Figure 13c, inset 2) and bubbles (Figure 13c, inset 1). Degassing is 
particularly important, because air bubble location is random and unpredictable. Furthermore, air 
bubbles are obscured once TiO2 particles are incorporated (not shown in Figure 13), making the 
phantom optically opaque. Therefore, unseen bubbles may undermine the phantom material’s 
representation of tissue optical properties. 
 
Figure 13. Representative airway phantoms with low scattering coefficient material to illustrate 
successful and suboptimal fabrication. Vapor polishing and degassing are integral steps in 
producing a phantom that has minimal uncharacterized scattering elements. A-B) White light 
images of phantoms without vapor polishing and degassing (A) and with vapor polishing and 
degassing (B). C-D) Phantoms from A-B are illuminated with 535 nm light. Insets from (C) are 
shown to depict scattering effects of 1) air bubbles and 2) a rough 3D printed surface. E) 
Rendering of an optical simulation based on the computer aided design (CAD) model used for the 
phantom fabrication. 
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3.4 Geometry verification and optical imaging 
For optically turbid phantoms with an internal void, geometry verification must be 
performed by means other than visual inspection. Methods for geometry verification of optical 
imaging of turbid phantoms is described for the preliminary block phantom with a fractal tree 
void. The vapor-polished 3D printed part was measured with calipers at the base and at the distal 
branches, and dimensions are compared to the 3D solid model in Table 8. Following fabrication 
of the polymer phantom, the phantom was imaged using a micro-CT imaging system. Using the 
3D dataset, dimensions of the internal void at the base and distal branches were measured for 
comparison (Table 8). Using micro-CT for geometry verification, a small amount of residual 
material was found within the airway void. Additionally, a segmentation of this same CT scan 
reveals a small air bubble next to the branching structure (Figure 14). During fabrication, 
optically clear phantoms yielded a full dissolution of the material of the internal structure and no 
air bubbles within the polymer matrix.  
 
Table 8. Effects of vapor polishing on size of 3D printed internal structure. The molded phantom 
was also measured for airway size using the micro-CT images for validation of internal geometry. 
  Base diameter (mm) Distal branch diameter (mm) 
Solid model 2.7 1.38 
Vapor polished print 2.56 ± 0.026 1.38 ± 0.141 
PDMS mold (measured from CT) 2.55 ± 0.021 1.39± 0.055 
 
Verification with micro-CT showed that the optically opaque phantoms may contain 
small flaws, not otherwise visible in turbid phantoms. The vapor polished tree is slightly smaller 
at the base because the smoothing of the surface by the acetone vapor causes the surface of the 
plastic to flow. With the 3D printed part suspended by the base, the surface flows towards the 
distal branches, causing a small change in dimension of the part. There is a trade-off between 
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surface smoothness and maintaining part size. A longer vapor polish will result in a smoother 
surface, but will cause more material to flow, resulting in altered dimensions. For the fractal 
geometry shown here, polishing the internal structure yielded a decrease in average surface 
roughness of molded PDMS from 37.4 µm to 7.2 µm.   
 
 
Figure 14. Validation of airway geometry. A segmented micro-computed tomography image of an 
optically turbid phantom reveals an air bubble near the airway surface. 
 
Phantoms were imaged in a PerkinElmer IVIS Lumina II with an access port for insertion 
of a microendoscope fiber bundle (Figure 15). The microendoscope was placed into the void 
within the phantoms from which the printed part had been dissolved. The microendoscope was 
used for internal illumination at 535 nm and the IVIS illumination pathway was blocked. The 
placement of the microendoscope is indicated in Figure 15a.The IVIS was used for external 
collection of signal. Phantoms imaged had the same internal structure as those imaged in Figure 
3. With identical internal structures and external dimensions, the difference in optical properties 
between healthy lung tissue (Figure 15a) and infected lung tissue (Figure 15a) is apparent in the 
surface irradiance of the phantoms. As these phantoms maintain an appropriate response to a 
change in optical properties, this method for phantom fabrication can be applied for phantoms 
used in internal illumination studies. 
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Figure 15. Imaging of phantoms with internal illumination. A computer simulation of the 
phantom (A) demonstrates the orientation of the internal geometry and source placement (yellow 
star) for the phantom images in panels (C) and (D).  A segmented micro-CT scan of the healthy 
lung tissue phantom (B) confirms the internal structure is present in the optically opaque phantom. 
The mock airway is used as a pathway for the endoscope for internal illumination of the optical 
phantoms at a wavelength of 535 nm. The two phantoms imaged with internal illumination are 
identical in external shape and internal structure, with material optical properties optimized for 
healthy (C) and inflamed (D) lung tissue. All images and renderings are on the same scale. Scale 
bar in panel (C) is 1 cm. 
 
3.5 Full torso and sparse tissue phantom design 
 The phantoms discussed above are single-layer phantoms with a complex structure 
dissolved out to mimic the mouse airway. However, the lung is a porous organ with a low tissue 
density. The porosity of the tissue greatly affects tissue scattering, so an improved physical 
model of the lung parenchyma would a polymer foam. Figure 16 shows representative images of 
PDMS phantoms loaded with glass microbubbles at 30%, 40%, 50%, and 60% volume fractions. 
The glass layer within these phantoms approximates scattering from the surfactant liquid layer 
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within the alveoli. Detailed scattering characteristics of this physical model are discussed in 
chapter 4. 
 
Figure 16. Inflated lung tissue modeled by glass microbubble phantoms. Fluorescence confocal 
images show an increase in microbubble concentration consistent with the intended recipe. 
 
The final iteration of these phantoms are composed of multiple layers of polymer 
mixtures representing the optical properties and general anatomy of the mouse torso. The 
stability of PDMS phantoms should allow these phantoms to serve as validations of the optical 
model and calibration standards for imaging experiments with intravital illumination. Figure 17 
shows the overall design of these phantoms, and the current status of the phantom fabrication. 
These phantoms consist of a 3D printed, dissolvable airway, a polymer mold of mouse lung 
tissue with glass microbubbles, and a final outer mold of the bulk tissue surrounding the lung. 
These phantoms are fabricated with a multi-layer molding process including 3D printing, clamp 
molding, and pour-over molds.  
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Figure 17. Flowchart of fabrication process for mouse torso phantoms. Uncured PDMS with the 
optical properties of lung tissue is loaded with microbubbles to represent inflated lung (A). The 
uncured mixture is placed in a lung-shaped clamp mold (C) with a 3D printed, dissolvable airway 
(B). The lung mold is degassed and heat cured (D). The cured lung phantom is secured in a 
cylindrical mold (E) and PDMS representing optical properties of bulk tissue is poured into the 
mold (shown optically clear for demonstration). This layer is degassed and cured, and the entire 
phantom is placed in a heated base bath to dissolve the internal airway (F). The final phantom (G) 
is shown with a clear bulk tissue layer and an absorbing lung layer for visualization.  
 
3.6 Optical phantom stability and tunability 
 We have demonstrated a method for creating optical phantoms to represent a murine lung 
with an internal branching structure to simulate the internal air-tissue interface. The optical 
properties of murine lung tissue are achieved by incorporating unique concentrations of optically 
scattering and absorbing particles distributed homogenously within the bulk matrix polymer. 
These optical properties can be tuned to mimic the physiological values within different spectral 
ranges of tissues in different states (i.e. healthy versus diseased tissue). The optical properties are 
dependent on the wavelength of interest, the base material, and the concentrations of the particles 
within the phantom. However, with multiple particles, the relationship between scattering and 
absorption is not always intuitive84. The rate of increase of absorption is dependent on the 
concentration of the scattering particle as well as the absorbing particle, and likewise for the rate 
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of increase of the reduced scattering coefficient. (Figures 9-10).  PDMS phantoms have also been 
shown to maintain their optical properties for up to 1 year 62, 85.  We have measured a 3-week 
stability of optical properties within the error of our integrating sphere measurements (< 15%). 
Storage of these phantoms and standards in a light-tight container can help preserve their optical 
properties for longer periods of time. 
 The design of these phantoms is limited by the 3D printed part. The mock airway is 
designed so that the support material can be pried off, as it is not dissolvable. This can be 
overcome by moving to a more advanced printer that can either print materials with varying 
solubility, or a laser sintering printer, that does not need support material. It is also important to 
note that the lung is inherently a very porous organ because of the distal airways and the alveoli. 
While that is not represented in this phantom, the optical effects of similar structures have been 
observed using a Bragg-Nye bubble raft for optical coherence tomography82, air bubbles in olive 
oil86, and shaving cream or dish detergent for nuclear magnetic resonance imaging87. Creating 
polymer foams with reproducible characteristics may be able to reconcile this difference between 
the solid phantoms presented here and the lung microstructure88. 
The shape of the final phantom can also be customized depending on the application. The 
rectangular phantom shown here was imaged with internal illumination and used for validation 
of a computational model of healthy and infected lungs (Figure 15). This design can be updated 
further to represent the cylindrical torso of the mouse by simply changing the design of the 
external polymer mold.  
While we have detailed here the design of a murine lung and airway phantom, these 
methods can be modified to fit other organs or animals of interest. The internal structure can be 
converted to a flow pathway for vascular phantoms, or can be used as a cast for a complex 
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internal structure with unique optical properties. The overall shape of the phantom can also be 
tuned to the application, animal, or organ of interest. 3D printing of both internal structures and 
polymer molds gives freedom to the design process of structured polymer optical phantoms. 
These are integral tools in simulation validation and calibration of in vivo optical imaging 
techniques, because they can more accurately represent the in vivo environment than 
homogeneous single or multi-layer phantoms. 
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4. MULTI-LAYER MIE SCATTERING MODEL FOR ALVEOLAR SCATTERING  
 
4.1 Concentric sphere Mie scattering model 
 Mie scattering theory is based on the propagation of electromagnetic waves in materials 
with different dielectrics. Traditionally, Mie theory approximates scattering particles as spherical 
inclusions with a different dielectric constant than the surrounding medium. Many adaptions of 
Mie theory have since been employed, including approximation of scatterers as ellipsoidal 
particles to better mimic cellular scattering events89, and multi-layer concentric sphere models, 
the first of which was conceived by Aden and Kerker in 195190. The concentric spheres in this 
model have variable dielectrics across each layer of the spherical particles (Figure 18), and are 
commonly used for modeling the enhanced scattering fields by semi-conductor nanoparticles 91-
93. 
 
Figure 18. Spherical particles modeled in traditional Mie scattering (a) and in the concentric 
sphere model (b). 
 
 Using the properties of the electromagnetic wave propagation in both the spherical 
particle and surrounding medium, Mie theory establishes equations for both the transmitted and 
scattered fields. In radiative transport for biological materials, we are mainly concerned with the 
scattered electric and magnetic fields94.  The Mie coefficients an and bn used in these field 
equations are given above in Equations 8 and 9, where m is the ratio of refractive indices of the 
particle and medium, and jn and hn are spherical Bessel functions of the first and third order, 
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respectively. Aden and Kerker first extrapolated these equations to a two layer concentric sphere 
model, where a third set of equations is included to describe the field in the second particle 
dielectric, or the field within the particle “shell”. Extra terms are added to the original 
transmitted and scattered fields to account for field interaction with the outer particle layer. The 
complete Mie coefficients for the scattered field in a concentric Mie model are listed in 
Equations 14-19, where n1 is the refractive index of the inner sphere, n2 is the refractive index of 
the shell, n3 is the refractive index of the medium, m1 is the ratio n1/n3, m2 is the ratio n2/n3, α is 
the inner sphere radius, and υ is the outer sphere radius (Figure 18).  
𝑎𝑛 =
(
[𝜈𝑗𝑛(𝜈)]′
𝜈
)𝐴1+𝑛3
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(
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𝜈
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2(
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𝜈
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𝐴3 = 𝑛2
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These coefficients can also translate into a scattering efficiency (Qsca) and scattering coefficient 
(µs) (Eqs. 10-12) to describe the optical properties of a bulk material. Scattering coefficient can 
also be determined with volume fraction rather than number fraction. Eq. 11-12 can be rewritten 
as Eq. 20 where υ is the particle outer diameter and f is the volume fraction of particles. 
𝜇𝑠 = 𝑄𝑠𝑐𝑎 [
𝜋𝜐2
4
] [
3𝑓
4𝜋𝜐3
] = 𝑄𝑠𝑐𝑎 [
3𝑓
16𝜐
]  (20) 
 
4.2 Phantom validation of concentric Mie model 
 A brief validation of the model was performed with silicone phantoms. The phantoms 
consisted of soda-lime borosilicate glass microbubbles (3M Glass Bubbles) embedded in a 
polydimethylsiloxane (PDMS, Sylgaard, Dow Corning) matrix. Prior to fabrication, 
microbubbles were filtered by size to select particles between 45-100 µm. Shell thickness was 
calculated to be ~2-5 µm based on material and particle density. Phantoms were fabricated with 
30-60% microbubbles by volume. Scattering coefficients were determined by inverse adding-
doubling (IAD) after obtaining sample reflectance and transmittance. As predicted by the 
concentric sphere model, the scattering coefficients were fairly constant over the visible 
spectrum, and were linearly correlated with the volume fraction of microbubbles (Figure 19). For 
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microbubbles with 95 µm diameter, 3.28 µm shell thickness, and a refractive index of 1.53 
embedded in PDMS (n = 1.43), the simulation predicted a 3.20 cm-1 change in µs per percent 
volume fraction. Phantoms showed a relationship of 3.31 cm-1 per percent volume fraction (R2 > 
0.93). The linear regression for this data was set to have an intercept at 0, as would be 
theoretically expected with 0% microbubbles. 
 
 
Figure 19. Phantom validation of the concentric sphere model shows a fairly constant µs for each 
volume fraction over the visible spectrum (a). The change in µs is linearly correlated with volume 
fraction in both the phantoms and the simulation (b). 
 
4.3 Pulmonary alveoli as concentric spheres 
 Here, we employ a two-layer concentric sphere Mie scattering model to investigate the 
effects of the pulmonary surfactant layer on light scattering within the lung in vivo across 
multiple species.  
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The lung presents a unique problem for modeling in vivo radiative transport. The tissue 
within the lung exhibits similar absorption and scattering properties as other highly perfused soft 
tissues92, 93. However, the airspace within the lung parenchyma is constantly changing in a living 
organism, which changes the bulk scattering properties of the lung47. Structurally, the lung can 
be likened to a foam, with a high volume-fraction of air held within the alveoli of the lung 
(Figure 20).  
 
Figure 20. Lung parenchyma consists of microscale air sacs connected by airway branching (a). 
The alveoli expand and contract over the respiratory cycle for passive and forced inspiration and 
expiration (b-c).  Residual volume (RV) is the minimal airspace a living organism can achieve 
without alveolar collapse. Expiratory reserve volume (ERV) is the difference between RV and 
passive breathing (forced exhale). Functional residual capacity (FRC) is the air volume in the lung 
at the end of passive breathing. Tidal volume (TV) is the volume fluctuation during passive 
breathing. Inspiratory reserve volume (IRV) is the difference between passive breathing and total 
lung capacity (TLC). 
 
However, unlike traditional foams, there is no foam coarsening within the lung; there is a 
set number of “bubbles” (alveoli), surrounded by cells and an elastic matrix of tissue. Each 
alveolus—composed of epithelial cells and a layer of pulmonary surfactant and hypophase 
(together ASL)—grows and shrinks over the respiratory cycle 51, 55. Over the course of this cycle, 
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the air volume within the lung will oscillate between the functional residual capacity (FRC) and 
the maximum tidal volume (VTmax) during passive breathing, and occasionally reach the extents 
of the vital capacity (VC) (Figure 20c)95.  The alveoli are therefore constantly changing size, 
along with the volume fraction of air in the lung. Modeling the alveoli as spherical bubbles 
within the lung, the fields calculated by Mie scattering become dependent on the point in the 
respiratory cycle. Previously, the optical properties of piglet lung over the course of respiration 
has been modeled and characterized47. However, this description is limited to a single animal 
model and ignores the effects of the airway surface liquid (ASL), a liquid coating the alveolar 
surface composed of fluid hypophase and pulmonary surfactant. Concentrating on the scattering 
due to alveolar size and structure, we expand on this model to include a surfactant and 
hypophase layer to the Mie alveolar model. We use this multi-layer model to estimate the lung 
optical properties for humans and multiple animal models for pulmonary disease, including mice, 
hamsters, rats, rabbits, and non-human primates (macaques) using values from the literature 
describing pulmonary anatomy96-99. 
4.4 Scattering properties of lung parenchyma along respiration  
 After validation, the inputs to the concentric sphere model inputs were edited to describe 
physiological values (Table 9). First, scattering within the human lung was modeled at four 
points along the respiratory cycle: total lung capacity (TLC), maximum tidal volume (VTmax), 
functional residual capacity (FRC), and residual volume (RV). VTmax, FRC, and RV were 
assumed to 50%, 40%, and 20% of TLC, respectively. These values correspond to the airspace 
within the lung, tissue volume is not included in these percentages. Weibel reports that tissue 
volume at TLC is roughly 12% of the total lung volume99. This constant volume is added to the 
airspace volume at each point in respiration to calculate a total lung volume. Alveolar diameter 
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was calculated for each lung volume based on the total air volume in the lung and a constant 
number of alveoli (Table 10). ASL thickness at the alveolar level is estimated to be 10-1000 nm 
55, 100-103. In this model, we conserve the total volume of the ASL, and model at two volumes. At 
the maximum tidal volume (VTmax), the ASL thickness is assumed to be 0.5% or 1% of the 
alveolar radius (ralv), corresponding to ~500 nm or ~1000nm thickness at VTmax. The volume of 
ASL at this thickness is conserved, so the shell thickness at all other points in the respiration 
cycle scales accordingly. 
Table 9. Inputs for phantom and tissue models. 
 Phantom Tissue 
n1 (air) 1.00 1.00 
n2 (Glass/ASL) 1.53 1.33 
n3 (PDMS/tissue) 1.43 1.40 
 
Table 10. Physiological parameters of the human lung over respiration 104, 105. 
 Airspace volume 
(mL) 
Tissue 
fraction 
Alveolus volume 
(µm3) 
Alveolar diameter 
(µm) 
RV 1000 0.38 2.06E+06 157.81 
FRC 2000 0.23 4.12E+06 198.82 
VTmax 2500 0.19 5.14E+06 214.17 
TLC 5000 0.12 1.03E+07 269.84 
 
  
The model showed that scattering coefficient (µs), anisotropy factor (g), and reduced 
scattering coefficient (µs’) remained relatively constant over the wavelength modeled. Table 11 
compares the scattering properties of the lung modeled with and without the ASL layer, averaged 
over the modeled wavelengths (400-850 nm). While only small changes emerge in µs between 
the simple and concentric model, the baseline of g increases with the addition of the ASL. As a 
result, the average µs’ decreases by 4-7% for the thinner ASL model and 5-9% for the thicker 
model. Because g has slightly more variability with wavelength, this decrease is more significant 
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in the blue/green (4.9%) compared to the near-infrared (2.9%).  As expected, the alveolar size 
and volume ratio affect µs values. 
 
Table 11. Scattering properties of human alveoli at discrete points along the respiratory cycle. 
Values are averaged over the spectrum modeled. ASL thickness modeled is 0.5% and 1% of ralv at 
VTmax. 
µs (cm-1) 
 No ASL 0.5% 1% 
RV 118.73 ± 0.73 118.31 ± 0.71 118.31 ± 0.74 
FRC 116.92 ± 0.59 116.61 ± 0.55 116.61 ± 0.55 
VTmax 114.15 ± 0.57 113.87 ± 0.56 113.86 ± 0.56 
TLC 98.36 ± 0.44 98.18 ± 0.42 98.16 ± 0.42 
g 
 No ASL 0.5% 1% 
RV 0.811 ± 0.001 0.824 ± 0.001 0.827 ± 0.001 
FRC 0.811 ±  0.001 0.821 ± 0.002 0.823 ± 0.001 
VTmax 0.811 ± 0.001 0.821 ± 0.002 0.822 ± 0.001 
TLC 0.810 ± <0.001 0.818 ± 0.002 0.820 ± 0.002 
µs’ (cm-1) 
 No ASL 0.5% 1% 
RV 22.45 ± 0.02 20.89 ± 0.09 20.44 ± 0.06 
FRC 22.1 ± 0.02 20.84 ± 0.17 20.67 ± 0.07 
VTmax 21.63 ± 0.01 20.41 ± 0.16 20.26 ± 0.08 
TLC 18.66 ± 0.01 17.86 ± 0.18 17.63 ± 0.14 
 
 
 
4.5 Modeling pathogenic states and animal models of disease 
 We also investigated the effect of ASL thickness on the scattering properties of the lung. 
Values for ASL thickness found in the literature spanned two orders of magnitude. Five points 
along this range were selected to compare scattering properties. It becomes clear that while the 
alveolar size and density affects µs and ASL thickness affects g—and µs’ by extension.  At a 
constant alveolar volume (corresponding to VTmax), a thicker ASL layer leads to a higher g 
(Figure 21b). A phase shift between the µs and g also begins to emerge, and µs’ becomes more 
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variable along the spectrum (Figure 21c). This insight can be applied to pulmonary pathologies. 
In the case of acute lung injury, the alveolar wall can become leaky, and fluid begins to fill the 
alveoli, resulting in pulmonary edema. Also, chronic pulmonary diseases such as asthma and 
cystic fibrosis result in a collection of mucous in the airways. While the ASL in cystic fibrosis 
patients actually gets thinner, the refractive index of ASL and mucous are similar, so the thicker 
mucous layer can be modeled as a thickening ASL layer106, 107. Table 12 shows the scattering 
properties of pathological thickening of this layer, and a full pulmonary edema, averaged over 
the modeled wavelength. The g value continues to rise with layer thickness, and a full edema—
collapsing the model inner diameter—results in such a high g that the reduced scattering falls 
below 1% of µs. This also converges with the simple Mie scattering model of a scatterer with a 
refractive index of 1.35 (roughly equivalent to water, blood and mucous). 
 
Figure 21. At a constant lung volume, µs is similar for all ASL thicknesses modeled (a). The 
change in baseline and phase of g (b) causes a shift in µs’ and leads to unique spectral features (c). 
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Table 12. Alveolar scattering values with pathological thickening of fluid in alveoli (ASL, 
mucous, or edema fluid).  
ASL (µm) µs (cm
-1) g µs’ (cm
-1) 
1.5 113.82 ± 0.57 0.820 ± 0.001 20.49 ± 0.05 
2.0 113.85 ± 0.65 0.822 ± 0.001 20.26 ± 0.04 
3.0 113.93 ± 0.99 0.826 ± 0.002 19.81 ± 0.03 
5.0 113.91 ± 0.84 0.834 ± 0.001 18.95 ± 0.02 
Edema 113.81 ± 1.37 0.991 ± <0.001 1.026 ± 0.004 
 
 Finally, we have also modeled the alveolar and ASL scattering in different animal models 
of pulmonary disease. Alveolar density and diameter changes between species, so the scattering 
modeled in human lungs cannot be extrapolated to these models. Using values from Mercer et. 
al., we have calculated the alveolar diameter at VTmax for macaque, rabbit, rat, hamster, and 
mouse lungs (Table 13)96. Values from Mercer et. al. were in agreement with previous studies 98, 
99, 105, 108. These values assume: 1) the lungs in Mercer et. al. were fixed at FRC and 2) the 
airspace volume at VTmax scales the same as human lungs (roughly 50% TLC). Using these 
values and an ASL thickness of 100 nm, µs, g, and µs’ were modeled for each species (Table 
14). While the alveolar size and density obviously affect the material scattering characteristics, it 
is important to note the model sensitivity to refractive index. Specifically, this model estimates 
the refractive index of tissue to be 1.40. Tables 11, 12 and 14 show the scattering properties of 
lung tissue with these assumptions. However, the accepted values for refractive index of 
biological tissue range from ~1.38-1.41. For a given alveolar radius and shell thickness, the 
difference in µs’ at the extents of this range is ~6.6% (data not shown). This shows that an 
accurate estimation of the refractive index of the tissue layer is equally important as modeling 
the scattering contribution of the ASL. 
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Table 13. Values describing alveolar physiology for different animal models of pulmonary disease 
as reported by Mercer et. al. and calculated at maximum tidal volume. 
 
Fixed Lung Volume 
(mL) 
(Mercer et. al.) 
Alveoli/lung (x106) 
(Mercer et. al.) 
Alveolar Diameter 
(µm) 
(Mercer et. al.) 
Human 2494 ± 300 486.0 ± 37.0 225 ± 15 
Macaque 313 ± 10 85 ± 3.0 212 ± 10 
Rabbit 59.9 ± 5.4 64.9 ± 7.0 97 ± 5 
Rat 8.4 ± 0.5 19.7 ± 2.0 94 ± 4 
Hamster 2.7 ± 0.5 6.9 ± 1.0 74 ± 2 
Mouse 0.7 ± 0.1 4.2 ± 1.0 58 ± 4 
 
Air space 
at VTmax (mL) 
Alveolus volume 
at VTmax (µm3) 
Diameter 
at VTmax (µm) 
Human 2500 5.14E+06 214.17 
Macaque 300.96 3.54E+06 189.10 
Rabbit 57.60 8.87E+05 119.23 
Rat 8.08 4.10E+05 92.17 
Hamster 2.60 3.76E+05 89.57 
Mouse 0.67 1.60E+04 67.39 
 
Table 14. Alveolar scattering for humans and animal models. 
 µs (cm
-1) g µs’ (cm-1) 
Human 114.01 ± 0.55 0.818 ± 0.001 20.75 ± 0.13 
Macaque 129.17 ± 0.61 0.818 ± 0.001 23.49 ± 0.14 
Rabbit 205.11 ± 1.31 0.819 ± 0.001 37.14 ± 0.21 
Rat 265.53 ± 2.08 0.820 ± 0.002 47.93 ± 0.26 
Hamster 273.24 ± 2.15 0.820 ± 0.002 49.30 ± 0.27 
Mouse 363.50 ± 2.87 0.820 ± 0.002 65.30 ± 0.33 
 
 
In conclusion, we have used a concentric sphere Mie scattering model to show the effects 
of ASL thickness on alveolar scattering at discrete points along the respiratory cycle, compared 
normal and pathological ASL/mucous thickness, and compared scattering across multiple 
species. It is important to note that these values are representative of the alveolar scattering, and 
that the absorption and scattering of the tissue of the lung will also play a role in the organ’s bulk 
optical properties. This model suggests that the higher anisotropy provided by the ASL 
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contributes to the diffusive properties of the lung seen in previous experiments and modeling of 
intravital pulmonary illumination [10, 11]. These results show the potential and versatility of this 
model to analyze optical scattering in a dynamic in vivo environment. 
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5. MONTE CARLO MODELING FOR OPTIMAL ILLUMINATION OF MOUSE LUNG * 
 
5.1 Illumination of mouse lung for detecting fluorescent targets 
 Whole-animal imaging is a powerful tool to measure biological fluorescence and 
bioluminescence in vivo; however, the thickness of tissue that the optical excitation and emission 
must traverse leads to low sensitivity for optical targets located deep within the body42. A small 
animal whole-body imaging system using epi- or trans-illumination [Figure. 22(a)-22(b)] has 
been employed to detect a tdTomato-expressing strain of mycobacteria (Bacillus Calmette-
Guerin - BCG) or Mtb-specific near infrared (NIR) reporter enzyme fluorescence (REF) probes 
in vivo in a mouse model39, 40, 109, 110. These external illumination methods allow for longitudinal 
studies, but unfortunately, suffer from a relatively high detection threshold compared to 
physiologically relevant infectious doses of 1-10 bacteria111. A pulmonary bacterial load of 105 
colony forming units (CFU) or higher is needed to effectively detect signal. This high detection 
threshold limits these methods when determining therapeutic efficacy of antimicrobials for 
pathogenic bacteria. Recently, a microendoscope has been incorporated into the animal imaging 
system as an alternate illumination source to more effectively deliver the higher energy 
excitation light into the lung of the animal where the bacterial fluorescent target resides [Figure. 
22(c)]. This addition to the imaging system improves the detection threshold by orders of 
magnitude 45, 83. 
                                                 
* Reprinted with permission from “Optical model of the murine lung to optimize pulmonary illumination” 
by Durkee, Madeleine S., Nooshabadi, Fatemeh, Cirillo, Jeffrey D., Maitland, Kristen C., 2018. Journal 
of Biomedical Optics, 23, 071208, Copyright 2018 by International Society for Optics and Photonics. 
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Figure 22. Fluorescence whole-animal imaging of mice can be accomplished through multiple 
illumination pathways including (a) external epi-illumination, (b) external trans-illumination, and 
(c) internal illumination with a microendoscope (ME) light source.  
 
 The sensitivity of whole-animal fluorescence imaging is also dependent on animal 
position. Figure 23 shows the irradiance collected from infected mice, including signal, tissue 
autofluorescence, and any source leakage. External illumination suffers from a high detection 
threshold at both ventral and dorsal positions. Fluorescence detection with internal illumination 
is also position dependent, with the dorsal position having an improved signal to noise ratio83. 
Whether these differences stem from ineffective illumination of the lung or a limitation of 
collecting fluorescence signal is unknown, but this knowledge is integral to optimization of the 
imaging system for detection of low bacteria levels. A three-dimensional model of animal 
illumination will help explain differences in both the light source and animal position in 
effectively coupling excitation light into the lung where the bacteria reside. 
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Figure 23. Position of the mouse in the imaging system effects collected fluorescence. Mice were 
intratracheally infected with 106 colony forming units BCG and administered REF substrate 24 
hours post-infection. Fluorescence distribution is different with external epi-illumination in the 
ventral (a) and dorsal (b) position. Under the same infection conditions, detected fluorescence 
intensity with internal illumination also varies for mice imaged in the ventral (c) and dorsal (d) 
positions. Although the fluorescence signal is higher in the ventral position (c), the signal to noise 
ratio was found to be significantly higher for the dorsal position (d).83 All radiance values are 
measured in photons/second/cm2/steradian. 
 
 Radiative transport models, specifically Monte Carlo simulations, are a powerful tool in 
quantifying the photon flux within biological tissue to help with optimizing medical and 
biological imaging techniques56, 112. These models are a stochastic version of the radiative 
transport equation (RTE) in which the optical properties of the material—in this case, biological 
tissue—determine the path of a photon through that material. Therefore, an accurate solution to 
the RTE can be generated with a sufficiently high photon count. The scope of the application of 
Monte Carlo methods to biological systems has been expanded to represent complex, 3D 
biological structures, ranging from cutaneous blood vessels to a whole-mouse model, by using a 
variety of methods including voxelated models and triangulated meshes 113-118. 
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 We are primarily interested in light transport within the lung as the predominant organ 
affected by tuberculosis. However, to compare the effects of external illumination and different 
animal positions to internal illumination with a fiber optic source, we must also simulate the 
torso of the animal, and other organs that may have a significant effect on delivery of excitation 
light to fluorescent targets within the lung. LightTools (Synopsys, Inc.) illumination software 
uses the Monte Carlo method to track photons through free space and turbid media. This 
software has been used to model radiative transport in multi-layer epithelial models 119 and in a 
more complex whole-finger model for the design of a ring pulse oximeter 120. For the purposes of 
designing a full-torso mouse model with external and internal illumination, the airway is a 
primary component of our illumination model. A solid model of the airway was imported into 
LightTools for the illumination model. The model described below compares various strategies 
of external and internal illumination of a mouse torso, including airway, lung, heart, and other 
soft tissues, to determine the optimal illumination strategy for sensing fluorescent bacteria or a 
bacteria-sensing probe at a low bacterial load in a live mouse. The system is modeled at visible 
and NIR wavelengths to account for fluorescence from genetically-modified bacteria (visible), 
and the bacteria-sensing fluorogenic probe (NIR) 45, 83. Rapid evaluation of modifications to the 
internal illumination system, including addition of a light diffuser tip, positioning of the fiber 
source within the airway, and modified divergence angle of the fiber source, are enabled by the 
computational model without the need for extensive animal experiments. 
5.2 Phantom design and simulation validation 
In the development of a computer model to simulate light transport in the mouse lung, a 
simplified physical lung phantom was first designed to validate the computational model. Optical 
properties of excised mouse lung tissue were experimentally measured and used as inputs into 
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the simplified model and phantom design. The validation model consisted of a block tissue 
phantom with the optical properties of a deflated mouse lung and a mesoscale, simplified airway. 
Once validated with imaging of the phantom, a more complex and anatomically representative 
airway, lung, and torso structure was generated in the computer model. Various illumination 
configurations were tested using this model. All Monte Carlo simulations (validation studies and 
the advanced model) were completed using LightTools Illumination software on a personal 
desktop computer (6 core Intel i7 processor, 3.3GHz, 72GB RAM). 
5.2.1 Optical properties of healthy and infected mouse lung 
 Optical phantoms were created from PDMS with India ink and titanium dioxide (TiO2) to 
replicate the measured absorbing and scattering properties of lung tissue, respectively. Two 
separate phantoms were created to simulate the optical properties of the tissue at the two 
wavelengths of interest (Table 15). Phantom 535 contains 3 mg TiO2 and 7.5 µL India ink per 
gram of PDMS and approximates infected lung measured at 535 nm. Phantom 730 contains 2 mg 
TiO2 and 3.5 µL India ink per gram of PDMS and models the infected lung at 730 nm. Both 
phantoms were imaged at both illumination wavelengths to provide additional validation data for 
the computer model. 
5.2.2 Phantom fabrication 
 Structurally, the lung has a unique surface for internal illumination through the trachea. 
On the mesoscale, the airway branching results in a complex air-tissue interface where a stark 
contrast in refractive index between air and tissue will affect the transport of photons within the 
organ. The airway was included in both the computational and physical models of the 
physiological system to better evaluate the accuracy of the simulation to a biological 
environment. A fractal tree mock-airway was designed and printed out of a base-soluble material 
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as an internal mold for the PDMS airway phantom. The preliminary structure shown in Figure 
24(a) was designed to be easily 3D printed in-house on a fused deposition modeling (FDM) 
printer (Stratasys®, Fortus360mc). This soluble structure was secured in a rectangular mold for 
pouring the PDMS and optical particle mixture. Upon curing, the mock airway was dissolved out 
of the phantom, leaving an airway void and a pathway for internal illumination of the solid 
rectangular block phantom. This method of incorporating complex geometry into a silicone 
matrix has previously been employed for designing flow systems for surgical training121. 3D 
printing is also becoming a popular method for fabricating phantom molds and for 
manufacturing the phantoms themselves 122-124. The phantom fabrication methods used here are 
described in full detail by Durkee et. al125. 
 
Figure 24. 3D models for photon transport in LightTools. The rectangular phantom used for 
validation studies has a 4-generation fractal tree as a model airway (a). The full-torso model of the 
mouse includes a more anatomically accurate model airway (b) and lungs of comparable volume 
to that of a mouse. The lung and heart are immersed in a cylindrical model of other soft tissues (d-
e). The star in (b) is the location of the internal illumination source. 
 
5.2.3 Validation of illumination model with phantom imaging 
 Imaging of the lung phantoms was performed in an IVIS Lumina II (PerkinElmer) whole-
animal optical imaging system to validate the computer simulation of the analogous simplified 
model. For internal illumination, the IVIS illumination pathway was blocked, and a fiber 
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microendoscope light source was inserted into the airway void until the tip was in contact with 
the wall at the bifurcation126. The microendoscope output power was set at 1 µW for both 
wavelengths. The IVIS emission filter wheel was set to ‘open’ to collect the illumination light, 
and camera settings were set to automatic exposure. Total irradiance of the top surface of a 
phantom measured by the IVIS imaging system was compared to the simulation for 535 nm and 
730 nm illumination studies.  
 
Figure 25. Validation of the computational model with IVIS imaging of optical phantoms shows a 
similar irradiance profile at the phantom surface. Phantom 535 is shown here illuminated 
internally with 535 nm (a) and 730 nm (c) microendoscope sources. The simulation replicates total 
flux output to the detector (Table 15) and the irradiance profile at 535 nm (b) and 730 nm (d). 
 
The measured optical properties of the phantoms and the accuracy of the simulation to 
reproduce the experimental IVIS imaging results are shown in Table 15. The simulation was able 
to replicate the total photon flux within 5.0% for both phantoms at both wavelengths. Figure 25 
also demonstrates a similar irradiance profile between phantom imaging and the computational 
model for both wavelengths. After verifying agreement between the computational and physical 
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models, we expanded on the computational model to better mimic the murine anatomy, as shown 
in Figure 24. All results following verification are from this advanced model. 
 
Table 15. Absorption coefficients (µa) and reduced scattering coefficients (µs’) of infected mouse 
lung and validation phantoms at wavelengths of interest. Percent error between total flux measured 
experimentally with the phantom and simulated in the model. 
Measured infected, deflated mouse lung tissue 
Wavelength (nm) µ
a
 (cm
-1
) µ
s
’ (cm
-1
) 
535 5.99 ± 1.92 43.5 ± 14.6 
730 1.06 ± 0.49 35.2 ± 11.7 
Phantom properties and validation results 
Phantom 535 µ
a
 (cm
-1
) µ
s
’ (cm
-1
) 
Error [%] of 
Simulation v. 
Phantom 
535nm 4.53 67.4 4.59 % 
730nm 3.75 52.1 4.40% 
Phantom 730 µ
a
 (cm
-1
) µ
s
’ (cm
-1
) 
Error [%] of 
Simulation v. 
Phantom 
535nm 2.22 44.5 3.66 % 
730nm 1.75 35.3 2.86% 
 
5.3 Simulation design of murine anatomy and optical properties 
 Once the simulation was validated using the simplified phantom, the airway structure 
within the simulation was updated to be more representative of the largest branches of the 
murine airway [Figure 23(b)] based on computed tomography (CT) images127, 128. The simulated 
lung was designed around the airway [Figure 23(c)], with the general anatomy and size 
constraints of the mouse lung modeled after similar CT images 129, 130. In vivo, the lung is a 
dynamic and porous organ that scatters light much more effectively than solid tissue. Within the 
computational model, the lung properties can be adapted from the measured values of deflated 
lung to represent inflated lung at different points in the respiratory cycle. Here, we optimize the 
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computational model to represent a point in the cycle indicative of passive respiration in order to 
analyze the illumination performance of external and internal illumination sources. The heart and 
other soft tissues are also represented [Figure 23(d)-23(e)] to more effectively model external 
illumination and to address photons scattered into the lung after traversing other tissues. 
5.3.1 Simulated properties of inflated mouse lung 
 The optical properties of the lung were measured after excision, assuming the organ was 
deflated. In a living mouse, the lung will always have some level of inflation, with air making up 
at least 30% of the organ volume after expiration, and up to 90% of the organ volume after 
inspiration131, 132. The simulated optical properties can be mathematically manipulated to 
represent the scattering and absorption of an inflated lung, based on the optical properties of the 
deflated lung, and the alveolar size and density 95.  
For this model, we assumed a constant alveolar diameter of 55 µm 133. Alveoli were 
assumed to be spherical in the calculation of the volume of a single alveolus, Valveolus. A number 
density of alveoli was calculated based on mouse lung characteristics. First, because we have a 
static model, we assumed a constant level of inflation with air composing 80% of the organ 
volume. Using this inflation factor, fi, and the properties listed in Table 16, the number of alveoli 
(Nalveoli) in the lung was calculated using 
𝑁𝑎𝑙𝑣𝑒𝑜𝑙𝑖 = 𝑓𝑖
𝑉𝑙𝑢𝑛𝑔
𝑉𝑎𝑙𝑣𝑒𝑜𝑙𝑢𝑠
 . (21) 
The alveolar density, 
𝜌𝑎𝑙𝑣𝑒𝑜𝑙𝑖 =
𝑁𝑎𝑙𝑣𝑒𝑜𝑙𝑖
𝑉𝑙𝑢𝑛𝑔
 , (22) 
was calculated to be 9,195 alveoli/mm3. The alveolar density was used to find the new reduced 
scattering coefficient, µs’, of the inflated lung,  
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𝜇𝑠′𝑙𝑢𝑛𝑔 = 𝜇𝑠′𝑡𝑖𝑠𝑠𝑢𝑒 +  𝜇𝑠′𝑎𝑙𝑣𝑒𝑜𝑙𝑖 
= 𝜇𝑠′𝑡𝑖𝑠𝑠𝑢𝑒 + (𝜌𝑎𝑙𝑣𝑒𝑜𝑙𝑖𝜎𝑠(1 − 𝑔𝑎𝑙𝑣𝑒𝑜𝑙𝑖))  (23) 
(adjusted from Beek, et. al. 95), where µs’tissue was measured from the deflated tissue. Treating the 
alveoli as scatterers dispersed in lung tissue, the radius and refractive index of the alveoli allow 
the alveolar cross section to be used as the scattering cross-section (σs), as the alveoli fall into the 
regime of geometric optics 134. The anisotropy factor, g, of the alveoli was estimated at 0.695. The 
resulting reduced scattering coefficients (µs’) and mean free paths (MFP = 1/µs’) are comparable 
to that of liquid foams with a similar liquid fraction to the air-tissue ratio used in the lung 135, 136. 
 
Table 16. Properties of inflated mouse lung used to calculate approximate optical properties. 
*Lung tissue volume was calculated from lung volume and an inflation factor of 0.8. 
Inflated lung characteristics 
Property Value(s) in literature Value used in model 
Lung volume at max 
inspiration (mm3) 
1000-1500 133, 137, 138 1060 
Lung tissue volume (mm3) 100-200 139, 140 212* 
Alveolar diameter (µm) 35-75 100, 141 55 
Lung optical properties 
Wavelength 
(nm) 
Deflated µa 
(cm-1) 
Deflated µs’ 
(cm-1) 
Inflated µa 
(cm-1) 
Inflated µs’ 
(cm-1) 
535 5.99 43.57 1.20 130.84 
730 1.07 35.27 0.21 122.54 
 
  
The absorption coefficient, µa, of inflated lung was also adjusted because the path length 
available for absorption changes significantly with air in the tissue95. For the level of static 
inflation assumed in this model, only 20% of the total lung volume, Vlung, is actually tissue, 
Vtissue. With no absorption occurring in the air-space, the absorption coefficient is reduced 
according by this factor, 
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𝜇𝑎,𝑙𝑢𝑛𝑔 = 𝜇𝑎,𝑡𝑖𝑠𝑠𝑢𝑒
𝑉𝑡𝑖𝑠𝑠𝑢𝑒
𝑉𝑙𝑢𝑛𝑔
 . (24) 
5.3.2 Heart and other soft tissues 
 The heart is important in this simulation because of its high blood content, and therefore 
high absorption in the visible range. While a majority of the photons contributing to the 
illumination profile of the lung come directly from the internal source, some fraction of the light 
will escape into the surrounding tissue. The properties of that tissue, including the heart, will 
determine how much the illumination of the lung is affected by its surroundings. The heart is 
assumed to be mainly an absorber, and the optical properties of partially oxygenated blood are 
used for the heart in this model (Table 17)142. The remaining tissue includes muscle, fat, skin, 
and bone; although, bone is not included in this model for simplicity. Overall optical properties 
for the collective “other soft tissues” are estimated based on values from the literature51 and are 
listed in Table 17. These values were used to determine the mean free path (MFP) and 
transmissivity (T) as inputs for the heart and other soft tissue materials. LightTools was set to 
interpolate values to determine the properties of material at wavelengths within the range listed 
in Table 17. If a wavelength simulated was out of the range listed, the value closest to that 
wavelength is used. For example, the optical properties of the heart at 535 nm were identical to 
those listed at 665 nm in Table 17. 
 
 
 
 
 
 
 
 
 
 
65 
 
 
Table 17. Optical properties for other soft tissues from Ref. 30. Values denoted with ‘*’ were 
calculated from scattering coefficient and anisotropy factor. Values from LightTools biological 
materials library were used for heart optical properties. 
Epidermis 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
514 3.0 58* 
585 3.0 41* 
800 2.3 30* 
Dermis 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
514 4.4 139* 
585 3.6 99* 
800 4.0 62* 
Subcutaneous fat 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
520 4.4 33.1 
570 3.1 28.9 
820 1.0 19.8 
Muscle 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
633 1.21 8.9 
900 0.32 5.9 
Calculated properties for “other soft tissues” 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
514 1.84 17.19 
585 1.70 16.33 
800 0.644 10.96 
Heart 
Wavelength (nm) µa (cm-1) µs’ (cm-1) 
665  12.37 6.23 
960  4.97 4.04 
 
5.3.3 Illumination and detection parameters 
 The fiber bundle microendoscope used for internal illumination has a divergence half 
angle of 20.5º, and experimental protocol specifies the endoscope should be in contact with the 
tissue for imaging. This internal source was modeled as a point source with a divergence half 
angle of 20.5° to mimic the fiber bundle used in imaging experiments 45, 83. To model epi-
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illumination within the whole-body imaging system, dorsal and ventral external illumination 
sources were placed 20 mm away from the simulated phantom or torso and uniformly 
illuminated a plane located at the surface nearest to that source. Validation simulations were run 
with 1e6 photons with a source power of 1 µW. All simulations of the mouse torso model were 
run in triplicate with 1e5 photons. External illumination simulation times ranged from 30-45 
minutes, and internal illumination simulation times ranged from 3.5-4 hours depending on source 
wavelength. External and internal sources at both wavelengths were set to 1 mW total power 
emitted.  
Illumination of the lung was analyzed using average fluence rate in the lung and source 
efficiency, defined as average fluence rate in the lungs relative to average fluence rate in the 
entire simulated torso. Detection planes parallel to the coronal plane were placed at 0.5 mm 
intervals through the solid model of the torso to directly record photon flux, with bins of 0.1 mm 
x 0.1 mm in each collection mesh. The complete detection matrix is 200 x 250 x 35 elements, 
corresponding to a total of 1.75e6 elements (8750 mm3).  
Spatial distribution of the light within the lung was analyzed by fitting the average 
fluence rate in the detection planes to the exponential curve, 
𝑓(𝑥) = 𝑎 ∗ 𝑒−𝑏𝑥 . (25) 
where a is the average fluence rate nearest the source and b is the decay constant. For external 
illumination, a is calculated at the ventral or dorsal plane, and for internal illumination, a is 
calculated at the plane intersecting the internal source. Therefore, these decay curves move 
across the body for external illumination, and from the source outward for internal illumination. 
To quantitatively compare different sources, an average fluence rate for the entire lung was 
calculated from the collection matrix by masking each detection plane with the intersecting lung 
 
67 
 
 
geometry. The fluence rates from the masked data were averaged over the collection matrix to 
get an average fluence rate within the lung. The computational model of the mouse torso was 
used to evaluate 1) internal and external illumination, including ventral and dorsal positioning of 
the mouse; 2) the addition of a diffuser tip for radial illumination from the internal source; 3) 
positioning of the internal illumination source relative to the tracheal bifurcation; and 4) 
divergence angle of the optical fiber output. 
5.4 Intravital v. external illumination of mouse lung 
 As described earlier, the position of the mouse relative to an external illumination source 
has an effect on the signal collected from a fluorescent target within the lung. The three-
dimensional illumination of the lung was analyzed for external illumination from the dorsal and 
ventral sides, and for internal illumination. An internal source in contact with the tissue with a 
divergence half angle of 20.5° was used for the comparison between internal and external 
illumination.  
Figure 24(e) shows a transverse view of the optical model, with the dorsal and ventral 
sides indicated. The asymmetry between dorsal and ventral causes a difference in the 
illumination profile of the lung [Figure 26(a)-26(b), 26(d)-26(e)]. Both positions yield an 
exponential decay in fluence rate with depth in the lung [Figure 26(g)]. The decay constant, b, 
varies for both orientation of the external source and wavelength (p < 0.0001) according to a 
comparison of fits of a nonlinear regression for each illumination strategy (Table 18). The 
difference in penetration depth of external illumination is most drastically affected by the heart, 
the main organ between the source and the lung in the ventral position. As a highly absorbing 
organ (due to blood content), the heart prevents a portion of the illumination from reaching the 
lungs, resulting in a lower a-parameter in the corresponding decay equations in Table 18. 
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Figure 26. Maximum intensity projections of fluence rate (mW/mm2) are shown for ventral 
external illumination (a, d), dorsal external illumination (b, e), and internal illumination (c, f). 
Greater penetration can be seen at the excitation wavelength for the REF NIR probe (d-f) 
compared to that of tdTomato (a-c). All projections with epi-illumination are normalized to have 
the same maximum. Internal illumination projections are saturated to that maximum to better 
represent the fluence rate on the same scale. The average fluence rate within the lung decreases 
exponentially with distance away from the source for both external illumination (g) and internal 
illumination (h). 
 
Internal illumination avoids the problem of traversing other tissues, and minimal light is 
lost to surrounding tissue. The illumination still decays exponentially with distance from the light 
source [Figure 26(h), Table 18], but the efficiency of the light source at coupling light into the 
lung is much higher (>60%), compared to less than 10% efficiency for either external 
illumination orientation at either wavelength (Table 19). The average fluence rate in the lung 
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with the internal source is also significantly higher than external illumination when the sources 
have equal power (p << 0.0001). 
 
Table 18. Decay of fluence rate within lung. Average power was fit to a decaying exponential:  
f(x) = a*exp(-b*x) where a is the initial average fluence rate at the detection plane nearest the 
source and b is the decay constant. 
External illumination 
(decay from lung surface 
inward) 
Initial average 
fluence rate 
(mW/mm2) (a) 
Decay constant 
(b) 
R2 
Dorsal- 535nm 0.9546 1.642 0.9958 
Ventral- 535nm 0.4476 1.631 0.999 
Dorsal- 730nm 1.563 0.8641 0.9978 
Ventral- 730nm 0.9782 0.997 0.9977 
Internal illumination 
(decay from trachea outward) 
Initial average 
fluence rate 
(mW/mm2) (a) 
Decay constant 
(b) 
R2 
Trachea Dorsal side- 535nm 4.948 1.194 0.9985 
Trachea Ventral side- 535nm 4.874 0.9384 0.9852 
Trachea Dorsal side- 730nm 9.476 0.6618 0.999 
Trachea Ventral side- 730nm 8.785 0.6207 0.9936 
 
 
Table 19. Ability of different illumination sources to couple light into the lung. 
Illumination 
Efficiency at 
535 nm 
Average 
fluence rate at 
535 nm 
Efficiency at 
730 nm 
Average 
fluence rate at 
730 nm 
External- Dorsal 3.14% 0.064 µW/mm2 2.77% 0.20 µW/mm2 
External- Ventral 1.05% 0.020 µW/mm2 1.21% 0.089 µW/mm2 
Internal 66.66% 3.8 µW/mm2 76.92% 8.9 µW/mm2 
 
Previous animal experiments show a difference in fluorescence detected in different 
positions of the mouse in the imaging system, specifically in positioning the mouse ventrally or 
dorsally within the imaging system83. Simulations of dorsal and ventral external illumination 
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show that positioning the mouse dorsally with respect to the external imaging source more 
effectively couples the excitation light into the lung, supporting previous experimental results. 
The main explanation for this is the location of the heart within the thoracic cavity. At visible 
wavelengths, the heart and blood are highly absorbing. In the NIR, the heart does not absorb as 
much light, but it increases the path length that a photon must travel to arrive at the lung, 
increasing the likelihood that a photon is absorbed or scattered away from the lung. This model 
demonstrates the effect of the heart on ventral illumination. The simplification of all other 
biological tissues into one layer is an approximation, but is anatomically similar from either side 
of the animal, incorporating skin, other soft tissue, and rib cage (not included in this model), 
which are all present both ventrally and dorsally.   
5.5 Intravital illumination source manipulation 
 The goal of the internal illumination source is to better couple excitation light into the 
tissue of interest, which may contain a fluorescent marker. For the specific application of 
detecting bacteria within the lung, there is no a priori knowledge about the location of the 
bacteria within the lungs of a given mouse. Diffuse, widespread illumination would therefore be 
an ideal tool for effectively detecting low numbers of bacteria within the lung. By simulating the 
physiology of the mouse and the optical system, the efficacy of different sources, different 
protocols, and even different animal positions can be analyzed without performing a large 
number of animal imaging experiments. 
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Figure 27. The fluence rate in the lung is sensitive to the parameters of the internal source, 
including diffuser tip (a), fiber position (b), and divergence angle of the fiber (c). The efficiency of 
a fiber diffuser increases as more source power is emitted through the tip of the fiber rather than 
radially (d). The microendoscope (ME) efficiency is more sensitive to position (e) than divergence 
angle (f). The average fluence rate in the lung follows similar trends to efficiency for all source 
manipulations (g-i). 
 
5.5.1 Fiber diffuser 
 Simulations and previous animal experiments indicate that internal illumination is more 
efficient than external illumination in either position. To estimate the potential for further 
improvement in illumination of the lung, modifications to the internal source were designed and 
tested with the optical model. First, a 5 mm long cylindrical light diffuser design was simulated 
[Figure 27(a)]. Diffusing fibers can be designed to preferentially emit light radially or out the 
distal end of the diffuser143. The percentage of power emitted from the distal end of the diffuser 
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relative to the homogeneous radial emission along the length of the diffuser was varied from 
10% to 100%. 100% power emitted from the tip of the diffuser is equivalent to the 
microendoscope condition. All simulations were performed with the diffusing fiber tip in contact 
with the tissue at the tracheal bifurcation. As less power was emitted along the length of the 
diffuser, the efficiency of the source at coupling light into the lung increased, along with average 
fluence rate in the lung. Trends in efficiency and average fluence rate were similar across both 
wavelengths of interest [Figure 27(d), 27(g)]. 
5.5.2 Position of internal illumination source 
 The original internal source modeled off the microendoscope specifications was 
simulated at different positions within the trachea to determine the effect of source placement on 
the illumination of the lung [Figure 27(b)]. Starting with the internal source in contact with the 
tissue at the tracheal bifurcation (0 mm), the endoscope was moved away from the tissue surface, 
up to 6 mm offset, effectively pulling the endoscope out of the airway. As the internal source 
was moved away from the tracheal bifurcation [Figure 27(e)], the efficiency increased 
moderately (p << 0.0001) until peaking near 2 mm distance from the bifurcation, then decreased 
below the initial efficiency at the tissue surface. In the region where efficiency hit a maximum, 
the simulation also indicated a maximum fluence rate within the lung [Figure 27(h)]. 
5.5.3 Divergence angle of microendoscope 
 The final source manipulation simulated was changing the divergence angle of the fiber 
bundle source [Figure 27(c)]. The effects of the divergence angle on illumination were simulated 
for angles above and below the current design (20.5° half angle). The simulation results show an 
upward trend with increasing angle [Figure 27(f), 27(i)], with a slope of 0.021 µW/mm2/° 
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divergence and 0.039 µW/mm2/° divergence for NIR and visible wavelengths, respectively (R2 > 
0.90). 
5.5.4 Optimal parameters of internal source 
 Illumination of the mouse lung was improved by independently changing the location and 
divergence of the internal source. The optimal source placement and optimal angle were 
combined to further improve the lung illumination. To find the optimal illumination, a 
divergence half angle of 40º and source locations of 0.7 mm and 1.7 mm away from the tracheal 
bifurcation were selected as inputs for the optical model. While these simulations show an 
improved illumination over the current experimental design, the optimal internal source 
parameters were achieved at the original 20.5° divergence half angle with the source placed 1.7 
mm away from the tissue surface at the tracheal bifurcation (Table 20). 
 
Table 20. Parameters and performance of optimized internal illumination. The bolded values are 
represented spatially in Figure 28. 
Modified Internal Source Parameters 
Divergence angle 20.5° 40° 20.5° 40° 40° 
Offset from tissue 0 mm 0 mm 1.7 mm  0.7 mm 1.7 mm 
535 nm 
Efficiency of 
coupling to lung 
66.66% 72.91% 74.40% 73.24% 62.90% 
Avg. fluence rate 
in lung 
3.8 µW/mm2 4.3 µW/mm2 4.9 µW/mm2 4.7 µW/mm2 4.4 µW/mm2 
730 nm 
Efficiency of 
coupling to lung 
76.92% 81.14% 82.05% 81.28% 72.30% 
Avg. fluence rate 
in lung 
8.9 µW/mm2 
10.1 
µW/mm2 
11.0 
µW/mm2 
10.8 
µW/mm2 
9.5 µW/mm2 
 
 
 The fiber diffuser was determined to be a poor illumination source in the trachea due to 
its low efficiency of coupling light into the lung. While it did show a more uniform illumination 
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of the lungs, the light coupled into the lung was much lower than the current microendoscope 
design. It is possible that a single lobe of the lung could be illuminated well by the fiber diffuser 
if the diffuser could be positioned deeper into the airway. In the current model, most of the 
power that was emitted along the length of the diffuser escaped through the trachea and into the 
surrounding tissue without ever reaching the lung. While positioning the diffuser deeper in the 
lung could remedy this, the current microendoscope does not have the capability to steer the tip 
in the airway. The current fiber bundle diameter (0.66 mm) is close to the inner diameter of the 
trachea (~1.3 mm), so there is also an anatomical size limitation with going much deeper in the 
mouse lung with these sources. Given a larger animal model, such experiments and 
corresponding simulations might be feasible.  
The most effective manipulation of the internal illumination source was the placement of 
the source within the trachea. While the simulations indicate an enhanced illumination of the 
lung model, the effect of source placement in vivo may vary between animals. The airway will 
follow similar branching patterns in every mouse, but variability in animal size and lung 
development will likely hinder the reproduction of the simulation results in vivo. A change in the 
experimental protocol would still be recommended, as a small distance between the light source 
and tracheal bifurcation should show an increase in delivery of light to the lungs in any animal.  
While changing the divergence angle of the source did not show the greatest increase in 
source efficiency or average fluence rate in the lung, it may be the best way to reproducibly 
enhance the illumination of the lung in animal experiments. An increase (p << 0.0001) in 
average fluence rate and coupling efficiency into the lung was found with the 40° half angle 
source relative to the current 20.5° half angle divergence of the micro-endoscope source. An 
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increase of average fluence rate in the lung is expected to be more consistent with this change to 
the optical system than with an optimized experimental protocol regarding source placement. 
5.5.5 Illumination with optimal source 
To illustrate the light distribution in the lungs, the radiant flux of each detection plane was 
combined into a 3D representation of intravital illumination of the lung at both wavelengths of 
interest. Maximum intensity projections for each orientation are shown in Figure 28(a)-28(c) for 
535 nm and Figure 28(d)-28(f) for 730 nm illumination to describe the spatial variance in the 
radiant flux. Video 1 [Figure 28(g)] of the complete rotating volumes at 535 nm (top) and 730 nm 
(bottom) show the dependence of radiant flux on the illumination wavelength due to the 
differences in optical properties.  
 
Figure 28. The three-dimensional illumination of the lung is shown for 535 nm (a-d) and 730 nm 
(e-h). Maximum intensity projections of the fluence rate (mW/mm2) in the coronal plane (a, d), 
sagittal plane (b, e), and transverse plane (c, f). A mask of the lung is also shown in each 
projection. (g) 3D rendering of the illumination is shown for both wavelengths.   
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5.6 Limitations of illumination model 
 The optical simulation was designed to analyze the three-dimensional illumination of a 
complex physiological system, and optimize the illumination source and protocol for detection of 
optical targets in vivo.  While the model is structurally and optically complex, it is important to 
note the assumptions and limitations of the optical model. An advanced phantom was designed 
to validate the ability of the optical model to replicate the boundary conditions of an internal 
airway and source placement within that airway. Due to manufacturing constraints, the airway 
modeled in the validation studies is less anatomically accurate than the airway in the full torso 
model. Assuming that this structural change does not affect the accuracy of the optical 
simulation, all tissue structure in the final model remains only an approximation of the natural 
anatomy.  
While the porous tissue of the lung is approximated with the shifted scattering properties, 
in reality, the airway is continuous with the alveolar ducts and sacs. The boundary between the 
airway and the tissue might lead to some inaccuracy in the model, but it is assumed to be an 
underestimation of the diffusive properties of the lung. As the airway acts somewhat as a light 
guide, a continuous structure would likely yield a more uniform illumination. Unfortunately, 
modeling a structure of this complexity within a high-photon count Monte Carlo simulation is 
highly intensive computationally.  
Simplifying all tissue except the lung and the heart into one bulk tissue layer might cause 
discrepancies in the model, particularly with the external illumination model. With fur 
unaccounted for on the external surface of the model, this model will overestimate the 
transmission of external illumination into the thoracic cavity. For internal illumination, the 
properties of this tissue layer have only a small effect on the illumination of the lung.  
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It is also important to note that both the internal and external power sources modeled are 
normalized to 1 mW. For animal experiments with this application, internal illumination power 
ranges from hundreds of microwatts to ~1.3 mW, and external illumination power is controlled 
by the IVIS software, but can be estimated to range from milliwatts to watts depending on filters 
and lamp settings. The average fluence rate calculation, used as a measure for illumination, 
scales well with source power, and efficiency of the source will not change. Therefore, with a 
consistent source power of 1 mW, the results for changing source power are easily predictable. 
As an estimation, if we were to operate at the American National Standards Institute (ANSI) 
standard for maximum permissible exposure (MPE) for a collimated beam on skin, the source 
power would scale by this value relative to the area of incidence of the source on the tissue. The 
smaller area of incidence of the internal source therefore requires a lower power than the external 
source to fall below the ANSI standard. While neither source is actually collimated, we are using 
these values to demonstrate the scalability of this model. Table 21 shows these values with the 
internal source in contact with the tissue and the external source incident on the cylindrical 
model, creating the largest difference in source power achievable while normalizing irradiance to 
the ANSI standard. The external source power becomes 1000x greater than the internal power. 
The corresponding average fluence rates for external illumination (Table 19) become roughly an 
order of magnitude higher than for internal illumination. However, as explained below, 
experimental limitations do not allow the external source to reach the same irradiance level as 
the internal source. If operation at the same irradiance levels was possible in the experimental 
setup, the efficiency rates and spatial distribution of light in the lung would remain poor for 
external illumination. 
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Table 21. Values relating source power in the simulations to ANSI standards for MPE of a 
collimated laser beam on skin for the wavelengths of interest.  
Area of incidence 
Internal source in contact with tissue 0.342 mm2 
External source 400 mm2 
535 nm 
MPE for skin 2.00 mW/mm2 
Internal source power 0.68 mW 
External source power 0.68 W 
730 nm 
MPE for skin 7.96 mW/mm2 
Internal source power 2.7 mW 
External source power 2.7 W 
 
Specifically for our application, the external source in the whole animal imaging system 
at the highest setting is roughly 3-8 mW, depending on the spectral filtering. This power is 
evenly distributed over the entire platform at the base of the chamber (~3500 cm2),144 and not 
over the surface of the animal (~400 mm2). A higher, yet still very safe, irradiance is achieved 
with the internal source, which operates at ~0.4-1.3 mW. This power is incident on a much 
smaller area than the external source (0.342 mm2). Using these values, the experimental 
irradiance ranges from 9-24 µW/mm2 for the external source and 1200-3800 µW/mm2 for the 
internal source, which is between 2 and 3 orders of magnitude difference. As stated earlier, the 
external source power would have to be about 1000x greater than the internal source to achieve 
the same irradiance. The comparisons drawn in this paper with the two sources both at 1 mW of 
power are therefore on the appropriate scale for comparing to experimental data. 
5.7 Summary 
 A three-dimensional Monte Carlo model of the mouse lung and torso has been developed 
to analyze the capabilities of different excitation sources to illuminate the lung. The model 
approximates the physiology of the mouse torso, and can simulate both internal and external 
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light sources. By isolating the lung tissue, the radiative transport within the lung has been 
compared across internal and external sources, and across modifications to the internal source. 
By optimizing the illumination of the lung with the computational model, the system will ideally 
be well-suited to detect infection of a range of bacterial loads, regardless of the localization of 
the infection within the lung. The results of these simulations do help to explain the 2-3 fold 
improvement of the detection threshold of bacterial load in previous experiments 45, 83. However, 
a full analysis of the limitations of fluorescence detection is planned by extrapolating this model 
to include fluorescent bacteria to estimate the effect of optimal illumination on fluorescence 
detection in various infection scenarios. The model indicates that the system is very sensitive to 
the placement of the internal source, a variable which is not easily controlled experimentally, and 
could change significantly between animals. However, slightly improved illumination of the lung 
can be achieved by increasing the divergence of the internal source, which is an instrumentation 
change that can more readily be applied to the system. Overall, the validated model approximates 
the physiology well, and can be used as a tool to help optimize the imaging system and animal 
imaging protocol for future experiments.   
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6. MODELING IN VIVO FLUORESCENCE DETECTION OF PATHOGENIC BACTERIA*  
 
6.1 Expanding the illumination model to cover fluorescence phenomena  
 We have previously modeled the illumination of the murine lung to understand and 
enhance widespread illumination to probe for infectious bacteria. The illumination model takes a 
mock murine torso with experimentally determined values and values from the literature for 
absorbing and scattering properties of mouse lung, heart, and bulk soft tissue51, 145. The model 
was used to describe the distribution of 535 nm and 730 nm light within the lung using three 
different illumination methods: 1) external illumination from the ventral side of the animal, 2) 
external illumination from the dorsal side of the animal, and 3) intravital illumination of the lung 
through an intratracheal microendoscope source. The intravital source was also manipulated 
within the simulation to describe the sensitivity of widespread illumination to scope position, 
divergence angle of the fiber microendoscope bundle, and diffusion efficiency of a fiber diffuser 
tip. We were able to gain an understanding of the physiological limitations imposed on each 
illumination method and provide a clear description of how source placement can affect inter-
animal variability in imaging experiments.  
 In this section, we take the information from the illumination model and test if the effects 
of the modeled source parameters translate to a better fluorescence signal or enhanced signal to 
noise ratio. We also examine placement of the internal source in more detail to determine if any 
correlation exists between internal source placement and fluorescence signal collected, which 
would indicate that the microendoscope camera signal could be a reliable guidance tool for 
                                                 
* Reprinted with permission from “A fluorescence model of the murine lung for optical detection of 
pathogenic bacteria” by Durkee, Madeleine S., Cirillo, Jeffrey D., Maitland, Kristen C., 2017. Clinical 
and preclinical diagnostics, Volume 10411 (2017), Copyright 2017 by International Society for Optics 
and Photonics. 
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optimal placement of the internal source. Finally, we predict the performance of this system in 
human children with different clinical presentations of TB.   
6.2 Preliminary infection model and validation 
Optical simulations of the lung were performed in LightTools (Synopsys Inc.). A solid 
model of a simplified three-dimensional branching structure was designed represent the trachea 
and bronchi of the lung. Optical properties of the tissue were based on ex vivo measurements of 
excised infected mouse lungs (Tables 2-3). For validation of the model, the simulation was 
completed using only these parameters for tissue properties. Alveoli, heart tissue, and bulk tissue 
were excluded in the validation. 
 An optical tissue phantom of the lung was created to validate the fluorescence model of 
the lung. The phantom was designed to have the same optical coefficients (absorption and 
reduced scattering) as ex vivo murine lung tissue. Small diameter nitinol wires were included in 
the molding process to allow fluorophores to be placed at known locations within the phantom. 
After curing, the wires were removed and replaced with capillary tubes of rhodamine b. The 
phantom was then imaged using internal and epi-illumination and external detection with the 
IVIS whole-animal imaging system. A corresponding simulation with identical parameters is 
shown in Figure 29.  This validation demonstrates that the simulation can predict the 
fluorescence signal with epi-illumination within an error of less than 3%. 
 After validating the simulation with the optical phantom, the physiology of the mouse 
was more accurately approximated. A cylindrical torso model including the lung, heart and bulk 
tissue (soft tissue, skin, and fur) was used to depict the in vivo environment. Separating the torso 
model into distinct regions also allows for the distribution of fluorophore (bacteria) to be 
localized to one region, specifically the lung for this application. Simulated fluorophores 
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matched the excitation and emission spectra of tdTomato (ex: 535nm; em: 585nm)45. The 
simulation is used to simulate murine infections with tdTomato-transfected BCG (bacillus 
Calmette-Guèrin), a strain derived by attenuation of Mycobacterium tuberculosis var. bovis. 
 
 
Figure 29. Validation of the fluorescence simulation. A) The IVIS image of the optical phantom 
shows the fluorescing capillary tubes emerging from the phantom. B) The optical simulations 
shows a very similar fluorescence distribution, with a percent error in radiant efficiency of only 
2.36%. 
 
 Infections of bacterial loads ranging from 100- 107 colony forming units (CFU) were 
simulated to determine the capabilities of the combined intra-vital illumination and small animal 
imaging system. A single CFU was estimated to contain 1000 tdTomato molecules. To predict 
the detection threshold of the optical system, the simulations represent the bacteria as being 
evenly distributed throughout the lung for each level of infection.  
Based on this uniform infection simulation, the level of detection for the optical system 
with internal illumination and external detection is roughly 2500 CFU (Figure 30). Once this 
threshold is reached, there is a linear relationship (R2 = 0.9994) between the bacterial load and 
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the fluorescence signal from the simulated infection. The number of photons collected for 
bacterial loads below 105 is low, resulting in larger error and more uncertainty. However, these 
data indicate that the signal collected for the system is limited by physiological variables, such as 
tissue scattering and absorption. These results correspond with previous animal experiments with 
the system45. Unlike the previous animal experiments, these simulations indicate a correlation 
with internal detection as well. It is possible that detection with the microendoscope is more 
sensitive to location of the bacteria within the lung, and this simplified model of a uniform 
spatial distribution of bacteria may not be sensitive to those differences in infection dynamics. 
 
 
Figure 30. A) Fluorescence signal from model related to bacterial load. Simulations of infections 
below the level of detection are not shown for clarity. For an evenly distributed infection, signal is 
expected to be linearly related to bacterial load in this simplified model. B) A characteristic 
irradiance map of a high bacterial load simulation is shown to reference the spatial distribution of 
fluorescence signal. 
 
Using this model that effectively retroactively validates the results from previous animal 
experiments, it is possible to test the effects of different light sources on sensitivity of the optical 
system, just as with the illumination model discussed in chapter 5. The first source tested was a 
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fiber diffuser. The diffuser was modeled to have the same diameter as the current scope with a 
length of 5 mm. The axial illumination of the diffuser was varied from 0% to 75% to view any 
effects on the bacterial signal (Figure 31a). While fluorescence is detected with all simulated 
diffusers, these results show a limitation of this model. The trachea is included in the lung layer, 
and is therefore part of the even distribution of fluorophores. This fluorescence signal detected 
on a plane that bisects the torso model is shown in Figure 31b. It is clear that the fluorescence 
signal is localized to the trachea and not the lung parenchyma, which is and unrealistic infection 
model.  
 
 
Figure 31. A) Predicted fluorescence signal after excitation with a fiber diffuser. The illumination 
profile of the fiber diffuser varies from 100% power coming from the tip of the diffuser (0/100) to 
only 25% reaching the tip, the remaining 75% of the power emitted from the length of the diffuser 
(75/25). ME: current microendoscope. B) Incident power density on a plane bisecting the torso 
model. The trachea is delineated in blue to show that fluorescence signal detected at lower CFU is 
in response to simulated bacteria residing in the trachea, and not the lung tissue. 
 
The second change in source, just as in the illumination model, was manipulating the 
divergence angle of excitation light from the fiber microendoscope (Figure 32). Neither 
 
85 
 
 
sensitivity nor level of detection was improved by changing the fiber bundle divergence. While 
the illumination model, showed a statistically significant enhancement in power density of 
excitation light within the lung for larger divergence angles, the enhancement does not translate 
to the fluorescence model. The simulation shows that while the illumination of the lung was 
enhanced by these source manipulations, the effect does not translate to fluorescence. A larger 
divergence angle has no effect on system sensitivity over the current intra-vital illumination 
design.  
 
Figure 32. Predicted fluorescence signal collected after excitation with a fiber source of varying 
numerical aperture. 
 
This preliminary model was able to retroactively validate previous animal imaging 
experiments, but there are still many limitations of the model. First, murine physiology can be 
better represented. In the next section, we discuss the addition of the airway surface liquid 
(ASL), a continuous lining of the airway that is hypothesized to improve delivery of light to 
more distal regions of the lung. Secondly, tissue autofluorescence (TAF) is very problematic for 
in vivo fluorescence detection, particularly in the visible wavelength range. Without TAF, all 
limitations come from the anatomical distribution of tissue absorption and scattering. Adding 
TAF will not only increase background, but the absorption of photons by the TAF molecules will 
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effectively increase the absorption coefficient of excitation light. However, it is difficult to 
elucidate the interplay between the excitation light, bacteria, and TAF excitation/emission 
without a more in depth model.  
6.3 Improved replication of the murine anatomy: TAF and ASL 
6.3.1 Improved representation of mouse torso anatomy 
This simulation builds on the illumination model discussed in Durkee et. al. 146 and the 
preliminary fluorescence model147. Briefly, the simulated mouse torso is composed of four 
compartments: bulk tissue, heart, lung, and a mucosal lining of the airway (ASL). The bulk 
tissue layer is representative of soft tissue, dermis, and epidermis. Fur is not accounted for in this 
model, but can be assumed to be a diffusing layer on the outer surface of the torso. Neglecting 
this effect, it can be assumed that this model slightly overestimates the fluorescence signal that is 
collected outside of the animal. The heart is modeled as a spherical organ with the optical 
properties of hemoglobin at a healthy (97%) oxygen saturation level.  
6.3.2 Airway surface liquid  
Anatomically, this model builds upon the previous models through the addition of the 
airway surface layer (ASL), a liquid layer lining the transport and respiratory airways in the lung 
99, 148, 149. In the large scale branching structure, the ASL is modeled as a 100 micron-thick layer 
coating the inner surface of the airway (Figure 33a). At the alveolar level, the ASL is modeled 
with the multi-layer Mie scattering model discussed in chapter 4. Rather than modeling the 
alveoli as air-filled sacs inside of the tissue to determine an alveolar scattering coefficient as 
done in the illumination model, the alveoli are modeled as coated spheres with a 1 micron thick 
ASL shell. Similar to the previous model, the overall scattering and absorption coefficients are 
calculated from the measured tissue properties and the calculated alveolar scattering. Figure 33b-
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33e show effect of this layer on the illumination of the lung. In these 100,000 photon 
simulations, the internal source was placed at the tracheal bifurcation, in contact with the ASL, 
(c&e), and offset within the airway (b&d). It is clear that the ASL has a “piping” effect on the 
illumination light when the source is in contact with this liquid layer. However, the overall 
power density of light within the lung is not significantly different when the source is offset from 
the ASL. The spatial distribution of light changes, but the overall power density of excitation 
light within the parenchyma does not. The ASL directs light deeper within the lung, resulting in 
an exponential decay outwards from the ASL, rather than outwards from the source location. 
 
Figure 33. Effects of ASL on illumination. A) A 3D representation of the torso structure in the 
simulation. The ASL is noted on the inset. B-E) Illumination on a plane bisecting the lung layer of 
the phantom. Panels B&C show illumination with the ASL included in the model with the internal 
source offset (B) and in contact with the ASL. Panels D&E show illumination with no ASL 
modeled with the source offset (D) and in contact (E) with the tissue at the tracheal bifurcation.  
 
6.3.3 Modeling tissue autofluorescence 
In addition to the ASL, this model also includes tissue autofluorescence (TAF). Including 
TAF in this model is integral for determining the SNR of the integrated imaging system. A single 
population of fluorescent particles was used to approximate all sources of TAF in the torso 
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(Figure 34). The emission spectra at excitation wavelengths ranging from blue (480 nm) to NIR 
(800 nm) at 20 nm intervals, the conversion efficiencies, and the absorption cross sections at 
each of these excitation wavelengths were taken from values in the literature150. Because up to 
80% of the lung layer is actually modeled as air (due to the Mie scattering calculations), the 
concentration of TAF fluorophores in the lung layer was set to be one order of magnitude less 
than in the bulk layer.  
 
Figure 34. Simulated tissue autofluorescence spectra when the tissue is illuminated with 535 nm 
light (black) and 730 nm light (red). Spectra are normalized to the 535 nm TAF peak.  
 
6.4 Spectral unmixing 
The largest source of noise in in vivo detection of pathogenic bacteria is tissue 
autofluorescence (TAF)45. Especially in the visible wavelength range, the endogenous molecules 
within the animal have a relatively high emission response to stimulation with visible light 52. 
Spectral unmixing is a mathematical processing technique to separate the animal TAF from 
desired signal. In a radiative transport model, the spectra of the TAF and the fluorophore are both 
inputs to the model, and for our model, TAF is uniform throughout each layer. Assuming the 
collected signal is a linear combination of the TAF and bacterial fluorescence, we can separate 
the signal from each population of fluorophores.  
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In animal imaging experiments, a series of emission filters are used to collect signal 
along the spectrum of light emitted from the animal. Usually, 3-5 images are taken along the 
fluorescence spectrum. The variable intensity of these images is used to estimate the signal 
collected from TAF and the signal collected from fluorescence signal. Ideally, this normalizes 
the inter-animal TAF variability; however, the limited number of collection points and spectral 
overlap between fluorophores (especially in the tdTomato wavelength range) makes it difficult to 
achieve an accurate estimation of bacterial signal. Additionally, the emission spectra from a 
fluorophore—tdTomato for example—will have a red shift after traversing perfused tissue 
(Figure 35). With no a priori knowledge of the depth of this embedded fluorophore, it is difficult 
to isolate its spectrum for the unmixing process. In the computational model, we have a well-
sampled tdTomato spectrum, and a simplified autofluorescence spectrum that does not vary 
between simulations (Figure 34). With these simplifications, we can still capture any interplay 
between the fluorophores, but can still analytically separate the spectral content collected.  
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Figure 35. tdTomato fluorescence traversing perfused tissue. As emitted photons travel through 
perfused tissue, the higher energy photons are more likely to be absorbed by hemoglobin. The 
result is a red-shifted fluorescence spectrum. The peak of the resulting spectrum (orange) will 
continue to shift from the original spectrum (blue) as it travels through more tissue. When sampled 
at discrete spectral points the shape of the spectrum appears quite different.  
 
6.5 Infection modeling in advanced murine torso model 
 The preliminary simulation of radiative transport simplified the mouse physiology and 
bacterial infection to isolate a few key variables related to the optical system. In this section, we 
expand on this model to better represent the murine physiology. We have improved the 
anatomical model of the mouse torso, improved the modeling of the optical properties of lung 
tissue, added a liquid lining to the airway, and modeled tissue autofluorescence. We have also 
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modeled fluorescence collection in both wavelength regions of interest: for detection of 
tdTomato fluorescent protein, and the bacteria-sensing fluorogenic probe. 
6.5.1 Simulating fluorescence for tdTomato-transfected BCG and exogenous CNIR probe  
As discussed earlier, we are modeling two different bacteria detection schemes: 1) 
tdTomato-transfected BCG and 2) an exogenous fluorogenic probe which is sensitive to the 
BCG/Mtb beta-lactamase enzyme (Figure 36). Because we do not have detailed information on 
the pharmacokinetics of the exogenous probe or the rate of conversion from the quenched to 
excitable state in vivo, we are assuming for this model that we are imaging at a post-
administration time point and probe dose that is equivalent to the quantum yield of the 
transfected bacteria. With this assumption, the conversion rate of a photon reaching a bacterium 
is the same between the two detection schemes, and the difference in signal collection comes 
from the underlying radiative transport phenomena at the excitation and emission wavelengths. 
In animal experiments, the cleaved NIR probe has been shown to build up in the infected 
macrophages, 39, 151 which would lead to a higher fluorescence for the same bacterial load. For 
simplification purposes, that effect is neglected in this optical model.  
 
Figure 36. Different mechanisms for detection fluorescence from bacteria include genetic 
modification (left), and sensing with an external molecular beacon (right). 
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6.5.2 Modeling infection 
6.5.2.1 Widespread infection 
The simplest pulmonary infection model is a widespread infection model. In this model, 
each infectious dose (control-107 CFU) is distributed evenly throughout the lung volume. 
Although the assumption of widespread infection is representative of late-stage, active TB, low 
doses were still modeled to estimate a detection threshold of the optical imaging system. Also, in 
mice at the time points imaged experimentally, there is not likely any isolation of bacteria. 
Within the model, fluorophores are defined as a single fluorescent molecule. However, 
transfected bacteria continually produces the fluorescent protein it is genetically modified to 
produce, so there is a baseline fluorescence level associated with 1 CFU 152-154. For the 
widespread fluorescence model, this value is assumed to be 1000 molecules per bacterium.  
In this fluorescence model of infection, we record total fluorescence signal at each 
wavelength, and mathematically unmix the TAF and bacterial signal. Placing the 
microendoscope in the same place in each animal is not only difficult, but impossible due to 
inter-animal anatomical variability. Additionally, in the previous illumination model146, we 
showed that the illumination of the lung by the microendoscope was very dependent on source 
location. To more accurately represent the experimental procedure, we have modeled signal 
collection with “pseudo-random” placement of the microendoscope. This “pseudo-random” 
placement assumes that the experimentalist can have millimeter precision in placing the scope, 
and that the projection angle of the source can divert within roughly 5 degrees in any direction 
from the central axis of the animal.  
Figure 37c-d shows the average unmixed bacterial signal with random source placement. 
The simulated fluorescence detected for this system varies with wavelength, animal position, and 
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illumination scheme. Table 22 compares the modeled detection thresholds for epi- and trans-
illumination with the animal in ventral and dorsal positions for tdTomato and CNIR 
fluorophores. Simulations of infection with a bacterial load lower than 100 CFU show 0 photons 
from the tdTomato emission spectrum reaching the detector, with the exception of one epi-
illumination trial, which is assumed to be a statistical anomaly due to the low (< 50) photon 
count on the simulated detector. We can assume that tissue absorption and scattering are the 
limiting factors in delivering of excitation photons to the bacteria and allowing transmission of 
emission photons outside of the body. For epi-illumination, the detection threshold was found to 
be position dependent, with dorsal illumination at both wavelengths showing roughly an order of 
magnitude decrease in detection threshold relative to ventral (Figure 37a). Trans-illumination 
was shown to be wavelength dependent, with the NIR probe yielding a lower detection threshold 
(Figure 37b). The detection threshold with internal illumination was also wavelength dependent, 
with collection from each position giving the same detection threshold (Figure 37c-d). A linear 
regression shows that collection in the dorsal position is more sensitive to CFU for epi- and 
internal illumination (Table 23). This indicates that a correlation between fluorescence signal and 
CFU is more likely to be achieved by imaging the mouse in the dorsal position. This model also 
shows a correlation between signal and CFU at the microendoscope tip (Figure 37c-d, Table 23), 
a result not found in past experiments. However, the data here is spectrally unmixed, and the 
current microendoscope design does not have multiple emission filters, so microendoscope 
detection does not currently have the capability of reaching this limit. 
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Figure 37. Unmixed tdTomato and CNIR probe fluorescence. A) For epi-illumination 
simulations, the unmixed detection threshold ranged from 10- 104 CFU. Error bars represent the 
post-unmixing standard deviation with n = 3 simulations. B) Trans-illumination simulations 
showed a detection threshold of 103 CFU, which was not dependent on position. C-D) Internal 
illumination yielded a wavelength-dependent detection threshold at every collection position.  
 
Table 22. Simulated detection thresholds for fluorescence detection are wavelength dependent 
after spectral unmixing for all internal and trans-illumination. The epi-illumination threshold is 
dependent on the positioning of the mouse. 
tdTomato 
  Ventral Dorsal Scope 
Epi-illumination 103-104 102-103 N/A 
Trans-illumination 103-104 103-104 N/A 
Internal illumination 103-104 103-104 103-104 
CNIR probe 
  Ventral Dorsal Scope 
Epi-illumination 103-104 102-103 N/A 
Trans-illumination 102-103 102-103 N/A 
Internal illumination 102-103 102-103 102-103 
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Table 23. Simulated fluorescence signal was linearly correlated with CFU. For epi- and internal 
illumination, the dorsal position was the most sensitive, while trans-illumination showed no 
position dependence. 
 Trans-illumination 
 tdTomato CNIR 
 Sensitivity 
([photons/sec]/CFU) R
2 Sensitivity 
([photons/sec]/CFU) R
2 
Dorsal 2.00E+08 0.988 2.00E+09 0.9533 
Ventral 2.00E+08 0.8275 2.00E+09 0.9553 
 
Epi-illumination 
 Sensitivity 
([photons/sec]/CFU) R
2 Sensitivity 
([photons/sec]/CFU) R
2 
Dorsal 4.00E+09 0.988 2.00E+10 0.8655 
Ventral 4.00E+08 0.9998 9.00E+09 0.9708 
 Internal illumination 
 Sensitivity 
([photons/sec]/CFU) R
2 Sensitivity 
([photons/sec]/CFU) R
2 
Dorsal 2.00E+06 0.9765 3.00E+07 0.9143 
Ventral 7.00E+05 0.9788 1.00E+07 0.9732 
Scope 2.00E+05 0.993 1.00E+06 0.9784 
 
Because the internal source is also a microendoscope capable of collecting fluorescence, 
this microendoscope could potentially be used as feedback to the experimentalist to optimize 
source placement before taking images, given a correlation between the signal at the scope tip 
and the externally detected fluorescence. To test this theory, we compared the fluorescence 
collected at the fiber tip to dorsally collected fluorescence (Figure 38). The fluorescence 
recorded on the dorsal detector and the internal detector from each pseudo-random internal 
source location is shown for 103 CFU in the tdTomato range (Figure 38a), and 104 CFU in the 
NIR range (Figure 38b). No correlation was found between the internal and external source 
locations. 
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Figure 38. Signal at the microendoscope tip and dorsal collection for six different positions of the 
microendoscope. No correlation between microendoscope signal and dorsal fluorescence was 
found for tdTomato (A) or CNIR probe (B). 
 
The illumination model showed an enhanced illumination for a higher divergence 
source146. However, the preliminary fluorescence model showed no significant enhancement of 
signal with a higher divergence155. To confirm this result, we also tested a source with a 40° 
divergence angle is this more advanced model. As with the internal illumination model with the 
20.5° divergence source, we modeled the fluorescence detected with random source placement. 
Figure 39 shows that in most cases, there was no significant enhancement in the average 
fluorescence collected. The 40° source was significantly (p < 0.005) better at detecting 100 CFU 
in the NIR range. It was also shown to be significantly better than the 20.5° source for detection 
of 104 CFU, specifically with ventral collection for tdTomato. However, the 20.5° source showed 
significantly better fluorescence detection (p < 0.05) for 106 CFU in the ventral position in the 
NIR range. There was no consistent change in standard deviation across all groups between the 
40° and the 20.5° source. This indicates that there is also no change in the robustness of the 
optical system with a higher divergence source because the inter-measurement variability is also 
not reduced.  
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Figure 39. Simulated fluorescence signal with internal illumination sources of 20° and 40° 
divergence angles. Only ventral collection with 104 CFU showed significant enhancement in the 
tdTomato range (p < 0.05) with increased divergence angle (A). Both dorsal and ventral collection 
with 102 CFU showed significant enhancement in the NIR range (p < 0.05) with increased 
divergence angle (B). However, there was also a significant decrease in fluorescence collection in 
the ventral position for 106 CFU in the NIR range (p < 0.05).   
 
6.5.2.2 Localized or cavitary infection: optical model of low bacterial loads 
For the larger infectious doses, assuming an even distribution of molecules is a valid 
assumption because the bacteria are highly concentrated in the lung at those high doses (104+ 
CFU). However, this is a poor assumption for lower numbers of bacteria. Therefore, we have 
also modeled the infection as a bolus of fluorescent particles. This can be thought of as a single 
lesion or granuloma containing multiple fluorescent bacteria. Not only does this better represent 
a low bacteria load, it also better represents the early stages of human pathogenesis, when Mtb is 
contained in by the immune system in a localized granuloma. Localizing the infection to a bolus 
of fluorescent particles allows us to analyze the sensitivity of the integrated imaging system to 
the location of the bacteria within the lung. We have modeled this bolus of infection to represent 
100-103 CFU, and placed this “lesion” at five distinct points within the left lobe of the lung. None 
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of these locations or bacterial loads yielded a fluorescence signal statistically greater than 
control, indicating that the optical system is limited by tissue scattering at low bacteria loads. 
Without the ability to steer the endoscope deeper into the lungs, it is highly improbable that this 
system could get a high enough power density of excitation light to a cavitation or single CFU to 
produce a detectable signal. 
6.6 Limitations of the infection model 
 The simulation of pulmonary infection supports results from previous animal 
experiments. Although the illumination simulation discussed in chapter 5 suggests that a higher 
divergence angle would improve illumination, this enhancement does not propagate to an 
improved threshold of detection for CFU in either the preliminary or advanced fluorescence 
models of infection. In this section we examine the limitations and assumptions of the 
fluorescence models, and discuss where these assumptions falter and how they might 
misrepresent in vivo infection. 
 The main limitation of the current model is the representation of anatomy. First, the mock 
torso does not have a fur layer. For internal illumination, this is not a very big concern, mainly 
because the illumination light is significantly attenuated by the time it reaches the outside of the 
animal. On the emission end of the process, the fur would act as a diffusing layer, mainly 
redirecting the emission light, but also absorbing and generating TAF. The redirection of the 
emission light will reduce overall signal collected and SNR, likely raising the detection threshold 
for bacteria. For external illumination, this fur layer would have a more significant effect. 
Illumination light would be reflected and scattered before entering the mouse, lowering the 
power density of excitation light reaching the lung. The attenuation of any resulting emission 
would be the same as the internal illumination case. The lack of this fur layer leads to a 
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discrepancy between the fluorescence model and previous experiments for both epi- and trans-
illumination techniques. Figure 36 shows the detection threshold of epi- and trans-illumination to 
be comparable to internal illumination (Figure 36) and a signal correlation with CFU down to 
this limit, which disagrees with past experiments. It is possible that with ideal spectral unmixing, 
these external illumination methods could reach the values modeled, but the fur of the animal 
generates too much reflection and TAF for the bacteria signal to be pulled out. Essentially, by 
not modeling this fur layer, we are modeling a system with much less background noise than 
occurs during in vivo imaging experiments. 
 Another pitfall of this model is that it does not account for inter-animal variability. The 
simplified geometry is assumed to be close to the average mouse, but variability in airway 
branching, animal weight, and relative lung size would affect system performance. Also, some 
mice have a higher TAF. The model assumes the same TAF for each trial, which is not the case 
in vivo. If a mouse has a higher metabolism or is more stressed than the others in its cohort, it 
could have a vastly different TAF intensity, and even a different spectrum. TAF also varies 
across the animal. The ears, feet, and tail of the mouse have minimal fur, and yield a different 
TAF spectrum. In animal experiments, this makes spectral unmixing more difficult, because the 
spectrum used for unmixing does not necessarily fit for all pixels. For this model, we used a 
single fluorophore population to represent general TAF. This will again result in a reduction of 
the noise and background relative to animal imaging.  
6.7 Summary of murine model of infection 
 We present results from an in-depth computational optical simulation of the mouse to 
investigate the performance of optical methods for detection of a pulmonary infection with Mtb. 
Retroactive validation with animal experiments demonstrate the accuracy of this fluorescence 
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model in replicating the results from animal experiments. Using the validated model, we can 
control physiological and system variables to better understand the interface between the optical 
system and the animal physiology. By controlling physiological variables and using a simplified 
TAF model, we were able to determine that tissue attenuation is the limiting factor for infectious 
doses below 100 CFU. We were also able to show that although the illumination model showed 
better illumination with a wider divergence angle at the endoscope tip, these results do not 
translate to fluorescence detection for either wavelength regime. The scattering-limited detection 
threshold for a mouse torso modeled without fur is between 10 and 100 CFU for internal 
illumination and external detection for the NIR, and between 100 and 1000 CFU for the 
tdTomato spectral region. A linear correlation between fluorescence signal and CFU is shown for 
all detectable, post-spectral unmixing signals—regardless of animal position or illumination 
method. One limitation of the model suggests that these values might be underestimating the true 
values. As shown in Figure 33, the ASL acts as somewhat of a light guide for the excitation light. 
In an animal, this layer is continuous between the large scale airway and the alveoli, which may 
provide even more efficient coupling of light in and out of the lung parenchyma. 
While none of the proposed manipulations of the internal source showed significant 
improvements across all bacterial loads, this model has been demonstrated as a readily available 
tool for feasibility testing of hypothetical enhancements. Based on the results from simulations 
so far, two changes can be recommended to enhance the imaging system. 1) Add more 
fluorescence filters to the microendoscope to allow for spectral unmixing. The signal as the 
scope tip was shown to have a correlation with bacterial load after spectral unmixing, albeit with 
a higher detection threshold than external detection methods. 2) Add a second, spectrally 
separated illumination source to analyze TAF.  Figure 40 shows an interesting result with 
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illumination strategy and TAF. While external illumination yields a higher TAF signal with 
visible wavelengths, TAF signal collected is higher in the NIR with internal illumination. Also, 
table 24 shows that the relationship between TAF at a given wavelength in preserved across 
animal position rather than external illumination strategy (epi- v. trans-illumination).  
 
Figure 40. A) Tissue autofluorescence decreases at higher wavelengths for external illumination 
in any position (VD = ventral illumination with dorsal collection, VV = ventral illumination with 
ventral collection, DD = dorsal illumination with dorsal collection, DV = dorsal illumination with 
ventral collection). B) For internal illumination, an inverse trend in tissue autofluorescence signal 
is found. (II = internal illumination with internal collection, ID = internal illumination with dorsal 
collection, IV = internal illumination with ventral collection). 
 
One of the simplifications of this model is that TAF is consistent throughout the torso and 
shows no regional dependence. Also, TAF intensity was not varied between trials. Animals show 
high variability in their TAF, between subjects and spatially within the same animal. Adding a 
secondary spectral illumination source would allow for a 2D TAF “map” for a given animal, 
which could be extrapolated to the spectral region of interest. Each animal could therefore serve 
as its own control, and spectral unmixing could better approach the theoretical limit. 
Fluorescence detection would become limited solely by tissue attenuation, and not by a high 
background (TAF) signal.   
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Table 24. Total TAF signal scales with wavelength at each position for external illumination. The 
trend does not hold for internal illumination.   
 730 nm TAF/535 nm TAF 
 Ventral Dorsal Internal 
Trans-illumination 0.409398 0.261786 -- 
Epi-illumination 0.405607 0.25142 -- 
Internal illumination 2.236976 1.548316 1.6532 
 
6.8 Preliminary model of human anatomy: A clinical outlook  
 With a few broad assumptions, simulation of murine infection can be extrapolated to 
predict feasibility in human infants and young children. TB remains one of the deadliest 
childhood diseases, largely due to poor diagnostic tools. It is estimated that, although childhood 
TB represents 3.5% of reported TB cases, the true burden is closer to 11% of TB cases156, but 
childhood TB is so underreported because it is so difficult to diagnose. Many rapid TB 
diagnostics rely on signals from the host immune system, indirectly determining if the patient 
has been exposed to the bacteria. However, young children—especially infants—have 
undeveloped immune systems, so their response to diagnostic tools and their disease progression 
vary from what is expected in adults. Because of this undeveloped immune response, infants are 
likely to progress to disease after the primary infection, and are very likely to succumb to 
disease.  
6.8.1 Clinical presentations of childhood TB 
 TB manifestation in children can be very different than adults, making detection, 
diagnosis, and treatment more difficult (Figure 41). First, the limited immune systems of children 
do not form granulomas (also known as cavitary TB), making the radiographic evidence of TB 
different or nonexistent. Many childhood TB cases are paucibacillary, meaning they occur with a 
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small number of bacteria. This is problematic for two main reasons: 1) a lower bacterial load can 
still lead to late-stage illness, and 2) lower numbers of bacteria lead to an even lower sensitivity 
of detection methods. Because young children cannot expectorate, collection of a sample for 
culture is difficult. In sufficiently equipped medical facilities, gastric aspirations can be 
performed to get a culture sample. However, this method has been shown to have only a 15% 
sensitivity157. Sputum can be induced from some children, which has a slight better sensitivity of 
about 40%158. The physical disease progression is also different, as the infection in children tends 
to spread to the lymph nodes, with nearly 85% of childhood TB cases exhibiting 
lymphadenopathy, with 85% of lymphadenitis cases localized to the hilar lymph nodes 157, 159.  
 
Figure 41. Clinical presentations of TB can vary. Adults usually exhibit cavitary TB, in which the 
bacteria reside in a focal lesion before reactivation and dissemination.  Children more frequently 
present with miliary TB, a widespread, multifocal infection. Young children are also more 
susceptible to lymphadenitis of the hilar lymph nodes. 
 
 In addition to paucibacillary infections, children are more likely to develop miliary TB. 
While miliary cases make up < 2% of TB cases160, 50% of miliary cases are in children161, with 
children also having a higher mortality rate162. Contrary to paucibacillary TB, miliary TB is 
associated with very high bacterial loads. The bacteria are encased in small (< 2 mm) “millet 
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seed” lesions disseminated throughout the lung and often also in extra-pulmonary sites 4, 163.  
These lesions have a much different radiographic presentation than cavitary TB, and often go 
unnoticed, with 50% of x-rays of miliary TB diagnosed as normal164. Miliary TB is also a 
sputum-negative manifestation of TB, even in adults 165, 166, and the tuberculin skin test is 
negative in up to 50% of miliary cases. Because of this, miliary TB is often diagnosed through 
bronchoscopy and biopsy.  
 With bronchoscopy part of diagnostic practices, detection of miliary TB is the 
preliminary goal for optical detection of clinical cases of TB. We are specifically interested in 
diagnosis in children because of the limited number of sensitive and specific diagnostic tools for 
childhood TB. Also, the size of a child makes optical detection more feasible. As visible and 
NIR light has a relatively high attenuation by biological tissue, smaller subjects would be more 
ideal to achieve a better sensitivity. The illumination light will probe a larger percentage of the 
tissue, increasing the likelihood of detecting a miliary infection. Also, the tendency for 
lymphadenitis gives a defined region to probe for signal, and with the hilar nodes residing close 
to the bronchial tree, the infection becomes even more accessible by bronchoscopy. Here, we 
extrapolate our mouse model of infection to model infection in a human child. We increase the 
size of the modeled torso, change the optical properties of tissue, and change the source 
parameters to match that of a clinically used fluorescence endoscope probe. We model miliary 
TB as a widespread, high-dose infection, and lymphadenitis of the hilar lymph nodes with a 
range of bacterial infections.  
6.8.2 Extrapolation of murine model to a human child 
 A young human child (< 5 years of age), has a total lung volume ranging from ~250 mL 
to ~1000 mL. For the purposes of this model, we assume a lung volume of 350 mL, 
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corresponding to the size of a young toddler (2-3 years of age)167. Young children also have a 
higher density of smaller alveoli. To model the alveolar scattering for the human child model, we 
used an alveolar diameter of 80 µm, and a volume fraction of 70%. The concentric sphere model 
discussed in chapter 4 was used to estimate alveolar scattering, and the tissue absorption and 
scattering from mice was scaled to represent a 30% tissue volume. Bulk tissue and heart layers 
used the same optical properties as the mouse model. Assuming a chest circumference of 55 cm, 
the mouse model is scaled up by a factor of ~10. The source power was increased to 25 mW, as 
the size of the clinical endoscope probe diameter (2 mm) is larger than the endoscope used in 
mouse experiments (0.66 mm). This larger area allows a higher power to be used while 
maintaining ANSI standard-safe irradiances at the probe tip. The miliary TB model of infection 
has a widespread distribution of fluorophores within the lung layer of the model, and the 
paucibacillary lymphadenitis model adds a hilar lymph node with fluorophores localized to the 
structure. Finally, because we are interested in diagnosis only for this model, we are only 
simulating infection in the NIR region. The assumptions for the pharmacokinetics of the CNIR 
fluorogenic probe are the same as discussed in section 6.5.1.  
6.8.3 Miliary model of childhood TB 
 A miliary infection was modeled in the scaled-up model by distributing fluorophores 
evenly throughout the lung layer. Although many miliary TB cases disseminate to 
extrapulmonary infection, we are strictly modeling pulmonary infection. Also, because miliary 
TB is characterized by a very high bacterial load, we only simulated infections with bacterial 
loads ranging from 104-1012 CFU. The internal light source was placed in at the distal end of the 
second generation of the fractal tree airway model, near the apex of the right lung. All 
simulations modeled this single lobe illumination, although the bacterial load was distributed 
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throughout the entire lung region of the model. Figure 42 shows that with internal collection, the 
microendoscope can detect signal for bacterial loads greater than 106 CFU. The data is linearly 
correlated with an R2 value of 1. 
 
Figure 42. Simulated bacterial fluorescence in a child model of infection indicates that miliary TB 
in a child could be detected at doses higher than 106 CFU. 
 
6.8.4 Lymphadenitis model of childhood TB 
 Previous simulations show that the optical system cannot detect very low levels of 
bacteria within the lung. However, if a paucibacillary infection were to cause lymphadenitis in 
the hilar lymph nodes, the localization of bacteria could allow for fluorescence detection of 
lower numbers of bacteria. Within this model, we place a spherical inclusion 4 mm in diameter 
near the apex of the lung, where the bronchus meets the parenchyma. The internal source is 
placed at the edge of the airway and directed at the simulated lymph node. Bacterial loads 
ranging from 0-106 CFU, localized to the lymph node, were modeled. After unmixing, the 
minimum detectable bacterial load within the hilar lymph node was between 105 and 106 CFU.  
6.8.5 Potential for optical diagnostic in children 
 Preliminary models show that the simulated fiber microendoscope could potentially serve 
as a diagnostic tool for childhood cases of miliary TB. However, it is unlikely that the device 
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will be able to detect paucibacillary infections, even in the case of lymphadenitis of the hilar 
lymph nodes. The current model assumes that the molecular probe associated with bacterial 
detection and fluorescence is roughly equivalent to fluorescence provided by genetically 
modified bacteria. However, previous studies indicate that the cleaved probe might remain 
within the infected macrophage with the bacteria for a period of time, serving as a molecular 
beacon for the bacteria. If this is the case in vivo, the buildup of this probe could result in signal 
amplification, which would enhance the detection threshold of the device, making it possible to 
detect lower numbers of bacteria. The radiative transport model indicates that it is possible to 
detect fluorescence with an internal source and detector, but the sensitivity of a translatable 
system will rely on the pharmacokinetics and signal amplification provided by the fluorogenic 
probe.  
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7. ENHANCMENT OF LUMINESCENCE COLLECTION USING TURNING MIRRORS  
 
7.1 Fluorescence detection of bacteria in vivo 
 Optical detection of pathogenic bacteria in animal models of disease is a powerful tool 
for longitudinal pathogenesis studies and therapy response trials. Bacterial infections of thoracic 
organs, such as pulmonary infections of Mtb, are more difficult to study because of the poor 
penetration of optical wavelengths in biological tissue. The optical attenuation of biological 
tissue limits both external and internal sources of excitation light and the collection of emitted 
photons from excited fluorophores146. Previously, improving the optical detection threshold and 
sensitivity to CFU have been attempted through experiments and simulations by delivering the 
excitation light in a more efficient manner. Nooshabadi et. al. showed multiple orders of 
magnitude of enhancement by illuminating the animal with an internal excitation source rather 
than an external excitation source and a positional dependence on signal acquisition 41. This 
enhancement minimized the path length of the excitation light, more efficiently delivering 
photons to fluorescent markers of bacteria within a live animal. However, the fluorescence signal 
from these internal excitation experiments is not always well correlated with bacterial load, and 
the threshold of detection is still two orders of magnitude higher than the infectious dose of Mtb. 
 We employ an external mirror platform to further improve fluorescence collection from 
the animal by collecting photons exiting the animal from multiple directions, increasing the 
number of photons collected. The mirror platform consists of two translatable 45° angled mirrors 
placed around the animal (Figure 43a, b). These mirrors will redirect light escaping the animal 
up to the external camera which would otherwise be undetectable (Figure 43c). Also, because the 
epi-illumination source of the IVIS is above the animal, the mirror platform should also improve 
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external illumination of the animal (Figure 43d). We use the fluorescence model discussed in 
earlier sections to predict the potential signal enhancement provided by this mirror platform, and 
use the platform to show signal enhancement in both phantom and animal imaging experiments.  
 
Figure 43. A) The mirror stage with 45° angled mirrors for use in the whole-animal imaging 
system. B) A photoreal rendering of the simulation in LightTools shows the multi-directional view 
provided by the mirrors. C) The mirrors are expected to enhance fluorescence collection from 
internal illumination experiments. D) The mirrors are also expected to provide multi-directional 
illumination in epi-illumination experiments. 
 
7.2 Phantom validation of model and mirror stage 
 A commercial luminescence phantom (Xenogen) was simulated with LightTools to 
predict signal enhancement provided by the mirror platform. The phantom consists of an 
optically turbid elastomeric polymer molded into the shape of a mouse. Two LEDs are 
embedded in the phantom at different locations. The phantom was modeled as a scattering 
cylinder with the scattering and absorption coefficients used in the bulk tissue layer of the full-
torso optical model discussed in chapter 5 (Figure 44a). Two monochromatic point sources (550 
nm) were placed at the approximate locations of the LEDs within the phantom. The phantom was 
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simulated with and without the mirror platform under four conditions: 1) only LED A turned on, 
2) only LED B turned on, 3) both LEDs turned on, and 4) both LEDs off. All simulations were 
run with 1e7 photons. Figure 44b-d shows the total flux collected at the simulated external 
detector from the mirrors and the phantom. The simulated signal enhancement provided by the 
mirror platform ranges from 53-82% (Table 25). 
 
Table 25. The simulations predict that the mirrors provide a signal enhancement ranging from 53-
82%. 
 
 
Figure 44. A) The simulated Xenogen phantom with two embedded LEDs (marked A and B) with 
angled mirrors. B) Predicted irradiance on the phantom and mirrors with only LED A turned on in 
the phantom. C) Predicted irradiance on the phantom and mirrors with only LED B turned on in 
the phantom. Note the image scale is one order of magnitude lower than panels B and D. D) 
Predicted irradiance on the phantom and mirrors with both LEDs turned on in the phantom. 
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 To validate the model and the efficacy of the mirror platform, the Xenogen phantom was 
imaged using the IVIS Lumina II. The IVIS excitation source was blocked, and the emission 
filter set to open. The phantom was imaged as simulated: with and without the mirror platform 
under four conditions: 1) only LED A turned on, 2) only LED B turned on, 3) both LEDs turned 
on, and 4) both LEDs off (Figure 45). Five images were taken for each condition and averaged. 
The signal enhancement provided by the mirrors was similar to the modeled enhancement, 
ranging from 49-79% (Table 26). All signal enhancements were found to be statistically 
significant (p << 0.0001) (Figure 46).  
 
 
Figure 45. IVIS imaging of Xenogen phantom. The top row of images show the phantom imaged 
without the mirror stage. LED illumination is noted on each panel. A direct comparison can be 
made with the images of the phantom and mirrors below. For LED B imaged with the mirrors, the 
maximum signal is found on the mirrors. 
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Figure 46. A statistical comparison shows that the mirrors provide a significant signal 
enhancement (*p << 0.05) for each source condition in the Xenogen phantom. 
 
Table 26. The measured signal enhancement from the Xenogen phantom agrees well with the 
simulation, serving as a validation.  
 
The phantom fluorescence was also imaged to estimate the enhancement of epi-
illumination in addition to the enhancement of signal collection (Figure 47). The IVIS 
illumination source was set to 465 nm, 500 nm, and 535 nm with the emission filter set to 580 
nm to minimize leakage from the source. The phantom was again imaged with and without the 
mirror platform. For the experiments with the mirror platform, the photon flux was recorded 
from a region of interest (ROI) over just the phantom, or the phantom + the mirrors. A 
significant enhancement (p << 0.005) was found for both cases (Figure 48). For each spectral 
region, the enhancement over just the phantom was found to be ~45% (Table 27), indicating that 
the mirrors were providing multi-directional illumination, and generating more fluorescence 
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signal. Including signal collection from the mirrors, the total enhancement of fluorescence signal 
collection was ~100% for all illumination wavelengths.  
 
Figure 47. Fluorescence from the Xenogen phantom was measured with epi-illumination. The 
emission filter was held at 580 nm, and the source wavelength was shifted. The signal 
enhancement from the mirrors is a result of both multi-directional illumination and multi-
directional fluorescence collection. 
 
 
Figure 48. The multi-directional illumination is shown to enhance fluorescence signal. With the 
measured ROI covering only the phantom, and not the mirrors in the second row of images in 
figure 46, a statistically significant enhancement is still found (*p << 0.005). 
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Table 27. The measured signal enhancement from the multi-directional illumination provided by 
the mirror device is roughly 45% for every illumination wavelength. If the mirrors are included in 
the measurement ROI, the enhancement is measured to be ~ 100%. 
 
7.3 Predicted performance with variable bacterial loads 
 After characterizing the mirror platform performance and validating the optical model of 
the mirrors with phantom imaging, the mouse torso model of infection was incorporated into the 
mirror model to predict the performance of the mirrors in a more complex sample. The mouse 
torso described in chapters 5-6 was used, including TAF and the ASL layer. Multiple variables 
were tested in the simulation. For each infectious dose (0, 102, 104, 106), fluorescence collection 
was simulated with and without the mirror platform, with internal and epi-illumination, with the 
mouse in ventral and dorsal positions (overall 8 different imaging conditions). For proof-of-
concept animal experiments, we only used tdTomato-transfected BCG, with no CNIR 
fluorogenic probe. Therefore, fluorescence was only simulated in the visible wavelength range, 
with an excitation wavelength of 535 nm and emission collection at wavelengths greater than 
580 nm. A single 106 photon count simulation was performed for each modeled CFU. Error for 
the total fluorescence collected was computed using Eq. 26, where σ is the variance at a given 
wavelength, and N is the number of photons reaching the detector in a given spectral bin.  
𝑒𝑟𝑟𝑜𝑟(𝜆) = 𝜎/√𝑁  (26) 
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Figure 49. A) Total fluorescence signal collected from the simulated detector for epi-illumination 
is shown for the ventral and dorsal positions, with and without the mirror stage for CFU ranging 
from control to 106. Error bars show average error in the simulation. NOTE: This error cannot be 
extrapolated to the unmixed data (B and D). B) The unmixed simulated fluorescence signal for 
epi-illumination shows the scattering-limited detection threshold. A signal enhancement from the 
mirrors is shown for both positions. C) Total simulated fluorescence signal for internal 
illumination is shown with ventral and dorsal collection, with and without the mirror stage. D) 
Unmixing the fluorescence signal shows the expected enhancement provided by the mirror 
platform for each CFU.   
 
 Figure 49 shows the predicted fluorescence signal for all 8 imaging conditions before and 
after spectral unmixing. Before spectral unmixing, only 106 CFU is different from control for all 
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epi-illumination simulations (Figure 49a). However, after spectral unmixing, dorsal collection 
with and without mirrors becomes significantly different from control at 102 CFU, and ventral 
collection becomes significantly different from control at 104 CFU (Figure 49b). Although 
internal illumination shows more difference from control pre-spectral unmixing, a similar trend 
with detection threshold emerges after spectral unmixing (Figure 49c-d).  
 
 
Figure 50. The predicted signal enhancement from the mirrors varies with CFU, animal position, 
and illumination method. 
 
The simulated enhancement from the mirrors ranged from 18% to ~190% (Figure 50). 
However, this 190% enhancement of the mirrors with epi-illumination in the dorsal position is 
likely a factor of the low signal to noise ratio of the 100 CFU models. Just as with animal 
experiments, the TAF signal is much higher than the bacterial signal. Because these are 
stochastic simulations, the photon count from the bacteria is low for all of these simulations, 
especially for low CFU. The simulated signal enhancement by the mirrors is artificially high 
because the model likely underestimated the signal after spectral unmixing due to the low 
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number of photons in each spectral bin corresponding to tdTomato signal. Similar to animal 
experiments, the number of photons collected for these low bacterial loads is limited by tissue 
scattering and absorption, leading to higher variability and uncertainty in these simulations. 
While the simulation error remained low for total fluorescence detection (TAF + signal), the 
number of photons from the tdTomato fluorophore population was significantly lower, resulting 
in higher uncertainty in these simulations.  
7.4 In vivo imaging of infection with turning mirrors for enhancement 
7.4.1 Animal Experiments 
Female BALB/C mice were separated into four different cohorts of three animals each. 
The control group was not infected with any bacteria, and each other cohort was anesthetized 
with a ketamine/xylazine mixture and intratracheally infected with a bacterial dose of 102, 104, or 
106 CFU of M. bovis BCG transfected with a tdTomato vector. 24 hours after infection, mice 
were re-anesthetized and imaged with the IVIS Lumina II (PerkinElmer). Each mouse was 
imaged under 8 conditions: internal and epi-illumination in ventral and dorsal positions, with and 
without the mirror platform. To enable internal illumination, a 22G catheter (TERUMO Medical) 
was inserted into the trachea of the anesthetized mouse. Excitation light from 535 nm LED 
(Thorlabs) was launched into a 10,000-fiber bundle (Fujikura), which was threaded into the 
catheter as an intravital excitation source. Epi-illumination experiments used the IVIS 
illumination source, a 150 W Quartz Tungsten Halogen lamp (Schott) and a 535 nm excitation 
filter with a 35 nm FWHM. For all imaging experiments, three fluorescence images were taken 
with 20 nm bandwidth emission filters at 580 nm, 600 nm, and 620 nm. Each image was taken 
with and f-stop of 2 and automatic exposure time. After imaging, mice were sacrificed by 
injection of 100 µL Fatal-Plus Solution (Vortech Pharmaceuticals Ltd.). The lungs were excised 
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and homogenized. Serial dilutions of the homogenized lung were plated on selective media to 
determine CFU. Animal use protocols were approved by the Texas A&M University Institutional 
Animal Care and Use Committee. 
7.4.2 Spectral Unmixing  
 Manual spectral unmixing with Living Image software (Caliper Life Sciences) was used 
to separate TAF from tdTomato signal for each mouse in each imaging condition. A single 
control mouse was selected to collect the TAF spectra from, and a TAF spectrum was recorded 
for each of the following imaging conditions: 1) epi-illumination in the ventral position, 2) epi-
illumination in the dorsal position, 3) internal illumination with ventral collection, and 4) internal 
illumination with dorsal collection. These TAF spectra were used for imaging experiments with 
and without mirrors. After loading the TAF spectra from the control mouse, the brightest pixel 
from the subject was selected from the merged image. The TAF spectrum was subtracted from 
the spectrum of that merged pixel to calculate a tdTomato spectrum. If there was not a relative 
maximum around 600 nm, as would be expected for tdTomato signal traveling through tissue 
(Figure 35), another pixel was selected. The software then unmixed the image pixel by pixel to 
separate the fluorescence overlay into tdTomato fluorescence and TAF. For all measurements, a 
measurement ROI was placed over the chest of the mouse, wide enough to cover both mirrors, 
even if there were no mirrors in that image. Total flux over the region of interest was used for 
statistical comparisons.  
7.4.3 Signal enhancement with mirrors    
 For epi-illumination experiments, no bacterial load tested was found to be statistically 
different from control for ventral or dorsal, with or without mirrors (Figures 51-52). However, 
for most mice, the mirrors showed a 50-100% increase in tdTomato signal collected (Table 28). 
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In some cases, the spectral unmixing caused the tdTomato signal from the mirror experiments to 
drop below that of the experiments with no mirrors. Although the multi-directional illumination 
provided by the mirrors will provide more TAF fluorescence and more tdTomato fluorescence, it 
is hypothesized that there is a spectral unmixing error in these images. The percent enhancement 
is so high for most epi-illumination trials, that it is likely there was improper pixel selection for 
the spectral unmixing process in the images that yield a negative “enhancement”. 
 
Figure 51. A) Representative spectrally unmixed images of mice imaged ventrally with epi-
illumination at 0, 102, 104, and 106 CFU. The top and bottom images show the same mouse 
imaged with and without the mirror platform. B) Representative spectrally unmixed images of 
mice imaged dorsally with epi-illumination at 0, 102, 104, and 106 CFU. The top and bottom 
images show the same mouse imaged with and without the mirror platform. 
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Figure 52. Spectrally unmixed data show no significant difference from control for any cohort, 
with or without the mirrors for ventral (A) or dorsal (B) epi-illumination experiments.  
 
 Internal illumination results showed a much more position-dependent enhancement. As 
shown by the representative results in Figure 53, qualitatively speaking, the mirrors do not direct 
much more signal to the camera than escapes off the ventral surface of the mouse. Contrarily, the 
fluorescence maximum for most dorsal images is actually located on one of the mirrors. Without 
the mirrors, only 106 CFU in the ventral position was found to be different than control (Figure 
54). However, in adding the mirrors, 102 CFU and 106 CFU cohorts became higher than control 
in the dorsal position.            
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Figure 53. A) Representative spectrally unmixed images of mice imaged ventrally with internal 
illumination at 0, 102, 104, and 106 CFU. The top and bottom images show the same mouse 
imaged with and without the mirror platform. B) Representative spectrally unmixed images of 
mice imaged dorsally with internal illumination at 0, 102, 104, and 106 CFU. The top and bottom 
images show the same mouse imaged with and without the mirror platform. 
 
 
Figure 54. Spectrally unmixed data show a significant difference from control for only the 106 
CFU cohort (p < 0.05), with and without the mirrors for internal illumination with ventral 
collection (A). For dorsal collection, no cohort without the mirrors is different from control. 
However, with mirrors, 102 and 106 CFU cohorts are significantly different from “control with 
mirrors” (p < 0.05).  
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Table 28. For an individual mouse, the mirrors usually provided a signal enhancement after 
spectral unmixing. Negative “enhancements” are bolded and italicized. These values are likely due 
to spectral unmixing errors. Average signal enhancement for each cohort is shown in the bottom 
section of the table.  
 
 
7.5 Summary 
 By adding angled mirrors to the whole-animal imaging system, we have improved 
fluorescence collection from an in vivo infection model. However, all phantom experiments and 
simulations show a much more significant signal enhancement than found with the animal 
experiments. We believe the primary reason for this discrepancy is the spectral unmixing errors. 
TAF and tdTomato emission have a large spectral overlap, and TAF intensity is much higher 
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than the signal from tdTomato for most bacterial loads. Also, as shown in Figure 55, the spatial 
dependence of TAF on a single mouse is a big issue. Unless the ideal pixel is selected, the 
sparsely sampled TAF spectrum can look nearly identical to the tdTomato emission spectrum. 
Pixel selection becomes extremely important in this situation. For these experiments, a blinded 
spectral unmixing analysis would provide a less biased, more reliable statistical comparison of 
the data. These animal experiments could also be improved with a TAF map of the animal. As 
discussed in section 6.7, a spectrally separate illumination source could be used to extrapolate the 
TAF of an individual mouse. The TAF map provided by this secondary source would make pixel 
selection for spectral unmixing a much more well-defined process. 
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Figure 55. A) Example spectra of tdTomato and TAF spectra used for spectral unmixing for 
animal experiments. B) With a control mouse in the ventral position, the TAF spectrum varies 
spatially, with some spectra approaching the shape of the tdTomato spectrum. C) A control mouse 
in the ventral position also shows variable TAF spectra across the fluorescence overlay.  
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 In closing, the mirror device is capable at further enhancing bacterial fluorescence 
collection, and even lowered the detection threshold of these experiments. A more controlled 
spectral unmixing process is expected to reduce the variability within animals for future 
experiments with and without the mirror platform.  
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8. CONCLUSION AND OUTLOOK  
 
8.1 Pre-clinical applications: Improving optical detection 
In vivo optical detection of pathogenic bacteria shows great potential as a tool for 
longitudinal pre-clinical studies of bacterial pathogenesis and therapeutic efficacy. In small 
animal models of disease, the optical path length of excitation and emission photons is reduced. 
This yields a more efficient delivery of excitation photons to fluorophores and a higher 
likelihood that the emitted photons will reach a detector. The physiological limitations that the 
optical system must overcome are tissue attenuation and low SNR due to TAF. Fortunately, the 
porous nature of the lung diffuses optical energy, increasing the probability that a photon will 
survive to excite a fluorophore. Here, we summarize the conclusions drawn from a 
computational model, and the implications that those have on using optical detection as a reliable 
tool for bacterial enumeration in longitudinal experiments. 
8.1.1 Detecting tdTomato-transfected BCG 
 The most common model of optical detection of infection uses genetic modification of 
the bacteria, yielding a strain of bacteria that can produce an optical signal. We use tdTomato-
transfected BCG for these experiments. The genetic modification of the bacteria allows a 
fluorescence signal to be generated from the bacteria themselves. With this model of infection, 
we know that any tdTomato fluorescence detected is localized to a live bacteria that is producing 
the tdTomato fluorescent protein. There is no time component associated with achieving optimal 
fluorescence, and the signal will always be spatially correlated with live bacteria. The major 
downfall of this method is the spectral range of tdTomato (530 nm – 600 nm). First, biological 
tissue has a fairly high attenuation coefficient in the spectral range of tdTomato excitation and 
emission. Hemoglobin absorption has a peak in this region, and the lung is a very well-perfused 
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organ, as it is responsible for blood oxygenation. Second, TAF has a similar spectral signature to 
tdTomato emission in this wavelength range. Both emission curves are decaying in this region 
after excitation with 535 nm light, making the two signals hard to spectrally unmix.  
8.1.2 Detecting bacteria with a fluorogenic NIR probe 
 Unlike tdTomato-transfected bacteria, detecting bacteria with an exogenous NIR probe is 
not always localized to the bacteria. There is in vitro evidence that the probe remains localized to 
infected macrophages, but these results have yet to be proven in vivo. Also, the body naturally 
breaks down foreign substances and delivers them to the kidneys for clearing. This 
pharmacokinetic process is not fully defined for this probe. While we do have an idea about the 
optimal imaging time point after administration of the probe, the amount of broken down probe 
and its expected location within the body are less well-defined. The strengths of this method is 
that it potentially provides signal amplification, as a single bacterium can cleave multiple 
molecules of the fluorogenic probe. Exploitation of this catalytic activity is key to improving 
SNR with the optical system. Also, this bacteria-sensing probe is the main reason why this 
optical system could potentially be translated to a diagnostic tool. Wild-type bacteria seen in a 
clinical case will not be modified to produce a fluorescent protein, so it is necessary to have a 
molecular beacon-type sensing mechanism to determine whether or not bacteria are present. 
Also, simply by changing the spectral region of detection to the NIR, the detection threshold is 
improved by nearly an order of magnitude.  
8.1.3 Potential improvements to device and protocol 
 Radiative transport modeling has shown that given complete spectral unmixing, the 
detection threshold of the optical system can reach between 10 and 1000 CFU depending on 
spectral region and animal position. An interesting result from the simulations suggest that the 
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TAF spectrum from internal illumination would actually increase with wavelength, rather than 
decrease as in external illumination experiments. This could be a contributing factor in the better 
performance of the internal illumination experiments. Not only is the excitation light being more 
efficiently delivered to the bacteria, but the high-intensity TAF becomes spectrally different from 
the bacterial signal and is spatially localized to similar tissues, meaning the same TAF spectrum 
will effectively unmix the entire fluorescence overlay.  
 To improve system performance in detecting bacteria in animal models, a few 
suggestions can be made. 1) Manipulate the molecular markers used for detection. Red-shifting 
the fluorescence signal for genetically modified bacteria would improve the optical transport 
within biological tissue. For tdTomato-transfected BCG, the main limiting factors relate to the 
spectral region. The NIR probe is at a more ideal spectral region, but there is potential here for 
even higher sensitivity by exploiting chemical amplification methods of the exogenous probe to 
improve SNR. 2) Illuminate the animal with a spectrally separated source for TAF mapping. 
TAF signal will be related when excited with two spectral bands. By illuminating with a light 
source that would not excite the bacteria, the spatial variability of TAF can be back-computed to 
the wavelength of interest. We suggest that this secondary light source be red-shifted from the 
bacterial excitation to minimize fluorophore cross-talk. Illuminating with a blue-shifted source 
could result in the TAF emission exciting the bacterial marker, which would contaminate a 
fluorescence signal meant to be used as a solely-TAF image for spectral unmixing. 3) Add extra 
emission filters to the microendoscope. The microendoscope has not shown a signal correlation 
with CFU in previous animal experiments, but the simulations indicated that the physiology is 
not the limiting factor here. Just as with external detection, spectral unmixing of the 
microendoscope images could make internal detection more sensitive to CFU. 
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8.2 Clinical implications: Potential diagnosis 
 The secondary focus of the optical simulations was to help predict the performance of an 
optical diagnostic tool in children. Because young children, infants in particular, cannot 
expectorate35, it is very difficult to achieve a sample for bacteriological isolation and 
confirmation of disease. Infants are also more likely to progress to active disease after the 
primary infection, and more likely to die from TB. Because of this, it is imperative that we 
develop more effective diagnostics for childhood TB, and get affected children effective 
treatment as early as possible. The optical system discussed in this dissertation has proven to be 
effective in sensing live bacteria in an animal model of disease, but not only do humans have 
different presentations of the disease, the fundamental light-tissue interactions are different, and 
something as simple as organism size can be highly limiting to the system performance. Because 
of the thickness of the human torso, even in infants and small children, internal illumination and 
fluorescence collection is the most likely method to achieve a signal from pulmonary bacteria.  
 Here, we have modeled two presentations of childhood TB, miliary TB and 
lymphadenitis. Although miliary TB is characterized by a high bacterial load, these bacteria are 
not usually present in the sputum, making traditional diagnostic methods ineffective at detecting 
the presence of Mtb. As shown by the optical simulations in chapter 6, it is very possible that a 
NIR system could detect miliary TB in a child the size of a toddler, a result that likely holds for a 
human infant. The model of lymphadenitis did not show as much potential in the simulation, but 
this could easily be due to the assumptions of the model. If the NIR probe truly does amplify the 
signal, lower numbers of bacteria within the hilar lymph nodes would provide a higher signal. To 
confirm this, experimental data on the NIR probe and bacterial load in human lymph nodes 
would be necessary to make more valid assumptions relative to this model of infection.  
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 Overall, the preliminary optical simulations of human infection show potential for a 
diagnostic tool for childhood TB. The limitations and assumptions of the model are clear, and 
experimental data with humans is necessary to build a better model of infection before this 
device could be tested in children.  
 
 
 
131 
 
 
REFERENCES 
1. W. H. Organization, "Global tuberculosis report 2016," (2016). 
2. C. Dye, "Global epidemiology of tuberculosis," The Lancet 367(9514), 938-940 (2006). 
3. C. J. Cambier, S. Falkow, and L. Ramakrishnan, "Host Evasion and Exploitation 
Schemes of Mycobacterium tuberculosis," Cell 159(7), 1497-1509 (2014). 
4. A. Fanning, "Tuberculosis: 6. Extrapulmonary disease," CMAJ: Canadian Medical 
Association Journal 160(11), 1597-1603 (1999). 
5. J. G. Vallejo, L. T. Ong, and J. R. Starke, "Clinical Features, Diagnosis, and Treatment of 
Tuberculosis in Infants," Pediatrics 94(1), 1 (1994). 
6. R. M. Jasmer, P. Nahid, and P. C. Hopewell, "Latent Tuberculosis Infection," New 
England Journal of Medicine 347(23), 1860-1866 (2002). 
7. H. S. Schaaf, and A. Zumla, Tuberculosis: A comprehensive clinical reference, 1 ed., 
Elsevier (2009). 
8. R. L. Riley, "Airborne infection," The American Journal of Medicine 57(3), 466-475 
(1974). 
9. A. Rouillon, S. Perdrizet, and R. Parrot, "Transmission of tubercle bacilli: The effects of 
chemotherapy," Tubercle 57(4), 275-299 (1976). 
10. G. Sgaragli, and M. Frosini, "Human Tuberculosis I. Epidemiology, Diagnosis and 
Pathogenetic Mechanisms," Curr Med Chem 23(25), 2836-2873 (2016). 
11. A. S. Piatek et al., "Molecular beacon sequence analysis for detecting drug resistance in 
Mycobacterium tuberculosis," Nature Biotechnology 16(359 (1998). 
 
132 
 
 
12. H. H. El-Hajj et al., "Detection of Rifampin Resistance inMycobacterium tuberculosis in 
a Single Tube with Molecular Beacons," Journal of Clinical Microbiology 39(11), 4131-
4137 (2001). 
13. W. A. Wells et al., "Alignment of new tuberculosis drug regimens and drug susceptibility 
testing: a framework for action," The Lancet Infectious Diseases 13(5), 449-458 (2013). 
14. C. Centers for Disease, and Prevention, "Extensively drug-resistant tuberculosis--United 
States, 1993-2006," MMWR. Morbidity and mortality weekly report 56(11), 250 (2007). 
15. Z. F. Udwadia et al., "Totally Drug-Resistant Tuberculosis in India," Clinical Infectious 
Diseases 54(4), 579-581 (2012). 
16. G. A. Colditz et al., "Efficacy of bcg vaccine in the prevention of tuberculosis: Meta-
analysis of the published literature," JAMA 271(9), 698-702 (1994). 
17. J. A. M. Langermans et al., "Divergent effect of bacillus Calmette–Guérin (BCG) 
vaccination on Mycobacterium tuberculosis infection in highly related macaque species: 
Implications for primate models in tuberculosis vaccine research," Proceedings of the 
National Academy of Sciences 98(20), 11497-11502 (2001). 
18. D. G. Russell, C. E. Barry, and J. L. Flynn, "Tuberculosis: What We Don’t Know Can, 
and Does, Hurt Us," Science 328(5980), 852-856 (2010). 
19. V. Balasubramanian et al., "Pathogenesis of tuberculosis: pathway to apical localization," 
Tubercle and Lung Disease 75(3), 168-178 (1994). 
20. D. G. Russell et al., "Foamy macrophages and the progression of the human tuberculosis 
granuloma," Nature Immunology 10(943 (2009). 
21. D. G. Russell et al., "The macrophage marches on its phagosome: dynamic assays of 
phagosome function," Nature Reviews Immunology 9(594 (2009). 
 
133 
 
 
22. C. E. Barry et al., "The spectrum of latent tuberculosis: rethinking the biology and 
intervention strategies," Nature Review Microbiology 7(12), 10 (2009). 
23. N. K. Dutta, and P. C. Karakousis, "Latent Tuberculosis Infection: Myths, Models, and 
Molecular Mechanisms," Microbiology and Molecular Biology Reviews 78(3), 343-371 
(2014). 
24. J. E. Gomez, and J. D. McKinney, "M. tuberculosis persistence, latency, and drug 
tolerance," Tuberculosis 84(1), 29-44 (2004). 
25. S. V. Capuano et al., "Experimental Mycobacterium tuberculosis Infection of 
Cynomolgus Macaques Closely Resembles the Various Manifestations of Human M. 
tuberculosis Infection," Infection and Immunity 71(10), 5831-5844 (2003). 
26. E. W. Tiemersma et al., "Natural History of Tuberculosis: Duration and Fatality of 
Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review," 
PLOS ONE 6(4), e17601 (2011). 
27. J. M. Davis, and L. Ramakrishnan, "The Role of the Granuloma in Expansion and 
Dissemination of Early Tuberculous Infection," Cell 136(1), 37-49 (2009). 
28. D. S. Ridley, and M. J. Ridley, "Rationale for the Histological Spectrum of Tuberculosis. 
a Basis for Classification," Pathology 19(2), 186-192 (1987). 
29. C. R. Shaler et al., "Within the Enemy’s Camp: contribution of the granuloma to the 
dissemination, persistence and transmission of Mycobacterium tuberculosis," Frontiers in 
Immunology 4(30 (2013). 
30. N. Fogel, "Tuberculosis: A disease without boundaries," Tuberculosis 95(5), 527-531 
(2015). 
 
134 
 
 
31. J. Burrill et al., "Tuberculosis: A Radiologic Review," RadioGraphics 27(5), 1255-1273 
(2007). 
32. L. Curvo-Semedo, L. Teixeira, and F. Caseiro-Alves, "Tuberculosis of the chest," 
European Journal of Radiology 55(2), 158-172 (2005). 
33. C. T. Sreeramareddy et al., "Time delays in diagnosis of pulmonary tuberculosis: a 
systematic review of literature," BMC infectious diseases 9(1), 91 (2009). 
34. P. Tucci, G. González-Sapienza, and M. Marin, "Pathogen-derived biomarkers for active 
tuberculosis diagnosis," Frontiers in Microbiology 5(549 (2014). 
35. D. S. Armstrong, "In Celebration of Expectoration," American Journal of Respiratory 
and Critical Care Medicine 168(12), 1412-1413 (2003). 
36. G. Manina, N. Dhar, and John D. McKinney, "Stress and Host Immunity Amplify 
Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing 
Metabolically Active Forms," Cell Host & Microbe 17(1), 32-46 (2015). 
37. K. Andries, T. Gevers, and N. Lounis, "Bactericidal Potencies of New Regimens Are Not 
Predictive of Their Sterilizing Potencies in a Murine Model of Tuberculosis," 
Antimicrobial Agents and Chemotherapy 54(11), 4540-4544 (2010). 
38. A. Koul et al., "The challenge of new drug discovery for tuberculosis," Nature 
469(7331), 483-490 (2011). 
39. H.-J. Yang et al., "Real-Time Imaging of Mycobacterium tuberculosis Using a Novel 
Near-Infrared Fluorescent Substrate," Journal of Infectious Diseases (2016). 
40. Y. Kong et al., "Application of optical imaging to study of extrapulmonary spread by 
tuberculosis," Tuberculosis 89(Supplement 1), S15-S17 (2009). 
 
135 
 
 
41. F. Nooshabadi et al., "Intravital excitation increases detection sensitivity for pulmonary 
tuberculosis by whole-body imaging with β-lactamase reporter enzyme fluorescence," 
Journal of Biophotonics (2016). 
42. M. Baker, "Whole-animal imaging: The whole picture," Nature 463(7283), 977-980 
(2010). 
43. F. Leblond et al., "Pre-clinical whole-body fluorescence imaging: Review of instruments, 
methods and applications," Journal of photochemistry and photobiology B: Biology 
98(1), 77-94 (2010). 
44. H. Xie et al., "Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-
specific fluorogenic probe," Nature chemistry 4(10), 802-809 (2012). 
45. F. Nooshabadi et al., "Intravital fluorescence excitation in whole-animal optical 
imaging," PLoS ONE 11(2), (2016). 
46. J. N. Bixler et al., "Multi-scale fluorescence imaging of bacterial infections in animal 
models," Photonic Therapeutics and Diagnostics IX (2013). 
47. C. F. Bohren, and D. R. Huffman, Absorption and scattering of light by small particles, 
John Wiley & Sons (2008). 
48. V. Venugopalan, J. S. You, and B. J. Tromberg, "Radiative transport in the diffusion 
approximation: An extension for highly absorbing media and small source-detector 
separations," Physical Review E 58(2), 2395-2407 (1998). 
49. S. A. Carp, S. A. Prahl, and V. Venugopalan, "Radiative transport in the delta-P1 
approximation: accuracy of fluence rate and optical penetration depth predictions in 
turbid semi-infinite media," J Biomedi Opt 9(3), 632-648 (2004). 
 
136 
 
 
50. S. L. Jacques, "Optical properties of biological tissues: a review," Physics in Medicine 
and Biology 58(11), R37 (2013). 
51. V. Tuchin, Tissue Optics: Light Scattering Methods and Instruments for Medical 
Diagnostics, 3 ed., SPIE, Bellingham, Washington, USA (2015). 
52. M. Monici, "Cell and tissue autofluorescence research and diagnostic applications," 
Biotechnology annual review 11(227-256 (2005). 
53. L. V. Wang, and H.-i. Wu, Biomedical optics: principles and imaging, John Wiley & 
Sons (2012). 
54. S. A. Prahl, M. J. C. van Gemert, and A. J. Welch, "Determining the optical properties of 
turbid media by using the adding-doubling method," Appl. Opt. 32(4), 559-568 (1993). 
55. J. Qu et al., "Optical properties of normal and carcinomatous bronchial tissue," Appl 
Optics 33(31), 7397-7405 (1994). 
56. L. Wang, S. L. Jacques, and L. Zheng, "MCML—Monte Carlo modeling of light 
transport in multi-layered tissues," Computer Methods and Programs in Biomedicine 
47(2), 131-146 (1995). 
57. C. K. Hayakawa et al., "Perturbation Monte Carlo methods to solve inverse photon 
migration problems in heterogeneous tissues," Optics Letters 26(17), 1335-1337 (2001). 
58. I. Pavlova et al., "Monte Carlo model to describe depth selective fluorescence spectra of 
epithelial tissue: applications for diagnosis of oral precancer," J Biomed Opt 13(6), 
064012-064012-064013 (2008). 
59. D. Arifler et al., "Spatially resolved reflectance spectroscopy for diagnosis of cervical 
precancer: Monte Carlo modeling and comparison to clinical measurements," J Biomed 
Opt 11(6), 064027-064027-064016 (2006). 
 
137 
 
 
60. M. Keijzer, J. W. Pickering, and M. J. van Gemert, "Laser beam diameter for port wine 
stain treatment," Lasers in surgery and medicine 11(6), 601-605 (1991). 
61. Y. C. Huang et al., "Noninvasive blood flow imaging for real‐time feedback during laser 
therapy of port wine stain birthmarks," Lasers in surgery and medicine 40(3), 167-173 
(2008). 
62. B. W. Pogue, and M. S. Patterson, "Review of tissue simulating phantoms for optical 
spectroscopy, imaging and dosimetry," J Biomed Opt 11(4), 041102-041102-041116 
(2006). 
63. A. Curatolo, B. F. Kennedy, and D. D. Sampson, "Structured three-dimensional optical 
phantom for optical coherence tomography," Opt. Express 19(20), 19480-19485 (2011). 
64. D. A. Miranda, K. L. Cristiano, and J. C. Gutiérrez, "Breast phantom for mammary tissue 
characterization by near infrared spectroscopy," Journal of Physics: Conference Series 
466(1), 012018 (2013). 
65. M. Solomon et al., "Multimodal Fluorescence-Mediated Tomography and SPECT/CT for 
Small-Animal Imaging," Journal of Nuclear Medicine 54(4), 639-646 (2013). 
66. G. Wagnières et al., "An optical phantom with tissue-like properties in the visible for use 
in PDT and fluorescence spectroscopy," Physics in Medicine & Biology 42(7), 1415 
(1997). 
67. N. Rajaram et al., "Non-Invasive, Simultaneous Quantification of Vascular Oxygenation 
and Glucose Uptake in Tissue," PLoS ONE 10(1), e0117132 (2015). 
68. M. J. Niedre, G. M. Turner, and V. Ntziachristos, "Time-resolved imaging of optical 
coefficients through murine chest cavities," J Biomed Opt 11(6), 064017-064017-064017 
(2006). 
 
138 
 
 
69. F. E. W. Schmidt et al., "Multiple-slice imaging of a tissue-equivalent phantom by use of 
time-resolvedoptical tomography," Appl. Opt. 39(19), 3380-3387 (2000). 
70. A. E. Cerussi et al., "Tissue phantoms in multicenter clinical trials for diffuse optical 
technologies," Biomed. Opt. Express 3(5), 966-971 (2012). 
71. N. M. Marín et al., "Calibration standards for multicenter clinical trials of fluorescence 
spectroscopy for in vivo diagnosis," J Biomed Opt 11(1), 014010-014010-014014 (2006). 
72. G. Alexandrakis, R. R. Fernando, and A. F. Chatziioannou, "Tomographic 
bioluminescence imaging by use of a combined optical-PET (OPET) system: a computer 
simulation feasibility study," Physics in Medicine and Biology 50(17), 4225 (2005). 
73. Q. Wan et al., "Monte Carlo modeling and phantom study for implantable fluorescent 
analyte sensors for human head," Optical Diagnostics and Sensing VII 64450J-64450J-
64457 (2007). 
74. C. Chen et al., "Preparation of a skin equivalent phantom with interior micron-scale 
vessel structures for optical imaging experiments," Biomed. Opt. Express 5(9), 3140-
3149 (2014). 
75. M. S. Wróbel et al., "Use of optical skin phantoms for preclinical evaluation of laser 
efficiency for skin lesion therapy," J Biomed Opt 20(8), 085003-085003 (2015). 
76. R. Cubeddu et al., "A solid tissue phantom for photon migration studies," Physics in 
Medicine and Biology 42(10), 1971 (1997). 
77. Y. Bae et al., "Fabrication of a thin-layer solid optical tissue phantom by a spin-coating 
method: pilot study," J Biomed Opt 18(2), 025006-025006 (2013). 
78. J. Park et al., "Fabrication of double layer optical tissue phantom by spin coating method: 
mimicking epidermal and dermal layer," Design and Performance Validaiton of 
 
139 
 
 
Phantoms Used in Conjunction with Optical Measurement of Tissue V 85830G-85830G-
85836 (2013). 
79. L. Luu et al., "Microfluidics based phantoms of superficial vascular network," Biomed. 
Opt. Express 3(6), 1350-1364 (2012). 
80. A. I. Chen et al., "Multilayered tissue mimicking skin and vessel phantoms with tunable 
mechanical, optical, and acoustic properties," Medical Physics 43(6Part1), 3117-3131 
(2016). 
81. K. L. Lurie et al., "Three-dimensional, distendable bladder phantom for optical coherence 
tomography and white light cystoscopy," J Biomed Opt 19(3), 036009-036009 (2014). 
82. A. Golabchi et al., "Refractive errors and corrections for OCT images in an inflated lung 
phantom," Biomed. Opt. Express 3(5), 1101-1109 (2012). 
83. F. Nooshabadi et al., "Intravital excitation increases detection sensitivity for pulmonary 
tuberculosis by whole-body imaging with β-lactamase reporter enzyme fluorescence," J 
Biophotonics 10(6-7), 821-829 (2017). 
84. G. J. Greening et al., "Characterization of thin poly(dimethylsiloxane)-based tissue-
simulating phantoms with tunable reduced scattering and absorption coefficients at 
visible and near-infrared wavelengths," J Biomed Opt 19(11), 115002 (2014). 
85. D. M. de Bruin et al., "Optical phantoms of varying geometry based on thin building 
blocks with controlled optical properties," J Biomed Opt 15(2), 025001-025001-025010 
(2010). 
86. S. Meissner et al., "Simultaneous three-dimensional optical coherence tomography and 
intravital microscopy for imaging subpleural pulmonary alveoli in isolated rabbit lungs," 
J Biomed Opt 14(5), 054020-054020-054026 (2009). 
 
140 
 
 
87. A. H. Morris et al., "A new nuclear magnetic resonance property of lung," Journal of 
Applied Physiology 58(3), 759-762 (1985). 
88. K. Hearon et al., "Porous shape-memory polymers," Polymer reviews 53(1), 41-75 
(2013). 
89. K. J. Chalut, M. G. Giacomelli, and A. Wax, "Application of Mie theory to assess 
structure of spheroidal scattering in backscattering geometries," J Opt Soc Am A 25(8), 
1866-1874 (2008). 
90. A. L. Aden, and M. Kerker, "Scattering of Electromagnetic Waves from Two Concentric 
Spheres," J Appl Phys 22(10), 1242-1246 (1951). 
91. T. K. Jain et al., "Magnetic nanoparticles with dual functional properties: Drug delivery 
and magnetic resonance imaging," Biomaterials 29(29), 4012-4021 (2008). 
92. E. C. Dreaden et al., "The golden age: gold nanoparticles for biomedicine," Chem Soc 
Rev 41(7), 2740-2779 (2012). 
93. E. Prodan et al., "A Hybridization Model for the Plasmon Response of Complex 
Nanostructures," Science 302(5644), 419 (2003). 
94. P. K. Jain et al., "Calculated Absorption and Scattering Properties of Gold Nanoparticles 
of Different Size, Shape, and Composition:  Applications in Biological Imaging and 
Biomedicine," The Journal of Physical Chemistry B 110(14), 7238-7248 (2006). 
95. J. Beek et al., "The optical properties of lung as a function of respiration," Phys Med Biol 
42(11), 2263 (1997). 
96. R. H. Notter, Lung Surfactants: Basic Science and Clinical Applications, Marcel Dekker, 
Inc. (2000). 
 
141 
 
 
97. J. A. J. Vanoirbeek et al., "Noninvasive and Invasive Pulmonary Function in Mouse 
Models of Obstructive and Restrictive Respiratory Diseases," Am J Resp Cell Mol 42(1), 
96-104 (2010). 
98. R. R. Mercer, M. L. Russell, and J. D. Crapo, "Alveolar septal structure in different 
species," J Appl Physiol 77(3), 1060-1066 (1994). 
99. H. Bachofen, and S. Schürch, "Alveolar surface forces and lung architecture," Comp 
Biochem Phys A 129(1), 183-193 (2001). 
100. S. E. Soutiere, C. G. Tankersley, and W. Mitzner, "Differences in alveolar size in inbred 
mouse strains," Resp Physiol Neurobi 140(3), 283-291 (2004). 
101. S. M. Tenney, and J. E. Remmers, "Comparative Quantitative Morphology of the 
Mammalian Lung: Diffusing Area," Nature 197(54 (1963). 
102. C. Mätzler, "MATLAB functions for Mie scattering and absorption, version 2," IAP Res. 
Rep 8(1-26 (2002). 
103. E. Fröhlich et al., "Measurements of Deposition, Lung Surface Area and Lung Fluid for 
Simulation of Inhaled Compounds," Front Pharmacol 7(181 (2016). 
104. E. R. Weibel, Morphometry of the human lung, Springer (1965). 
105. K. E. Barrett et al., "Ganong’s review of medical physiology. 23," NY: McGraw-Hill 
Medical (2009). 
106. N. Wauthoz, and K. Amighi, "Formulation Strategies for Pulmonary Delivery of Poorly 
Soluble Drugs," in Pulmonary Drug Delivery: Advances and Challenges, p. 87, John 
Wiley & Sons (2015). 
107. H. D. C. Smyth, and A. J. Hickey, Controlled pulmonary drug delivery, Springer (2011). 
 
142 
 
 
108. A. N. Bashkatov et al., "Optical properties of human skin, subcutaneous and mucous 
tissues in the wavelength range from 400 to 2000 nm," J Phys D Appl Phys 38(15), 2543 
(2005). 
109. V. E. Calderon et al., "A Humanized Mouse Model of Tuberculosis," PLOS ONE 8(5), 
e63331 (2013). 
110. Y. Kong et al., "Whole‐Body Imaging of Infection Using Fluorescence," Current 
protocols in microbiology 2C. 3.1-2C. 3.21 (2011). 
111. E. A. Nardell, "Transmission and institutional infection control of tuberculosis," CSH 
Perspect Med 6(2), a018192 (2016). 
112. C. Zhu, and Q. Liu, "Review of Monte Carlo modeling of light transport in tissues," 
BIOMEDO 18(5), (2013). 
113. D. A. Boas et al., "Three dimensional Monte Carlo code for photon migration through 
complex heterogeneous media including the adult human head," Opt. Express 10(3), 159-
170 (2002). 
114. Q. Fang, "Mesh-based Monte Carlo method using fast ray-tracing in Plücker 
coordinates," Biomed. Opt. Express 1(1), 165-175 (2010). 
115. H. Li et al., "A mouse optical simulation environment (MOSE) to investigate 
bioluminescent phenomena in the living mouse with the monte carlo method," Academic 
Radiology 11(9), 1029-1038 (2004). 
116. S. Ren et al., "Molecular Optical Simulation Environment (MOSE): A Platform for the 
Simulation of Light Propagation in Turbid Media," PLOS ONE 8(4), e61304 (2013). 
117. D. J. Smithies, and P. H. Butler, "Modelling the distribution of laser light in port-wine 
stains with the Monte Carlo method," Physics in medicine and biology 40(5), 701 (1995). 
 
143 
 
 
118. T. J. Pfefer et al., "A three-dimensional modular adaptable grid numerical model for light 
propagation during laser irradiation of skin tissue," IEEE Journal of Selected Topics in 
Quantum Electronics 2(4), 934-942 (1996). 
119. H. Funamizu et al., "Simulation of spectral reflectances in human skin tissue using ray 
tracing and GPU-based Monte Carlo method," OPT REV 21(3), 359-363 (2014). 
120. C.-Y. Huang et al., "Novel Wearable and Wireless Ring-Type Pulse Oximeter with 
Multi-Detectors," Sensors 14(9), (2014). 
121. W. Hwang et al., "In Vitro Study of Transcatheter Delivery of a Shape Memory Polymer 
Foam Embolic Device for Treating Cerebral Aneurysms," Journal of Medical Devices 
7(2), 020932-020932-020932 (2013). 
122. P. Diep et al., "Three-dimensional printed optical phantoms with customized absorption 
and scattering properties," Biomed. Opt. Express 6(11), 4212-4220 (2015). 
123. J. Wang et al., "Three-dimensional printing of tissue phantoms for biophotonic imaging," 
Optics Letters 39(10), 3010-3013 (2014). 
124. G. T. Smith et al., "Multimodal 3D cancer-mimicking optical phantom," Biomed. Opt. 
Express 7(2), 648-662 (2016). 
125. M. S. Durkee et al., "Fabrication and Characterization of Optical Tissue Phantoms 
Containing Macrostructure," JoVE 132), e57031 (2018). 
126. N. Mufti et al., "Fiber optic microendoscopy for preclinical study of bacterial infection 
dynamics," Biomed. Opt. Express 2(5), 1121-1134 (2011). 
127. X. Artaechevarria et al., "Evaluation of micro-CT for emphysema assessment in mice: 
comparison with non-radiological techniques," European Radiology 21(5), 954-962 
(2011). 
 
144 
 
 
128. N. L. Ford et al., "Optimization of a retrospective technique for respiratory-gated high 
speed micro-CT of free-breathing rodents," Physics in Medicine and Biology 52(19), 
5749 (2007). 
129. X. Artaechevarria et al., "Airway segmentation and analysis for the study of mouse 
models of lung disease using micro-CT," Physics in Medicine and Biology 54(22), 7009 
(2009). 
130. E. Namati et al., "Longitudinal assessment of lung cancer progression in the mouse using 
in vivo micro-CT imaging," Medical Physics 37(9), 4793-4805 (2010). 
131. W. Mitzner, R. Brown, and W. Lee, "In vivo measurement of lung volumes in mice," 
Physiological Genomics 4(3), 215 (2001). 
132. C. G. Tankersley, R. Rabold, and W. Mitzner, "Differential lung mechanics are 
genetically determined in inbred murine strains," Journal of Applied Physiology 86(6), 
1764 (1999). 
133. C. Irvin, and J. Bates, "Measuring the lung function in the mouse: the challenge of size," 
Respir Res 4(1), 1-9 (2003). 
134. L. Bi et al., "Single-scattering properties of triaxial ellipsoidal particles for a size 
parameter range from the Rayleigh to geometric-optics regimes," Appl. Opt. 48(1), 114-
126 (2009). 
135. M. U. Vera, A. Saint-Jalmes, and D. J. Durian, "Scattering optics of foam," Appl. Opt. 
40(24), 4210-4214 (2001). 
136. D. J. Durian, D. A. Weitz, and D. J. Pine, "Multiple Light-Scattering Probes of Foam 
Structure and Dynamics," Science 252(5006), 686 (1991). 
 
145 
 
 
137. L. Knudsen et al., "Assessment of air space size characteristics by intercept (chord) 
measurement: an accurate and efficient stereological approach," J Appl Physiol 108(2), 
412-421 (2010). 
138. N. L. Ford et al., "Optimization of a retrospective technique for respiratory-gated high 
speed micro-CT of free-breathing rodents," Phys Med Biol 52(19), 5749-5769 (2007). 
139. C. G. Tankersley, R. S. Fitzgerald, and S. R. Kleeberger, "Differential control of 
ventilation among inbred strains of mice," Am J Physiol Regul Integr Comp Physiol 
267(5), R1371-R1377 (1994). 
140. C. G. Tankersley, R. Rabold, and W. Mitzner, "Differential lung mechanics are 
genetically determined in inbred murine strains," J Appl Physiol 86(6), 1764-1769 
(1999). 
141. E. Osmanagic et al., "Quantitative assessment of lung microstructure in healthy mice 
using an MR-based lung morphometry technique," J Appl Physiol 109(6), 1592-1599 
(2010). 
142. "LightTools Biological Materials Library," Synopsys, Inc. (2014). 
143. W. Small et al., "Fabrication and characterization of cylindrical light diffusers comprised 
of shape memory polymer," J. Biomed. Opt. 13(2), 024018 (2008). 
144. "IVIS Lumina System Manual," Xenogen Corporation (2006). 
145. "LightTools Biological Materials Library," Synopsys, Inc. (2014). 
146. M. S. Durkee et al., "Optical model of the murine lung to optimize pulmonary 
illumination," J Biomed Opt 23(7), 071208 (2018). 
 
146 
 
 
147. M. S. Durkee, J. D. Cirillo, and K. C. Maitland, "A Fluorescence Model of the Murine 
Lung for Optical Detection of Pathogenic Bacteria," in SPIE Proceedings, Clinical and 
Preclinical Optical Diagnostics 104110H (2017). 
148. D. Yager et al., "Airway surface liquid thickness as a function of lung volume in small 
airways of the guinea pig," Journal of Applied Physiology 77(5), 2333 (1994). 
149. S. Jayaraman et al., "Noninvasive in vivo fluorescence measurement of airway-surface 
liquid depth, salt concentration, and pH," Journal of Clinical Investigation 107(3), 317-
324 (2001). 
150. M. Zellweger et al., "Absolute autofluorescence spectra of human healthy, metaplastic, 
and early cancerous bronchial tissue in vivo," Appl. Opt. 40(22), 3784-3791 (2001). 
151. Y. Kong et al., "Imaging tuberculosis with endogenous β-lactamase reporter enzyme 
fluorescence in live mice," Proceedings of the National Academy of Sciences 107(27), 
12239-12244 (2010). 
152. J. T. Panteli et al., "Genetically modified bacteria as a tool to detect microscopic solid 
tumor masses with triggered release of a recombinant biomarker," Integrative biology : 
quantitative biosciences from nano to macro 7(4), 423-434 (2015). 
153. N. C. Shaner et al., "Improved monomeric red, orange and yellow fluorescent proteins 
derived from Discosoma sp. red fluorescent protein," Nature Biotechnology 22(1567 
(2004). 
154. N. Soundrarajan et al., "Green fluorescent protein as a scaffold for high efficiency 
production of functional bacteriotoxic proteins in Escherichia coli," Scientific Reports 
6(20661 (2016). 
 
147 
 
 
155. M. S. Durkee, J. D. Cirillo, and K. C. E. D. B. J. Maitland, "A Fluorescence Model of the 
Murine Lung for Optical Detection of Pathogenic Bacteria," in SPIE Proceedings, 
Clinical and Preclinical Optical Diagnostics 104110H (2017). 
156. B. Marais et al., "A proposed radiological classification of childhood intra-thoracic 
tuberculosis," Pediatr Radiol 34(11), 886-894 (2004). 
157. P. Piccini et al., "Clinical peculiarities of tuberculosis," BMC Infectious Diseases 14(1), 
S4 (2014). 
158. H. J. Zar et al., "Induced sputum versus gastric lavage for microbiological confirmation 
of pulmonary tuberculosis in infants and young children: a prospective study," The 
Lancet 365(9454), 130-134 (2005). 
159. M. R. Boloursaz et al., "Radiologic Manifestation of Pulmonary Tuberculosis in Children 
Admitted in Pediatric Ward-Massih Daneshvari Hospital: A 5-Year Retrospective 
Study," Acta Medica Iranica; Vol Vol. 48, No No. 4 (2010). 
160. S. K. Sharma et al., "Miliary tuberculosis: new insights into an old disease," The Lancet 
Infectious Diseases 5(7), 415-430 (2005). 
161. P. J. Dodd, C. Sismanidis, and J. A. Seddon, "Global burden of drug-resistant 
tuberculosis in children: a mathematical modelling study," The Lancet Infectious 
Diseases 16(10), 1193-1201 (2016). 
162. P. Glaziou et al., "Global Epidemiology of Tuberculosis," Cold Spring Harbor 
Perspectives in Medicine 5(2), (2015). 
163. S. K. Sharma et al., "Cytokine Polarization in Miliary and Pleural Tuberculosis," Journal 
of Clinical Immunology 22(6), 345-352 (2002). 
164. P. D. O. Davies, "The mycobacterioses," Imaging (09656812) 20(4), 252-263 (2008). 
 
148 
 
 
165. P. J. Sime, E. R. Chilvers, and A. G. Leitch, "Miliary tuberculosis in edinburgh—A 
comparison between 1984–1992 and 1954–1967," Respiratory Medicine 88(8), 609-611 
(1994). 
166. S. Menitove, and H. W. Harris, "Miliary Tuberculosis," in Tuberculosis D. Schlossberg, 
Ed., pp. 179-189, Springer New York, New York, NY (1988). 
167. G. Davies, and L. Reid, "Growth of the alveoli and pulmonary arteries in childhood," 
Thorax 25(6), 669-681 (1970). 
  
 
149 
 
 
APPENDIX A 
 
Listed below are the inputs to the fluorescence model of murine infection including mouse tissue 
optical properties, tissue autofluorescence spectra, and bacteria fluorescence spectra.  
Lung optical properties 
Refractive Index 1.396        
Tissue Reduced MFP (mm) Tissue Transmissivity (T) Alveoli 
λ (nm) Healthy Infected λ (nm) Healthy Infected λ (nm) MFP (mm) T 
469 0.2608 0.3097 469 0.9707 0.9465 400 0.1530 1 
493 0.1940 0.2428 493 0.9701 0.9249 420 0.1539 1 
517 0.2044 0.2629 517 0.9666 0.9141 440 0.1547 1 
541 0.1971 0.2443 541 0.9595 0.8704 460 0.1549 1 
565 0.1878 0.2915 565 0.9596 0.8652 480 0.1548 1 
589 0.1703 0.2741 589 0.9654 0.8666 500 0.1544 1 
613 0.1600 0.2921 613 0.9827 0.9323 520 0.1538 1 
637 0.1940 0.3112 637 0.9857 0.9514 540 0.1531 1 
661 0.1935 0.3305 661 0.9880 0.9609 560 0.1525 1 
685 0.2074 0.3113 685 0.9878 0.9649 580 0.1520 1 
709 0.1985 0.3433 709 0.9901 0.9672 600 0.1513 1 
733 0.2260 0.3540 733 0.9897 0.9736 620 0.1508 1 
757 0.2126 0.3531 757 0.9827 0.9650 640 0.1505 1 
781 0.2606 0.3870 781 0.9897 0.9681 660 0.1503 1 
805 0.2124 0.3530 805 0.9876 0.9714 680 0.1502 1 
829 0.3155 0.3373 829 0.9860 0.9740 700 0.1503 1 
853 0.2667 0.3736 853 0.9883 0.9902 720 0.1506 1 
877 0.5125 0.3826 877 0.9939 0.9897 740 0.1507 1 
901 5.8662 0.2931 901 1.0000 0.9991 760 0.1508 1 
      780 0.1511 1 
      800 0.1513 1 
      820 0.1517 1 
      840 0.1522 1 
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Heart optical properties 
Refractive Index 1.371  
λ (nm) MFP (mm) Transmissivity 
665 0.0080 0.8781 
685 0.0071 0.7672 
960 0.0198 0.7528 
 
Bulk tissue optical properties 
Refractive Index 1.396  
λ (nm) MFP(mm) Transmissivity 
665 3.0613 0.8990 
685 3.2191 0.9010 
960 4.7971 0.9430 
 
  Tissue Autofluorescence 
Absorption  
λ (nm) Absorption Value 
490 0.2380 
505 0.2143 
520 0.1930 
535 0.1737 
550 0.1564 
565 0.1408 
580 0.1268 
595 0.1141 
610 0.1028 
625 0.0925 
640 0.0833 
655 0.0750 
670 0.0675 
685 0.0608 
700 0.0547 
715 0.0493 
730 0.0444 
745 0.0399 
760 0.0360 
775 0.0324 
790 0.0292 
805 0.0262 
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Tissue Autofluorescence 
Particle number density 1e4-1e5 /mm^3       
Particle radius 1000 nm        
Conversion Efficiency (all λ) 1        
Em. λ\Ex. 
λ 480 500 520 540 560 580 600 
560 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
580 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 
600 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 
620 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 
640 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 
660 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 
680 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 
700 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 
720 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 
740 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 
760 0.0001 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 
780 0.0001 0.0001 0.0004 0.0011 0.0031 0.0087 0.0300 
800 0.0000 0.0001 0.0001 0.0004 0.0011 0.0031 0.0087 
820 0.0000 0.0000 0.0001 0.0001 0.0004 0.0011 0.0031 
840 0.0000 0.0000 0.0000 0.0001 0.0001 0.0004 0.0011 
860 0.0000 0.0000 0.0000 0.0000 0.0001 0.0001 0.0004 
880 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 0.0001 
900 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0001 
920 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
940 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
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Tissue Autofluorescence (cont'd) 
Em. λ\ 
Ex. λ 620 640 660 680 700 720 740 760 780 
560 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
580 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
600 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
620 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
640 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
660 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
680 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
700 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
720 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
740 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
760 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 0.0000 
780 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 0.0000 
800 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 0.0000 
820 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 0.0000 
840 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 0.0000 
860 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 0.9900 
880 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 0.8520 
900 0.0001 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 0.4910 
920 0.0001 0.0001 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 0.2190 
940 0.0000 0.0001 0.0001 0.0004 0.0011 0.0031 0.0087 0.0300 0.0810 
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tdTomato Fluorescence  CNIR REF Probe Fluorescence 
Particle number 
density 
1- 1e7/mm3  
Particle number 
density 
1-1e7 /mm3 
Particle radius 1500 nm  Particle radius 1500 nm 
Conversion Efficiency 
(all λ) 
1  
Conversion Efficiency 
(all λ) 
1 
Em. WL\Ex. WL 535  Em. WL\Ex. WL 730 
490 0.275  750 0.606531 
500 0.498  760 0.726149 
510 0.705  770 0.83527 
520 0.857  780 0.923116 
530 0.941  790 0.9801 
540 0.977  800 1 
550 0.99  810 0.982199 
560 0.99  820 0.923116 
570 0.974  830 0.83527 
580 0.995  840 0.726149 
590 0.852  850 0.606531 
600 0.76  860 0.486752 
610 0.677  870 0.375311 
620 0.583  880 0.278037 
630 0.491  890 0.197899 
640 0.407  900 0.135335 
650 0.333  910 0.088922 
660 0.274  920 0.056135 
670 0.219    
680 0.174    
690 0.139    
700 0.104    
710 0.081    
720 0.065    
730 0.049    
740 0.039    
750 0.03    
760 0.02    
770 0.016    
780 0.009    
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APPENDIX B 
Appendix B contains the code for the multi-layer concentric sphere model. 
clc; 
%demoMie_shell_constant_ASL_vol.m 
% 
% Demonstrate use of Maetzler's MATLAB Mie calculation. 
% Plots scattering, anisotropy, and reduced scattering  
% for a range of wavelengths and range of particle diameters. 
% - Steven Jacques 2009 
% 
% Christian Maetzler,  
% MATLAB Functions for Mie Scattering and Absorption 
% University of Bern, Institut fuer Angewandte Physik, 
% Research Report No. 2002-08,June, 2002  
% http://arrc.ou.edu/~rockee/NRA_2007_website/Mie-scattering-Matlab.pdf 
  
% Corrected some errors, added table printing function in getMieScatter.m 
% -Rob Brown, Rockwell Collins, June 2017 
    %home 
    %disp('=============') 
    %disp('lambda outer dia inner dia rho mus g ')  %header for printing 
table of interesting parameters for use elsewhere... 
%disp('lambda dia rho npar nmed real(m) imag(m) x qext qsca qabs qb asy 
qratio mus g musp') 
  
% Converted eqs. to concentric sphere Mie scattering model in mie_abcd.m file 
% Other nested functions adjusted to account for extra inputs  
% New file names: demoMie_shell.m, getMieScatter_shell.m, mie_shell.m, 
% mie_abcd_shell.m 
% - Madeleine S. Durkee, October 2017 
  
% Adapted shell model to maintain constant shell volume when OD changes 
% New file names: demoMie_shell_constant_ASL_vol.m, demoMie_shell_loop.m 
% - Madeleine S. Durkee, February 2018 
  
  
%%%% 
% USER CHOICES 
%%% 
%% tissue model 
  
n_med = 1.4; 
n_par = 1.00; 
n_shell = 1.33; 
fv = [0.62 0.77 0.81 0.88]; 
  
outdia = [157.81 198.82 214.17 269.84]; 
asl_vol = (4/3)*pi*((outdia(3)/2)^3-((outdia(3)/2)-0.005*(outdia(3)/2))^3); 
d = zeros(1,4); 
for index = 0:3 
    d(index+1) = (outdia(index+1)/2)-((outdia(index+1)/2)^3-
(3*asl_vol/(4*pi)))^(1/3); 
 
155 
 
 
end 
% inner_diadia2 = zeros(length(outer_diadia),length(d)); 
%  
% for index = 1:length(d) 
%     for index2 = 1:length(outer_diadia) 
%         inner_diadia2(index,index2) = outer_diadia(index)-d(index2); 
%     end 
% end 
  
%change n, vf, outer dia, inner dia 
  
l_outerdia = length(outdia); 
Lambda = zeros(1,451); 
MusGP = zeros(451,l_outerdia,3); 
  
for ii = 1:4 
    india(ii) = outdia(ii)-2*d(ii); 
    [Lambda,MusGP(:,ii,:)] = 
demoMie_shell_loop(n_med,n_par,n_shell,fv(ii),outdia(ii),india(ii)); 
end 
             
            %% plot results 
figure(2);clf 
clr = 'rgbmckyrb'; 
sz  = 14; 
  
yname(1).s = '\mu_s [cm^{-1}]'; 
yname(2).s = 'g [-]'; 
yname(3).s = '\mu_s'' [cm^{-1}]'; 
ymax = [3000 1 400]; 
  
for k=1:3 
  
    subplot(3,1,k) 
    for j=1:l_outerdia 
        switch j 
            case 1 
                name = 'no ASL, V_{Tmax}'; 
            case 2 
                name = 'RV'; 
            case 3 
                name = 'FRC'; 
            case 4 
                name = 'V_{Tmax}'; 
            case 5 
                name = 'TLC'; 
         end 
        plot(Lambda, MusGP(:,j,k),[clr(j) '-'],'DisplayName',name) 
        hold on 
        y = ymax(k); dy = y/10; x = mean(Lambda); 
  
    end 
    set(gca,'fontsize',sz) 
    xlabel('wavelength \lambda [\mum]') 
    ylabel(yname(k).s) 
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end 
 
 
function [lambdalambda,musgp] = 
demoMie_shell_loop(nmed,npar,nshell,vf,outer_diadia,inner_diadia); 
  
lambdalambda = .4:.001:.85; % [um] (starting wavelength, interval, ending 
wavelength) 
%outer_diadia = [50 75 100 150 200 250]'; % [um]  list them, [a b c]  
%inner_diadia = [50 75 100 150 200 250]';%[155.33 155.25 155.15 154.35 153.85 
153.35]'; % [um]  list them, [a b c], must be less than outer_diadia 
  
musgp = zeros(length(lambdalambda),1,3); 
  
  
    out_dia = outer_diadia; 
    in_dia = inner_diadia; 
     
    for i=1:length(lambdalambda) 
        lambda = lambdalambda(i); 
  
        [musgp(i,1,:)] = getMieScatter_shell(lambda, out_dia, in_dia, vf, 
npar, nmed, nshell); 
         
  
    end % i 
     
end  
 
clc; 
%demoMie.m 
% 
% Demonstrate use of Maetzler's MATLAB Mie calculation. 
% Plots scattering, anisotropy, and reduced scattering  
% for a range of wavelengths and range of particle diameters. 
% - Steven Jacques 2009 
% 
% Christian Maetzler,  
% MATLAB Functions for Mie Scattering and Absorption 
% University of Bern, Institut fuer Angewandte Physik, 
% Research Report No. 2002-08,June, 2002  
% http://arrc.ou.edu/~rockee/NRA_2007_website/Mie-scattering-Matlab.pdf 
  
% Corrected some errors, added table printing function in getMieScatter.m 
% -Rob Brown, Rockwell Collins, June 2017 
    %home 
    %disp('=============') 
    %disp('lambda outer dia inner dia rho mus g ')  %header for printing 
table of interesting parameters for use elsewhere... 
%disp('lambda dia rho npar nmed real(m) imag(m) x qext qsca qabs qb asy 
qratio mus g musp') 
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% Converted eqs. to concentric sphere Mie scattering model in mie_abcd.m file 
% Other nested functions adjusted to account for extra inputs  
% New file names: demoMie_shell.m, getMieScatter_shell.m, mie_shell.m, 
% mie_abcd_shell.m 
% - Madeleine S. Durkee, October 2017 
  
%%%% 
% USER CHOICES 
%%% 
  
nmed = 1.40; % medium refractive index (air) 
npar = 1.00; % particle refractive index (water) 
nshell = 1.33; % shell refractive index glass or surfactant 
vf   = 0.81; % volume fraction of spheres in medium (PAY ATTENTION TO THIS. 
Rho (concentration) changes with particle size!) 
  
lambdalambda = .4:.001:.85; % [um] (starting wavelength, interval, ending 
wavelength) 
outer_diadia = [67.39]'; % [um]  list them, [a b c]  
inner_diadia = [67.39 67.37 67.29 67.19 66.39 65.39]';%[155.33 155.25 155.15 
154.35 153.85 153.35]'; % [um]  list them, [a b c], must be less than 
outer_diadia 
  
musgp = zeros(length(lambdalambda),length(outer_diadia),3); 
  
for j=1:length(inner_diadia) 
    out_dia = outer_diadia; 
    in_dia = inner_diadia(j); 
     
    for i=1:length(lambdalambda) 
        lambda = lambdalambda(i); 
  
        [musgp(i,j,:)] = getMieScatter_shell(lambda, out_dia, in_dia, vf, 
npar, nmed, nshell); 
         
  
    end % i 
     
end % j 
  
%% plot results 
figure(2);clf 
clr = 'rgbmckyrb'; 
sz  = 14; 
  
yname(1).s = '\mu_s [cm^{-1}]'; 
yname(2).s = 'g [-]'; 
yname(3).s = '\mu_s'' [cm^{-1}]'; 
ymax = [3000 1 400]; 
  
for k=1:3 
  
    subplot(3,1,k) 
    for j=1:length(inner_diadia) 
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        switch j 
            case 1 
                name = 'no shell'; 
            case 2 
                name = '10 nm'; 
            case 3 
                name = '50 nm'; 
            case 4 
                name = '100 nm'; 
            case 5 
                name = '500 nm'; 
            case 6 
                name = '1000 nm'; 
            case 7 
                name = '150 um'; 
            case 8 
                name = '200 um'; 
            case 9 
                name = '250 um'; 
         end 
        plot(lambdalambda, musgp(:,j,k),[clr(j) '-'],'DisplayName',name) 
        hold on 
        y = ymax(k); dy = y/10; x = mean(lambdalambda); 
  
    end 
    set(gca,'fontsize',sz) 
    xlabel('wavelength \lambda [\mum]') 
    ylabel(yname(k).s) 
end 
  
disp('done') 
 
function [musgp] = getMieScatter_shell(lambda, out_dia, in_dia, fv, 
npar,nmed,nshell) 
% function musgp = getMieScatter(lambda, dia, fv) 
%  fv            = volume fraction of spheres in medium (eg., fv = 0.05) 
%  lambda        = wavelength in um (eg., lambda = 0.633) 
%  dia           = sphere diameter in um (eg., dia_um = 0.0500) 
%  npar          = particle refractive index (eg. polystyrene = 1.57) 
%  nmed          = medium refractive index (eg., water = 1.33) 
%                  Note: npar and nmed can be imaginary numbers. 
%  returns musgp = [mus g musp]   
%       mus      = scattering coefficient [cm^-1] 
%       g        = anisotropy of scattering [dimensionless] 
%       musp     = reduced scattering coefficient [cm^-1] 
%  Uses 
%       Mie.m, which uses mie_abcd.m, from Maetzler 2002 
%        
% - Steven Jacques, 2009 
  
% Corrected some errors, added table format printing of selected 
% parameters. -Rob Brown, Rockwell Collins, June 2017 
  
V1 = 4/3*pi*(out_dia/2)^3;     % volume 1 
 
159 
 
 
V2 = 4/3*pi*(in_dia/2)^3;     % volume inner sphere 
V3 = V1-V2;                     % volume of shell 
  
d_shell = (out_dia-in_dia)/2;       % thickness of shell 
r_in = in_dia/2; 
  
rho     = fv/V1;           % #/um^3, concentration of spheres 
  
m_13 = npar/nmed;                  % ratio of refractive indices 
m_23 = nshell/nmed; 
  
x_1 = pi*in_dia/(lambda/nmed);       % ratio circumference/wavelength in 
medium 
x_2 = pi*out_dia/(lambda/nmed); 
  
if r_in == 0; 
    r_in = out_dia/2; 
    x_1 = x_2; 
    m_13 = m_23; 
end 
  
[u] = mie_shell(m_13, m_23, x_1, x_2, r_in);  % <----- Matzler's subroutine 
u = u'; 
  
% u = [real(m_13) imag(m_13) real(m_23) imag(m_23) x_1 x_2 qext qsca qabs qb 
asy qratio]; 
%% edited through here 20171027 
qsca = u(8);                    % scattering efficiency, Qsca 
g    = u(11);                    % anisotropy, g 
  
A       = pi*out_dia^2/4;       % geometrical cross-sectional area, um^2 
sigma_s = qsca*A;               % scattering cross-section, um^2 
mus     = sigma_s*rho*1e4;      % scattering coeff. cm^-1 
musp    = mus*(1-g);            % reduced scattering coeff. cm^-1 
  
if 0 % 1 = print full report, 0 = disable 
    disp('----- choice:') 
    fprintf('lambda  \t= %0.3f um\n', lambda) 
    fprintf('out_dia     \t= %0.3f um\n', out_dia) 
    fprintf('in_dia    \t= %0.3f\n', in_dia) 
    fprintf('rho     \t= %0.3f #/um^3\n', rho) 
    fprintf('npar    \t= %0.3f\n', npar) 
    fprintf('nmed    \t= %0.3f\n', nmed) 
    fprintf('nshell    \t= %0.3f\n', nshell) 
    disp('----- result:') 
    fprintf('real(m_13) \t= %0.3f\n', u(1)) 
    fprintf('imag(m_13) \t= %0.3f\n', u(2)) 
    fprintf('real(m_23) \t= %0.3e\n', u(3)) 
    fprintf('imag(m_23) \t= %0.3f\n', u(4)) 
    fprintf('x_1       \t= %0.3e\n', u(5)) 
    fprintf('x_2       \t= %0.3e\n', u(6)) 
    fprintf('qext    \t= %0.3e\n', u(7)) 
    fprintf('qsca    \t= %0.3e\n', u(8)) 
    fprintf('qabs    \t= %0.3e\n', u(9)) 
    fprintf('qb      \t= %0.3e\n', u(10)) 
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    fprintf('asy     \t= %0.4f\n', u(11)) 
    fprintf('qratio  \t= %0.3e\n', u(12)) 
    disp('----- optical properties:') 
    fprintf('mus     \t= %0.3f cm^-1\n', mus) 
    fprintf('g       \t= %0.4f\n', g) 
    fprintf('musp    \t= %0.3f cm^-1\n', musp) 
end 
%Print the just parameters you want, in table format. Mod header from 
%demoMie (line 15) to properly label columns 
%fprintf('%0.3f %0.3f %0.3f %0.3f %0.3f %0.3f %0.3f %0.3f %0.3f %0.3f %0.3f 
%0.3f %0.3f %0.3f %0.3f %0.3f %0.3f  \n', lambda, dia, rho, npar, nmed, 
u(1),u(2),u(3),u(4),u(5),u(6),u(7),u(8),u(9), mus, g, musp) 
%fprintf('%0.3f %0.3f %0.3f %0.6f %0.3f %0.3f \n', lambda, out_dia, in_dia, 
rho, mus, g) 
  
musgp= real([mus g musp]); 
 
function [result] = mie_shell(m_13, m_23, x_1, x_2, r_in) 
  
% Computation of Mie Efficiencies for given 
% complex refractive-index ratio m=m'+im" 
% and size parameter x=k0*a, where k0= wave number in ambient 
% medium, a=sphere radius, using complex Mie Coefficients 
% an and bn for n=1 to nmax, 
% s. Bohren and Huffman (1983) BEWI:TDD122, p. 103,119-122,477. 
% Result: m', m", x, efficiencies for extinction (qext), 
% scattering (qsca), absorption (qabs), backscattering (qb), 
% asymmetry parameter (asy=<costeta>) and (qratio=qb/qsca). 
% Uses the function "mie_abcd" for an and bn, for n=1 to nmax. 
% C. MŠtzler, May 2002. 
  
if x_2==0 % To avoid a singularity at x=0 
    result=[real(m_13) imag(m_13) real(m_23) imag(m_23) 0 0 0 0 0 0 1.5]; 
elseif x_2>0 % This is the normal situation 
    % summation terms 
    nmax=round(2+x_2+4*x_2^(1/3)); 
    n1=nmax-1; 
    n=(1:nmax); 
    % coefficient for E and B fields 
    cn=2*n+1; c1n=n.*(n+2)./(n+1); c2n=cn./n./(n+1); 
    % size parameter squared 
    x1_2 = x_1*x_1; 
    x2_2=x_2*x_2; 
    % get Mie coefficients 
    f=mie_abcd_shell(m_13, m_23, x_1, x_2, r_in); 
    % real and imaginary parts of an_in coefficient 
    anp=(real(f(1,:))); anpp=(imag(f(1,:))); 
    % real and imaginary parts of an_out coefficient 
    bnp=(real(f(2,:))); bnpp=(imag(f(2,:))); 
%     % real and imaginary parts of bn_in coefficient 
%     bnp_in=(real(f(3,:))); bnpp_in=(imag(f(3,:))); 
%     % real and imaginary parts of bn_out coefficient 
%     bnp_out=(real(f(4,:))); bnpp_out=(imag(f(4,:))); 
    g1(1:4,nmax)=[0; 0; 0; 0]; % displaced numbers used for 
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    g1(1,1:n1)=anp(2:nmax); % asymmetry parameter, p. 120 
    g1(2,1:n1)=anpp(2:nmax); 
    g1(3,1:n1)=bnp(2:nmax); 
    g1(4,1:n1)=bnpp(2:nmax); 
    dn=cn.*(anp+bnp); % real part of sum of a_n and b_n  
    q=sum(dn); 
    qext=2*q/x2_2; % extinction coefficient; based on size parameter of 
larger r 
    en=cn.*(anp.*anp+anpp.*anpp+bnp.*bnp+bnpp.*bnpp); % sum or magnitudes of 
a_n and b_n 
    q=sum(en); % re-establish q 
    qsca=2*q/x2_2; % scattering coefficient; based on size parameter of 
larger r 
    qabs=qext-qsca; 
    fn=(f(1,:)-f(2,:)).*cn; 
    gn=(-1).^n; 
    test=fn.*gn; 
    q=sum(test); 
    qb=q*q'/x2_2; 
    % asymmetry parameter 
    asy1=c1n.*(anp.*g1(1,:)+anpp.*g1(2,:)+bnp.*g1(3,:)+bnpp.*g1(4,:)); 
    asy2=c2n.*(anp.*bnp+anpp.*bnpp); 
    asy=4/x2_2*sum(asy1+asy2)/qsca; 
    qratio=qb/qsca; 
    % result gives real and imaginary parts of refractive index for each 
layer, size 
    % parameter for each layer, extinction efficiency, scattering efficiency, 
backscatter 
    % efficiency, asymmetry parameter, and ratio of backscatter efficiency 
    % to scattering efficiency 
    result=[real(m_13) imag(m_13) real(m_23) imag(m_23) x_1 x_2 qext qsca 
qabs qb asy qratio]; 
end; 
 
function result = mie_abcd_shell(m_13, m_23, x_1, x_2,r_in) 
  
% Computes a matrix of Mie coefficients, a_n, b_n, c_n, d_n, 
% of orders n=1 to nmax, complex refractive index m=m'+im", 
% and size parameter x=k0*a, where k0= wave number 
% in the ambient medium, a=sphere radius; 
% p. 100, 477 in Bohren and Huffman (1983) BEWI:TDD122 
% C. MŠtzler, June 2002 
  
% terms of summation 
nmax=round(2+x_2+4*x_2^(1/3));  
n=(1:nmax);  
% Step for spherical Bessel and Hankel functions 
nu = (n+0.5); 
% ratio of circumference to wavelength in particle layer 
a = x_1; 
v = x_2; 
N1 = m_13; 
N2 = m_23; 
N1a = N1.*a; 
N1v = N1.*v; 
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N2a = N2.*a; 
N2v = N2.*v; 
% Y terms 
Y1 = (m_13.*a)./r_in; 
Y2 = (m_23.*a)./r_in; 
Y3 = a./r_in; 
% Bessel coefficients 
sqa = sqrt(0.5*pi./a); 
sqv = sqrt(0.5*pi./v); 
sqN1a = sqrt(0.5*pi./N1a); 
sqN1v = sqrt(0.5*pi./N1v); 
sqN2a = sqrt(0.5*pi./N2a); 
sqN2v = sqrt(0.5*pi./N2v); 
% bessel fn of first kind 
ba = besselj(nu,a).*sqa; 
bv = besselj(nu,v).*sqv; 
bN1a = besselj(nu,N1a).*sqN1a; 
bN1v = besselj(nu,N1v).*sqN1v; 
bN2a = besselj(nu,N2a).*sqN2a; 
bN2v = besselj(nu,N2v).*sqN2v; 
% bessel fn of second kind 
ba2 = bessely(nu,a).*sqa; 
bv2 = bessely(nu,v).*sqv; 
bN1a2 = bessely(nu,N1a).*sqN1a; 
bN1v2 = bessely(nu,N1v).*sqN1v; 
bN2a2 = bessely(nu,N2a).*sqN2a; 
bN2v2 = bessely(nu,N2v).*sqN2v; 
% Hankel fn of first kind  
ha = ba+1i.*ba2; 
hv = bv+1i.*bv2; 
hN1a = bN1a+1i.*bN1a2; 
hN1v = bN1v+1i.*bN1v2; 
hN2a = bN2a+1i.*bN2a2; 
hN2v = bN2v+1i.*bN2v2; 
% derivative term, bessel fn of first kind 
dba = [sin(a)/a, ba(1:nmax-1)]; 
dbv = [sin(v)/v, bv(1:nmax-1)]; 
dbN1a = [sin(N1a)/N1a, bN1a(1:nmax-1)]; 
dbN1v = [sin(N1v)/N1v, bN1v(1:nmax-1)]; 
dbN2a = [sin(N2a)/N2a, bN2a(1:nmax-1)]; 
dbN2v = [sin(N2v)/N2v, bN2v(1:nmax-1)]; 
% derivative term, bessel fn of second kind 
dba2 = [-cos(a)/a, ba2(1:nmax-1)]; 
dbv2 = [-cos(v)/v, bv2(1:nmax-1)]; 
dbN1a2 = [-cos(N1a)/N1a, bN1a2(1:nmax-1)]; 
dbN1v2 = [-cos(N1v)/N1v, bN1v2(1:nmax-1)]; 
dbN2a2 = [-cos(N2a)/N2a, bN2a2(1:nmax-1)]; 
dbN2v2 = [-cos(N2v)/N2v, bN2v2(1:nmax-1)]; 
% derivative term, hankel 
dha = dba+1i.*dba2; 
dhv = dbv+1i.*dbv2; 
dhN1a = dbN1a+1i.*dbN1a2; 
dhN1v = dbN1v+1i.*dbN1v2; 
dhN2a = dbN2a+1i.*dbN2a2; 
dhN2v = dbN2v+1i.*dbN2v2; 
% eta functions; bessel 
eta1_a = (a.*dba-n.*ba)./a; 
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eta1_v = (v.*dbv-n.*bv)./v; 
eta1_N1a = (N1a.*dbN1a-n.*bN1a)./N1a; 
eta1_N1v = (N1v.*dbN1v-n.*bN1v)./N1v; 
eta1_N2a = (N2a.*dbN2a-n.*bN2a)./N2a; 
eta1_N2v = (N2v.*dbN2v-n.*bN2v)./N2v; 
% eta functions; hankel 
eta3_a = (a.*dha-n.*ha)./a; 
eta3_v = (v.*dhv-n.*hv)./v; 
eta3_N1a = (N1a.*dhN1a-n.*hN1a)./N1a; 
eta3_N1v = (N1v.*dhN1v-n.*hN1v)./N1v; 
eta3_N2a = (N2a.*dhN2a-n.*hN2a)./N2a; 
eta3_N2v = (N2v.*dhN2v-n.*hN2v)./N2v; 
  
% solution terms 
A1 = (Y2.^2).*eta1_N1a.*(bN2v.*hN2a-
bN2a.*hN2v)+Y1.*Y2.*bN1a.*(eta1_N2a.*hN2v-eta3_N2a.*bN2v); 
A2 = Y2.*eta1_N1a.*(bN2a.*eta3_N2v-
hN2a.*eta1_N2v)+Y1.*bN1a.*(eta1_N2v.*eta3_N2a-eta1_N2a.*eta3_N2v); 
A3 = (Y2.^2).*bN1a.*(eta1_N2v.*eta3_N2a-
eta1_N2a.*eta3_N2v)+Y1.*Y2.*eta1_N1a.*(bN2a.*eta3_N2v-hN2a.*eta1_N2v); 
A4 = Y2.*bN1a.*(eta1_N2a.*hN2v-eta3_N2a.*bN2v)+Y1.*eta1_N1a.*(bN2v.*hN2a-
bN2a.*hN2v); 
  
an = -(eta1_v.*A1+Y3.*bv.*A2)./(eta3_v.*A1+Y3.*hv.*A2); 
bn = -(bv.*A3+Y3.*eta1_v.*A4)./(hv.*A3+Y3.*eta3_v.*A4); 
  
result = [an; bn]; 
end 
